Document and Entity Information
Document and Entity Information - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 01, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Transition Report | false | ||
Entity File Number | 1-5467 | ||
Entity Registrant Name | VALHI, INC. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 87-0110150 | ||
Entity Address, Address Line One | 5430 LBJ Freeway | ||
Entity Address, Address Line Two | Suite 1700 | ||
Entity Address, City or Town | Dallas | ||
Entity Address, State or Province | TX | ||
Entity Address, Postal Zip Code | 75240-2620 | ||
City Area Code | 972 | ||
Local Phone Number | 233-1700 | ||
Title of 12(b) Security | Common stock | ||
Trading Symbol | VHI | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Financial Statement Error Correction [Flag] | true | ||
Document Financial Statement Restatement Recovery Analysis [Flag] | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 31.2 | ||
Entity Common Stock, Shares Outstanding | 28,288,493 | ||
Documents Incorporated by Reference | The information required by Part III is incorporated by reference from the Registrant’s definitive proxy statement to be filed with the Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this report. | ||
Entity Central Index Key | 0000059255 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Firm ID | 238 | ||
Auditor Location | Dallas, Texas |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 407 | $ 478.5 |
Restricted cash equivalents | 22.6 | 46.3 |
Marketable securities | 56.1 | 75.1 |
Accounts and other receivables, net | 321.1 | 271 |
Receivables from affiliates | $ 17.5 | $ 2.9 |
Other Receivable, after Allowance for Credit Loss, Current, Related Party, Type [Extensible Enumeration] | Related Party | Related Party |
Refundable income taxes | $ 1.8 | $ 8 |
Inventories, net | 596.1 | 640.8 |
Prepaid expenses and other | 53.2 | 66.9 |
Total current assets | 1,475.4 | 1,589.5 |
Other assets: | ||
Marketable securities | 4.8 | 1.2 |
Investment in TiO2 manufacturing joint venture | 111 | 112.9 |
Goodwill | 379.7 | 379.7 |
Deferred income taxes | 67 | 40.5 |
Pension asset | 8.1 | 9.3 |
Other assets | 173.7 | 178.8 |
Total other assets | 744.3 | 722.4 |
Property and equipment: | ||
Land | 45.1 | 42.5 |
Buildings | 271.2 | 249.2 |
Equipment | 1,179.4 | 1,106.5 |
Mining properties | 89.2 | 78.6 |
Construction in progress | 23.6 | 77.2 |
Gross property and equipment | 1,608.5 | 1,554 |
Less accumulated depreciation and amortization | 1,091.2 | 1,030.2 |
Net property and equipment | 517.3 | 523.8 |
Total assets | 2,737 | 2,835.7 |
Current liabilities: | ||
Current maturities of long-term debt | 0.7 | 1.8 |
Accounts payable | 228.5 | 199.4 |
Accrued liabilities | 220.3 | 243.6 |
Accrued litigation settlement | 11.8 | 11.8 |
Payables to affiliates | $ 30.1 | $ 22.9 |
Other Liability, Current, Related Party, Type [Extensible Enumeration] | Related Party | Related Party |
Income taxes | $ 15.7 | $ 13.3 |
Total current liabilities | 507.1 | 492.8 |
Noncurrent liabilities: | ||
Long-term debt | 545.8 | 557.7 |
Deferred income taxes | 31.8 | 63.5 |
Long-term litigation settlement | 16.1 | 27.4 |
Accrued pension costs | 151.6 | 131.6 |
Accrued environmental remediation and related costs | 93.2 | 93.5 |
Other liabilities | 111.4 | 129 |
Total noncurrent liabilities | 968.4 | 1,036.1 |
Equity: | ||
Preferred stock, $.01 par value; 500,000 shares authorized, none issued | ||
Common stock, $.01 par value; 50.0 million shares authorized; 29.6 million shares issued and outstanding | 0.3 | 0.3 |
Additional paid-in capital | 669.5 | 669.5 |
Retained earnings | 461.1 | 482.3 |
Accumulated other comprehensive loss | (145.5) | (143.9) |
Treasury stock, at cost - 1.1 million shares | (49.6) | (49.6) |
Total Valhi stockholders' equity | 935.8 | 958.6 |
Noncontrolling interest in subsidiaries | 325.7 | 348.2 |
Total equity | 1,261.5 | 1,306.8 |
Total liabilities and equity | 2,737 | 2,835.7 |
Commitments and contingencies (Notes 9, 14, 17 and 18) | ||
Related Party | ||
Current assets: | ||
Receivables from affiliates | 17.5 | 2.9 |
Current liabilities: | ||
Payables to affiliates | 30.1 | 22.9 |
Noncurrent liabilities: | ||
Payable to affiliate - income taxes | $ 18.5 | $ 33.4 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 500,000 | 500,000 |
Preferred stock, shares issued | 0 | 0 |
Common stock, par value | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 50,000,000 | 50,000,000 |
Common stock, shares issued | 29,600,000 | 29,600,000 |
Common stock, shares outstanding | 29,600,000 | 29,600,000 |
Treasury stock, shares | 1,100,000 | 1,100,000 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues and other income: | |||
Net sales | $ 1,921.7 | $ 2,222.5 | $ 2,296.4 |
Other income, net | 55.4 | 43.7 | 39 |
Total revenues and other income | 1,977.1 | 2,266.2 | 2,335.4 |
Cost and expenses: | |||
Cost of sales | 1,676.5 | 1,732.1 | 1,716.2 |
Selling, general and administrative | 277.4 | 304 | 311.9 |
Other components of net periodic pension and OPEB expense | 11.8 | 13.9 | 17 |
Loss on sale of Basic Power Company (BPC) | 2.6 | ||
Water system fixed asset impairment | 16.4 | ||
Loss on deconsolidation of Basic Water Company (BWC) | (2) | ||
Interest | 28.3 | 27.9 | 32.5 |
Total costs and expenses | 1,996.6 | 2,096.3 | 2,077.6 |
Income (loss) before income taxes | (19.5) | 169.9 | 257.8 |
Income tax expense (benefit) | (22.4) | 33.8 | 60.1 |
Net income | 2.9 | 136.1 | 197.7 |
Noncontrolling interest in net income of subsidiaries | 15 | 45.9 | 70.5 |
Net income (loss) attributable to Valhi stockholders | $ (12.1) | $ 90.2 | $ 127.2 |
Amounts attributable to Valhi stockholders: | |||
Basic net income (loss) per share (in dollars per share) | $ (0.42) | $ 3.16 | $ 4.46 |
Diluted net income (loss) per share (in dollars per share) | $ (0.42) | $ 3.16 | $ 4.46 |
Weighted average shares outstanding - basic (in shares) | 28.5 | 28.5 | 28.5 |
Weighted average shares outstanding - diluted (in shares) | 28.5 | 28.5 | 28.5 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement Of Income And Comprehensive Income [Abstract] | |||
Net income | $ 2.9 | $ 136.1 | $ 197.7 |
Other comprehensive income (loss), net of tax: | |||
Currency translation | 3.6 | (26.1) | (6.8) |
Defined benefit pension plans | (5.9) | 89.4 | 45.3 |
Other | (0.6) | 1 | (0.3) |
Total other comprehensive income (loss), net | (2.9) | 64.3 | 38.2 |
Comprehensive income | 200.4 | 235.9 | |
Comprehensive income attributable to noncontrolling interest | 13.7 | 62.8 | 80.6 |
Comprehensive income (loss) attributable to Valhi stockholders | $ (13.7) | $ 137.6 | $ 155.3 |
CONSOLIDATED STATEMENTS OF STOC
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions | Common stock | Additional paid-in capital | Retained earnings | Accumulated other comprehensive loss | Treasury stock | Non-controlling interest | Total |
Balance at Dec. 31, 2020 | $ 0.3 | $ 668.3 | $ 282.9 | $ (219.4) | $ (49.6) | $ 324.4 | $ 1,006.9 |
Net income | 127.2 | 70.5 | 197.7 | ||||
Cash dividends | (9) | (9) | |||||
Dividends paid to noncontrolling interest | (74.4) | (74.4) | |||||
Other comprehensive income (loss), net | 28.1 | 10.1 | 38.2 | ||||
Equity transactions with noncontrolling interest and other, net | 0.7 | (1.7) | (1) | ||||
Balance at Dec. 31, 2021 | 0.3 | 669 | 401.1 | (191.3) | (49.6) | 328.9 | 1,158.4 |
Net income | 90.2 | 45.9 | 136.1 | ||||
Cash dividends | (9) | (9) | |||||
Dividends paid to noncontrolling interest | (38.9) | (38.9) | |||||
Other comprehensive income (loss), net | 47.4 | 16.9 | 64.3 | ||||
Equity transactions with noncontrolling interest and other, net | 0.5 | (4.6) | (4.1) | ||||
Balance at Dec. 31, 2022 | 0.3 | 669.5 | 482.3 | (143.9) | (49.6) | 348.2 | 1,306.8 |
Net income | (12.1) | 15 | 2.9 | ||||
Cash dividends | (9.1) | (9.1) | |||||
Dividends paid to noncontrolling interest | (34) | (34) | |||||
Other comprehensive income (loss), net | (1.6) | (1.3) | (2.9) | ||||
Equity transactions with noncontrolling interest and other, net | (2.2) | (2.2) | |||||
Balance at Dec. 31, 2023 | $ 0.3 | $ 669.5 | $ 461.1 | $ (145.5) | $ (49.6) | $ 325.7 | $ 1,261.5 |
CONSOLIDATED STATEMENTS OF ST_2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement Of Stockholders Equity [Abstract] | |||
Cash dividends per share | $ 0.32 | $ 0.32 | $ 0.32 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows from operating activities: | |||
Net income | $ 2.9 | $ 136.1 | $ 197.7 |
Depreciation and amortization | 54.1 | 58.5 | 59.3 |
Gain from sale of land | (1.5) | (16) | |
Loss on pension plan termination | 6.2 | ||
Water system fixed asset impairment | 16.4 | ||
Fixed asset impairment | 3.8 | ||
Loss on sale of Basic Power Company (BPC) | 2.6 | ||
Loss on deconsolidation of BWC | 2 | ||
Noncash interest expense | 2 | 2.2 | 2.9 |
Benefit plan expense greater (less) than cash funding | (6.2) | 8.6 | 11.4 |
Deferred income taxes | (48.1) | 0.6 | 12.1 |
Distributions from (contributions to) TiO2 manufacturing joint venture, net | 3.1 | (10.5) | 3.8 |
Other, net | 2.6 | 10.1 | 2.3 |
Change in assets and liabilities: | |||
Accounts and other receivables, net | (44.6) | 81.1 | (64.6) |
Inventories, net | 56.7 | (204.2) | 58.3 |
Land held for development, net | 0.8 | 21.4 | 49.6 |
Accounts payable and accrued liabilities | 11.2 | 3.9 | 154.3 |
Income taxes | 9.3 | (0.5) | (1.6) |
Accounts with affiliates | (27.8) | 9.4 | (24.3) |
Other noncurrent assets | (9.5) | (3.4) | (15.9) |
Other noncurrent liabilities | (19.3) | (83.9) | 53.7 |
Other, net | 5.6 | (12.9) | (23.3) |
Net cash provided by operating activities | 3.9 | 34.9 | 459.7 |
Cash flows from investing activities: | |||
Capital expenditures | (48.5) | (67.6) | (64.1) |
Cash and cash equivalents of BPC at time of sale | (1.7) | ||
Cash, cash equivalents and restricted cash of BWC | (8.6) | ||
Purchases of marketable securities | (66.4) | (73.6) | (4) |
Proceeds from disposal of marketable securities | 85.7 | 2.9 | 5.2 |
Proceeds from land sales | 1.8 | 23.4 | |
Other, net | 0.1 | 0.2 | 2.1 |
Net cash used in investing activities | (29) | (146.7) | (37.4) |
Cash flows from financing activities: | |||
Principal payments on indebtedness | (29.8) | (62) | (102.3) |
Valhi cash dividends paid | (9.1) | (9) | (9) |
Distributions to noncontrolling interest in subsidiaries | (34) | (38.9) | (74.4) |
Subsidiary treasury stock acquired | (2.9) | (4) | (1.5) |
Other, net | (0.1) | (0.1) | (1.9) |
Net cash used in financing activities | (75.9) | (114) | (189.1) |
Cash, cash equivalents and restricted cash and cash equivalents - net change from: | |||
Operating, investing and financing activities | (101) | (225.8) | 233.2 |
Effect of exchange rates on cash | 1 | (5.1) | (10.6) |
Balance at beginning of year | 562 | 792.9 | 570.3 |
Balance at end of year | 462 | 562 | 792.9 |
Cash paid for: | |||
Interest, net of amounts capitalized | 26.6 | 25.8 | 29.2 |
Income taxes, net | 27.4 | 43.7 | 65.9 |
Noncash investing activities: | |||
Change in accruals for capital expenditures | $ 1.1 | $ 6.6 | $ 4.6 |
Summary of significant accounti
Summary of significant accounting policies | 12 Months Ended |
Dec. 31, 2023 | |
Summary of significant accounting policies | |
Summary of significant accounting policies | Note 1 – Summary of significant accounting policies: Nature of our business. Organization. Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Valhi, Inc. and its subsidiaries, taken as a whole. Management’s estimates. Principles of consolidation. Foreign currency translation. Derivatives and hedging activities. Cash and cash equivalents. Restricted cash and cash equivalents. Marketable securities and securities transactions. Fair Value Measurements and Disclosures ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the assets or liability; and ● Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable. We classify all of our marketable securities as available-for-sale. Any unrealized gains or losses on our marketable equity securities are recognized in other income, net on our Consolidated Statements of Operations. We accumulate unrealized gains and losses on marketable debt securities as part of accumulated other comprehensive income (loss), net of related deferred income taxes. See Notes 6, 11 and 13. We base realized gains and losses upon the specific identification of the securities sold. Accounts receivable. Inventories and cost of sales. Land held for development. identification, relative sales value, square footage or a combination of these methods. All sales and marketing activities and general overhead are charged to selling, general and administrative expense as incurred. Investment in TiO 2 manufacturing joint venture. Leases. We determine if an arrangement is a lease (including leases embedded in another type of contract) at inception. All of our leases are classified as operating leases. Operating leases are included in operating lease right-of-use assets, current operating lease liabilities and noncurrent operating lease liabilities in our Consolidated Balance Sheets. See Notes 7 and 10. As permitted by ASC Topic 842, Leases Right-of-use assets represent our right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease. The right-of-use operating lease assets and liabilities are recognized based on the estimated present value of lease payments over the lease term as of the respective lease commencement dates. We use an estimated incremental borrowing rate to determine the present value of lease payments (unless we can determine the rate implicit in the lease, which is generally not the case). Our incremental borrowing rate for each of our leases is derived from available information, including our current debt and credit facilities and U.S. and European yield curves as well as publicly available data for instruments with similar characteristics, adjusted for factors such as collateralization and term. Our leases generally do not include termination or purchase options. Certain of our leases include an option to renew the lease after expiration of the initial lease term, but we have not included such renewal periods in our lease term because it is not reasonably certain that we would exercise the renewal option. Our leases generally have fixed lease payments, with no contingent or incentive payments. Certain of our leases include variable lease payments that depend on a specified index or rate. Our lease agreements do not contain any residual value guarantees. Goodwill and other intangible assets; amortization expense. Property and equipment; depreciation expense. Asset Useful lives Buildings and improvements 10 Machinery and equipment 3 Mine development costs Units-of-production We use accelerated depreciation methods for income tax purposes, as permitted. Upon the sale or retirement of an asset, we remove the related cost and accumulated depreciation from the accounts and recognize any gain or loss in income currently. We expense expenditures for maintenance, repairs and minor renewals as incurred that do not improve or extend the life of the assets, including planned major maintenance. We have a governmental concession with an unlimited term to operate our ilmenite mine in Norway. Mining properties consist of buildings and equipment used in our Norwegian ilmenite mining operations. While we own the land and ilmenite reserves associated with the mining operations, such land and reserves were acquired for nominal value and we have no material asset recognized for the land and reserves related to our mining operations. We perform impairment tests when events or changes in circumstances indicate the carrying value may not be recoverable. We consider all relevant factors. We perform the impairment test by comparing the estimated future undiscounted cash flows (exclusive of interest expense) associated with the asset or asset group to the asset’s net carrying value to determine if a write-down to fair value is required. During the fourth quarter of 2023, our Chemicals Segment recorded a fixed asset impairment of $3.8 million related to the write-off of certain costs resulting from a capital project termination. Excluding this project, we did not evaluate any long-lived assets for impairment during 2023 because no such impairment indicators were present. During the preparation of our second quarter 2023 interim financial statements, we identified a prior period misclassification related to the presentation of the gross value of the classes of property and equipment and accumulated depreciation and amortization. This misclassification had no impact to net property and equipment; however, total gross property and equipment increased $19.1 million (a decrease of $5.3 million and $45.8 million in land and equipment, respectively, and an increase of $5.1 million and $65.1 million in buildings and mining properties, respectively), and accumulated depreciation and amortization increased by the same amount. Property and equipment presented on the December 31, 2022 Consolidated Balance Sheet has been revised to reflect these changes. We have evaluated the misclassifications and determined the related changes are not material to any previously issued annual or interim financial statements. Long-term debt. Employee benefit plans. Income taxes. We recognize deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the income tax and financial reporting carrying amounts of assets and liabilities, including investments in our subsidiaries and affiliates who are not members of the Contran Tax Group and undistributed earnings of our Chemicals Segment’s non-U.S. subsidiaries which are not deemed to be permanently reinvested. At December 31, 2023, we continue to assert indefinite reinvestment as it relates to our outside basis difference attributable to our Chemicals Segment’s investments in non-U.S. subsidiaries, other than post-1986 undistributed earnings of our Chemicals Segment’s European subsidiaries and all undistributed earnings of our Chemicals Segment’s Canadian subsidiary, which are not subject to permanent reinvestment plans. It is not practical for us to determine the amount of the unrecognized deferred income tax liability related to our investments in our Chemicals Segment’s non-U.S. subsidiaries which are permanently reinvested due to the complexities associated with our organizational structure, changes in the Tax Cuts and Jobs Act (2017 Tax Act) and the U.S. taxation of such investments in the states in which we operate. Deferred income tax assets and liabilities for each tax-paying jurisdiction in which we operate are netted and presented as either a noncurrent deferred income tax asset or liability, as applicable. We periodically evaluate our deferred tax assets in the various taxing jurisdictions in which we operate and adjust any related valuation allowance based on the estimate of the amount of such deferred tax assets that we believe does not meet the more-likely-than-not recognition criteria. The U.S. Federal tax code imposes a tax on global intangible low-tax income (GILTI). We record GILTI tax as a current period expense when incurred under the period cost method. While our future global operations depend on a number of different factors, we do expect to have future U.S. inclusions in taxable income related to GILTI. We account for the tax effects of a change in tax law as a component of the income tax provision related to continuing operations in the period of enactment, including the tax effects of any deferred income taxes originally established through a financial statement component other than continuing operations (i.e. other comprehensive income). Changes in applicable income tax rates over time as a result of changes in tax law, or times in which a deferred income tax asset valuation allowance is initially recognized in one year and subsequently reversed in a later year, can give rise to “stranded” tax effects in accumulated other comprehensive income in which the net accumulated income tax (benefit) remaining in accumulated other comprehensive income does not correspond to the then-applicable income tax rate applied to the pre-tax amount which resides in accumulated other comprehensive income. As permitted by GAAP, our accounting policy is to remove any such stranded tax effect remaining in accumulated other comprehensive income, by recognizing an offset to our provision for income taxes related to continuing operations, only at the time when there is no remaining pre-tax amount in accumulated other comprehensive income. For accumulated other comprehensive income related to currency translation, this would occur only upon the sale or complete liquidation of one of our Chemicals Segment’s non-U.S. subsidiaries. For defined pension benefit plans and OPEB plans, this would occur whenever one of our subsidiaries which previously sponsored a defined benefit pension or OPEB plan had terminated such a plan and had no future obligation or plan asset associated with such a plan. We record a reserve for uncertain tax positions where we believe it is more-likely-than-not our position will not prevail with the applicable tax authorities. The amount of the benefit associated with our uncertain tax positions that we recognize is limited to the largest amount for which we believe the likelihood of realization is greater than 50%. We accrue penalties and interest on the difference between tax positions taken on our tax returns and the amount of benefit recognized for financial reporting purposes. We classify our reserves for uncertain tax positions in a separate current or noncurrent liability, depending on the nature of the tax position. See Note 14. Environmental remediation and related costs. Revenue recognition. Chemicals and Component Products Segments – Revenue from Contracts with Customers to our customers by transferring control of our products to them, which generally occurs at point of shipment or upon delivery. Such transfer of control is also evidenced by transfer of legal title and other risks and rewards of ownership (giving the customer the ability to direct the use of, and obtain substantially all of the benefits of, the product), and our customers becoming obligated to pay us and it is probable we will receive payment. In certain arrangements we provide shipping and handling activities after the transfer of control to our customer (e.g. when control transfers prior to delivery). In such arrangements shipping and handling are considered fulfillment activities, and accordingly, such costs are accrued when the related revenue is recognized. Revenue is recorded in an amount that reflects the net consideration we expect to receive in exchange for our products. Prices for our products are based on terms specified in published list prices and purchase orders, which generally do not include financing components, noncash consideration or consideration paid to our customers. As our standard payment terms are less than one year, we have elected the practical expedient under ASC 606 and we have not assessed whether a contract has a significant financing component. We state sales net of price, early payment and distributor discounts as well as volume rebates (collectively, variable consideration). Variable consideration, to the extent present, is recognized as the amount to which we are most-likely to be entitled, using all information (historical, current and forecasted) that is reasonably available to us, and only to the extent that a significant reversal in the amount of the cumulative revenue recognized is not probable of occurring in a future period. Differences, if any, between estimates of the amount of variable consideration to which we will be entitled and the actual amount of such variable consideration have not been material in the past. We occasionally receive partial or full consideration from our customers prior to the completion of our performance obligation (shipment of product). We record estimated deferred revenue on the amount to which we are most-likely to be entitled and deferred revenue is recognized into revenue as our performance obligation has been satisfied. Deferred revenue has not been material in the past. We report any tax assessed by a governmental authority that we collect from our customers that is both imposed on and concurrent with our revenue-producing activities (such as sales, use, value added and excise taxes) on a net basis (meaning we do not recognize these taxes either in our revenues or in our costs and expenses). Frequently, we receive orders for products to be delivered over dates that may extend across reporting periods. We invoice for each delivery upon shipment and recognize revenue for each distinct shipment when all sales recognition criteria for that shipment have been satisfied. As scheduled delivery dates for these orders are within a one year period, under the optional exemption provided by ASC 606, we do not disclose sales allocated to future shipments of partially completed contracts. Real Estate Management and Development Segment – Our revenues also are related to efforts to develop certain real estate in Henderson, Nevada, including approximately 2,100 acres zoned for residential/planned community purposes. Contracts for land sales are negotiated on an individual basis, involve single performance obligations, and generally require us to complete property development and improvements after title passes to the buyer and we have received all or a substantial portion of the selling price. We recognize land sales revenue associated with the residential/planned community over time using cost-based input methods. Land sales associated with the residential/planned community have variable consideration components which are based on a percentage of the builder’s ultimate selling price of a residential housing unit to their customer (ranging from 2.5% to 3.5% of such sales price). The amount we recognize when a parcel is sold to a home builder is the amount to which we are most-likely to be entitled, using all information (historical, current and forecasted) that is reasonably available to us, and only to the extent that a significant reversal in the amount of the cumulative revenue recognized is not probable of occurring in a future period. By recognizing revenue over time using cost-based input methods, revenues (including variable consideration) and profits are recognized in the same proportion of our progress towards completion of our contractual obligations, with our progress measured by costs incurred as a percentage of total costs estimated to be incurred relative to the parcels sold. Estimates of total costs expected to be incurred require significant management judgment, and the amount of revenue and profits that have been recognized to date are subject to revisions throughout the development period. The impact on the amount of revenue recognized resulting from any future change in the estimate of total costs estimated to be incurred would be accounted for prospectively in accordance with GAAP. We record estimated deferred revenue on the amount to which we are most-likely to be entitled and deferred revenue is recognized into revenue as the housing units are sold. Selling, general and administrative expenses; shipping and handling costs; advertising costs; research and development costs. |
Business and geographic segment
Business and geographic segments | 12 Months Ended |
Dec. 31, 2023 | |
Business and geographic segments | |
Business and geographic segments | Note 2 – Business and geographic segments: % controlled at Business segment Entity December 31, 2023 Chemicals Kronos 81% Component products CompX 87% Real estate management and development BMI and LandWell 63% - 77% Our control of Kronos includes 50% we hold directly and 31% held directly by NL. We own 83% of NL. Our control of CompX is through NL. We own 63% of BMI. Our control of LandWell includes the 27% we hold directly and 50% held by BMI. We are organized based upon our operating subsidiaries. Our operating segments are defined as components of our consolidated operations about which separate financial information is available that is regularly evaluated by our chief operating decision maker in determining how to allocate resources and in assessing performance. Each operating segment is separately managed and each operating segment represents a strategic business unit offering different products. We have the following three consolidated reportable operating segments. ● Chemicals – Our Chemicals Segment is operated through our majority control of Kronos. Kronos is a leading global producer and marketer of value-added titanium dioxide pigments (TiO 2 ). TiO 2 is used to impart whiteness, brightness, opacity and durability to a wide variety of products, including paints, plastics, paper, fibers and ceramics. Additionally, TiO 2 is a critical component of everyday applications, such as coatings, plastics and paper, as well as many specialty products such as inks, cosmetics and pharmaceuticals. See Note 7. ● Component Products – We operate in the component products industry through our majority control of CompX. CompX is a leading manufacturer of security products used in the postal, recreational transportation, office and institutional furniture, cabinetry, tool storage, healthcare and a variety of other industries. CompX is also a leading manufacturer of wake enhancement systems, stainless steel exhaust systems, gauges, throttle controls, trim tabs and related hardware and accessories for the recreational marine industry. All CompX production facilities are in the United States. ● Real Estate Management and Development – We operate in real estate management and development through our majority control of BMI and LandWell. BMI and LandWell own real property in Henderson, Nevada. LandWell is engaged in efforts to develop certain land holdings for commercial, industrial and residential purposes in Henderson, Nevada. BMI previously, through wholly-owned subsidiaries, also was responsible for the delivery of water to the City of Henderson and various other users through September 2022, and provided utility services to certain industrial customers prior to December 2023. We evaluate segment performance based on segment operating income, which we define as income before income taxes and interest expense, exclusive of certain non-recurring items (such as gains or losses on disposition of business units and other long-lived assets outside the ordinary course of business and certain legal settlements) and certain general corporate income and expense items (including securities transactions gains and losses and interest and dividend income), which are not attributable to the operations of the reportable operating segments. The accounting policies of our reportable operating segments are the same as those described in Note 1. Segment results we report may differ from amounts separately reported by our various subsidiaries and affiliates due to purchase accounting adjustments and related amortization or differences in how we define operating income. Intersegment sales are not material. Interest income included in the calculation of segment operating income is not significant in 2021, 2022 or 2023. Capital expenditures include additions to property and equipment. Depreciation and amortization related to each reportable operating segment includes amortization of any intangible assets attributable to the segment. Amortization of deferred financing costs and any premium or discount associated with the issuance of indebtedness is included in interest expense. Segment assets are comprised of all assets attributable to each reportable operating segment, including goodwill and other intangible assets. Our investment in the TiO 2 manufacturing joint venture (see Note 7) is included in the Chemicals Segment’s assets. Corporate assets are not attributable to any operating segment and consist principally of cash and cash equivalents, restricted cash and restricted cash equivalents and marketable securities. Years ended December 31, 2021 2022 2023 (In millions) Net sales: Chemicals $ 1,939.4 $ 1,930.2 $ 1,666.5 Component products 140.8 166.6 161.3 Real estate management and development 216.2 125.7 93.9 Total net sales $ 2,296.4 $ 2,222.5 $ 1,921.7 Cost of sales: Chemicals $ 1,494.5 $ 1,540.2 $ 1,502.7 Component products 98.1 117.8 112.1 Real estate management and development 123.6 74.1 61.7 Total cost of sales $ 1,716.2 $ 1,732.1 $ 1,676.5 Gross margin: Chemicals $ 444.9 $ 390.0 $ 163.8 Component products 42.7 48.8 49.2 Real estate management and development 92.6 51.6 32.2 Total gross margin $ 580.2 $ 490.4 $ 245.2 Operating income (loss): Chemicals $ 200.8 $ 174.6 $ (41.1) Component products 20.5 25.4 25.4 Real estate management and development 97.3 39.4 49.9 Total operating income 318.6 239.4 34.2 General corporate items: Interest income and other 4.0 10.4 21.3 Gain on land sales 16.0 — 1.5 Other components of net periodic pension and OPEB expense (17.0) (13.9) (11.8) Changes in market value of Valhi common stock held by subsidiaries 3.3 (1.6) (1.7) General expenses, net (34.6) (36.5) (34.7) Interest expense (32.5) (27.9) (28.3) Income (loss) before income taxes $ 257.8 $ 169.9 $ (19.5) Included in the determination of Chemicals operating income is restructuring costs related to workforce reductions of $5.8 million (see Note 20) and a fixed asset impairment related to the write-off of certain costs resulting from a capital project termination of $3.8 million, both recognized in the fourth quarter of 2023. Also included in the determination of Chemicals operating income are business interruption insurance settlement gains of $2.7 million recognized in the third quarter of 2022 and an aggregate $2.5 million recognized in the first, second and third quarters of 2023. See Note 13. Infrastructure reimbursements and land related income is included in the determination of Real Estate Management and Development operating income. See Notes 7 and 13. Prior to BWC’s bankruptcy filing on September 10, 2022, BMI was responsible for the delivery of water to the City of Henderson and various other users under long-term contracts through a water delivery system owned and operated by BWC. BWC’s water delivery system operated on Lake Mead in Nevada. Due to the Western drought, water levels in Lake Mead have been declining for much of the last twenty years. As a result of water release curtailments upstream of Lake Mead which began late in the second quarter of 2022, Lake Mead water levels dropped precipitously to historically low levels. On June 30, 2022 BWC was no longer able to pump water without the risk of damaging the system and consequently ceased operations at its water intake facility to best preserve the system. We considered BWC’s inability to pump water from Lake Mead to be a triggering event under ASC 360 Property, Plant, and Equipment , which caused us to evaluate the water system fixed assets for impairment. Because BWC was unable to deliver water under its current contracts and therefore unable to generate revenue, we determined the water system’s assets were fully impaired except to the extent certain equipment had alternative use outside of BWC’s operations, in which case those assets were written down to estimated salvage value. The $16.4 million impairment charge primarily recognized in the second quarter of 2022 represented the write down of the book value to the estimated salvage value of the assets. Without the ability to pump and deliver water to its customers, BWC’s operating expenses exceeded its revenues, and on September 10, 2022 BWC and its subsidiaries voluntarily filed for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the District of Nevada. Because BWC filed for bankruptcy protection, we and BMI could no longer affirmatively assert we control BWC and, as such, in accordance with ASC 810, Consolidation, we deconsolidated BWC as of the date of the bankruptcy filing and recognized a loss of $2.0 million in the third quarter of 2022 on the deconsolidation. In addition, BMI had an outstanding intercompany accounts receivable balance with BWC on the date of the bankruptcy filing, and we recognized $1.3 million of bad debt expense to fully reserve this balance during the third quarter of 2022. All of these charges are included in the determination of the Real Estate Management and Development’s operating income in 2022. Operating income comparisons between 2023, 2022 and 2021 are also affected by BWC’s water delivery sales and related cost of sales. See Note 3. Years ended December 31, 2021 2022 2023 (In millions) Depreciation and amortization: Chemicals $ 52.8 $ 53.1 $ 49.9 Component products 3.8 4.0 4.0 Real estate management and development 2.7 1.4 .2 Total $ 59.3 $ 58.5 $ 54.1 Capital expenditures: Chemicals $ 58.6 $ 63.2 $ 47.4 Component products 4.1 3.7 1.1 Real estate management and development 1.4 .7 — Total $ 64.1 $ 67.6 $ 48.5 December 31, 2021 2022 2023 (In millions) Total assets: Operating segments: Chemicals $ 2,373.1 $ 2,293.5 $ 2,196.8 Component products 146.4 131.3 141.5 Real estate management and development 259.3 219.2 200.9 Corporate and eliminations 226.4 191.7 197.8 Total $ 3,005.2 $ 2,835.7 $ 2,737.0 Geographic information Years ended December 31, 2021 2022 2023 (In millions) Net sales - point of origin: United States $ 1,409.1 $ 1,518.9 $ 1,284.4 Germany 971.7 895.4 726.4 Canada 371.9 389.4 351.0 Norway 257.2 273.5 252.1 Belgium 295.7 306.5 217.1 Eliminations (1,009.2) (1,161.2) (909.3) Total $ 2,296.4 $ 2,222.5 $ 1,921.7 Net sales - point of destination: North America $ 999.7 $ 985.4 $ 871.0 Europe 945.7 879.0 738.5 Other 351.0 358.1 312.2 Total $ 2,296.4 $ 2,222.5 $ 1,921.7 December 31, 2021 2022 2023 (In millions) Net property and equipment: United States $ 63.6 $ 45.8 $ 40.0 Germany 214.8 204.7 213.0 Belgium 107.7 101.4 98.5 Norway 86.4 83.6 83.5 Canada 91.1 88.3 82.3 Total $ 563.6 $ 523.8 $ 517.3 |
Business combinations, disposit
Business combinations, dispositions and related transactions | 12 Months Ended |
Dec. 31, 2023 | |
Business combinations, dispositions and related transactions | |
Business combinations, dispositions and related transactions | Note 3 – Business combinations, dispositions and related transactions: Kronos Worldwide, Inc. Prior to 2021, Kronos’ board of directors authorized the repurchase of up to 2.0 million shares of its common stock in open market transactions, including block purchases, or in privately-negotiated transactions at unspecified prices and over an unspecified period of time. Kronos may repurchase its common stock from time to time as market conditions permit. The stock repurchase program does not include specific price targets or timetables and may be suspended at any time. Depending on market conditions, Kronos may terminate the program prior to its completion. Kronos uses cash on hand or other sources of liquidity to acquire the shares. Repurchased shares are added to Kronos’ treasury shares and subsequently cancelled upon approval of the Kronos board of directors. In 2021, Kronos acquired 14,409 shares of its common stock in market transactions for an aggregate purchase price of $.2 million. In 2022, Kronos acquired 217,778 shares of its common stock in market transactions for an aggregate purchase price of $2.5 million. In 2023, Kronos acquired 313,814 shares of its common stock in market transactions for an aggregate purchase price of $2.8 million. At December 31, 2023, 1,017,518 shares are available for repurchase under this stock repurchase program. CompX International Inc. Prior to 2021, CompX’s board of directors authorized various repurchases of its Class A common stock in open market transactions, including block purchases, or in privately-negotiated transactions at unspecified prices and over an unspecified period of time. CompX may repurchase its common stock from time to time as market conditions permit. The stock repurchase program does not include specific price targets or timetables and may be suspended at any time. Depending on market conditions, CompX may terminate the program prior to its completion. CompX would generally use cash on hand to acquire the shares. Repurchased shares will be added to CompX’s treasury and cancelled. In 2021 CompX acquired 75,000 shares of its Class A common stock in market transactions for an aggregate purchase price of $1.3 million. During the second quarter of 2022, CompX acquired 78,900 shares of its Class A common stock for an aggregate amount of $1.7 million. Of the shares repurchased in 2022, 70,000 shares were purchased in a market transaction, and 8,900 shares were purchased from two affiliates in two separate private transactions that were also approved in advance by CompX’s independent directors. CompX did not make any repurchases under the plan during 2023. At December 31, 2023, 523,647 shares were available for purchase under these authorizations. NL Industries, Inc. During the second quarter of 2022, NL purchased 2,000 shares of its common stock from Kronos for a nominal amount in a private transaction that was approved in advance by NL’s independent directors and subsequently cancelled all such shares. BMI As discussed above, BWC filed for Chapter 11 bankruptcy protection on September 10, 2022. On November 8, 2023, the Bankruptcy Court for the District of Nevada entered an order approving BWC’s plan of reorganization, which provided for the sale of substantially all BWC’s assets and the transfer of substantially all of its operating and other agreements to one of its industrial customers. The transaction closed on November 17, 2023 at which time BWC discontinued its water delivery operations. As part of the transaction, BWC is providing transition services to the purchaser for a limited time. The proceeds of the sale will be used to repay creditors of BWC and its wholly-owned subsidiary. BWC’s assets may not be sufficient to fully repay its creditors, and the timing of the resolution of the bankruptcy proceedings remains uncertain. On December 1, 2023, BMI sold its subsidiary BPC, which provides electricity to four customers located in the industrial park, and its sewer system assets to another of its industrial customers. The sale was for minimal cash consideration and the assumption of liabilities, and upon the closing of the sale we recognized a loss of $2.6 million. BMI is providing transition services to the purchaser of the businesses for a limited time. With the sale of BPC, we no longer provide services to the industrial park which allows us to focus on land sales and development activity for the residential/planned community. |
Accounts and other receivables,
Accounts and other receivables, net | 12 Months Ended |
Dec. 31, 2023 | |
Accounts and other receivables, net | |
Accounts and other receivables, net | Note 4 – Accounts and other receivables, net: December 31, 2022 2023 (In millions) Trade accounts receivable: Kronos $ 220.3 $ 273.6 CompX 17.9 17.1 BMI/LandWell 2.3 1.2 VAT and other receivables 35.4 33.4 Allowance for doubtful accounts (4.9) (4.2) Total $ 271.0 $ 321.1 |
Inventories, net
Inventories, net | 12 Months Ended |
Dec. 31, 2023 | |
Inventories, net | |
Inventories, net | Note 5 – Inventories, net: December 31, 2022 2023 (In millions) Raw materials: Chemicals $ 145.3 $ 188.3 Component products 6.2 5.7 Total raw materials 151.5 194.0 Work in process: Chemicals 32.0 30.8 Component products 20.0 19.1 Total in-process products 52.0 49.9 Finished products: Chemicals 350.7 250.4 Component products 5.1 5.9 Total finished products 355.8 256.3 Supplies (chemicals) 81.5 95.9 Total $ 640.8 $ 596.1 |
Marketable securities
Marketable securities | 12 Months Ended |
Dec. 31, 2023 | |
Marketable securities | |
Marketable securities | Note 6 – Marketable securities: Cost or amortized Unrealized Market value cost loss, net (In millions) December 31, 2022: Current assets $ 75.1 $ 75.7 $ (.6) Noncurrent assets $ 1.2 $ 1.2 $ — December 31, 2023: Current assets $ 56.1 $ 56.1 $ — Noncurrent assets $ 4.8 $ 5.0 $ (.2) Fair Value Measurements Quoted Significant Prices in Other Active Observable Markets Inputs Total (Level 1) (Level 2) (In millions) December 31, 2022: Current assets: Fixed income securities $ 73.3 $ — $ 73.3 Mutual funds 1.8 1.8 — Total $ 75.1 $ 1.8 $ 73.3 Noncurrent assets - fixed income securities $ 1.2 $ — $ 1.2 December 31, 2023: Current assets - fixed income securities $ 56.1 $ — $ 56.1 Noncurrent assets: Fixed income securities $ 2.6 $ — $ 2.6 Mutual funds 2.2 2.2 — Total $ 4.8 $ 2.2 $ 2.6 Our marketable securities are primarily invested in U.S. government treasuries. The fair value of our marketable securities are either determined using Level 1 inputs (because the securities are actively traded) or determined using Level 2 inputs (because although these securities are traded, in many cases the market is not active and the year-end valuation is generally based on the last trade of the year, which may be several days prior to December 31). |
Investment in TiO2 manufacturin
Investment in TiO2 manufacturing joint venture and other assets | 12 Months Ended |
Dec. 31, 2023 | |
Investment in TiO2 manufacturing joint venture and other assets | |
Investment in TiO2 manufacturing joint venture and other assets | Note 7 – Investment in TiO 2 December 31, 2022 2023 (In millions) Other assets: Restricted cash and cash equivalents $ 37.2 $ 32.4 Note receivables - OPA 49.3 69.1 Operating lease right-of-use assets 21.5 22.7 Land held for development 29.7 19.4 IBNR receivables 16.8 13.4 Other 24.3 16.7 Total $ 178.8 $ 173.7 Investment in TiO 2 manufacturing joint venture. Our Chemicals Segment owns a 50% interest in Louisiana Pigment Company, L.P. (LPC). LPC is a manufacturing joint venture whose other 50% -owner is Venator Investments LLC (Venator Investments). Venator Investments is a wholly-owned subsidiary of Venator Group, of which Venator Materials PLC owns 100% and is the ultimate parent. LPC owns and operates a chloride-process TiO 2 plant near Lake Charles, Louisiana. Kronos and Venator Investments are both required to purchase one-half of the TiO 2 produced by LPC, unless Kronos and Venator Investments agree otherwise. LPC operates on a break-even basis and, accordingly, we report no equity in earnings of LPC. Each owner’s acquisition transfer price for its share of the TiO 2 produced is equal to its share of the joint venture’s production costs and interest expense, if any. Kronos’ share of net cost is reported as cost of sales as the related TiO 2 acquired from LPC is sold. We report distributions Kronos receives from LPC, which generally relate to excess cash generated by LPC from its non-cash production costs, and contributions Kronos makes to LPC, which generally relate to cash required by LPC when it builds working capital, as part of our cash flows from operating activities in our Consolidated Statements of Cash Flows. The components of our net cash distributions from (contributions to) LPC are shown in the table below. Years ended December 31, 2021 2022 2023 (In millions) Distributions from LPC $ 28.5 $ 58.3 $ 52.8 Contributions to LPC (24.7) (68.8) (49.7) Net distributions (contributions) $ 3.8 $ (10.5) $ 3.1 Summary balance sheets of LPC are shown below: December 31, 2022 2023 (In millions) ASSETS Current assets $ 122.2 $ 118.5 Property and equipment, net 147.4 148.4 Total assets $ 269.6 $ 266.9 LIABILITIES AND PARTNERS' EQUITY Other liabilities, primarily current $ 41.2 $ 42.1 Partners' equity 228.4 224.8 Total liabilities and partners' equity $ 269.6 $ 266.9 Summary income statements of LPC are shown below: Years ended December 31, 2021 2022 2023 (In millions) Revenues and other income: Kronos $ 188.6 $ 225.6 $ 231.7 Venator Investments 189.6 225.9 231.7 Total 378.2 451.5 463.4 Cost and expenses: Cost of sales 377.8 451.1 463.0 General and administrative .4 .4 .4 Total 378.2 451.5 463.4 Net income $ — $ — $ — Leases. We enter into various operating leases for manufacturing facilities, land and equipment. Our operating leases are included in operating lease right-of-use assets, current operating lease liabilities and noncurrent operating lease liabilities on our Consolidated Balance Sheets. Also see Note 10. Our Chemicals Segment’s principal German operating subsidiary leases the land under its Leverkusen TiO 2 production facility pursuant to a lease that expires in 2050. The Leverkusen facility itself, which Kronos owns and which represents approximately one-third of its current TiO 2 production capacity, is located within an extensive manufacturing complex. During 2021, 2022 and 2023, our operating lease expense approximated $7.7 million, $5.5 million and $5.6 million, respectively, (which approximates the amount of cash paid during the period for our operating leases included in the determination of our cash flows from operating activities). During 2021, 2022 and 2023, variable lease expense and short-term lease expense were not material. During 2021, 2022 and 2023, we entered into new operating leases which resulted in the recognition of $3.8 million, $6.6 million and $4.6 million, respectively, in right-of-use operating lease assets and corresponding liabilities on our Consolidated Balance Sheets. At December 31, 2022 and 2023, the weighted average remaining lease term of our operating leases was approximately 15 years and 14 years, respectively, and the weighted average discount rate associated with such leases was approximately 5.0% in both 2022 and 2023. Such average remaining lease term is weighted based on each arrangement’s lease obligation, and such average discount rate is weighted based on each arrangement’s total remaining lease payments. At December 31, 2023, maturities of our operating lease liabilities were as follows: Years ending December 31, Amount (In millions) 2024 $ 4.6 2025 3.6 2026 3.3 2027 2.2 2028 2.0 2029 and thereafter 17.0 Total remaining lease payments 32.7 Less imputed interest 10.2 Total lease obligations 22.5 Less current obligations 3.9 Long term lease obligations $ 18.6 With respect to our land lease associated with our Chemical Segment’s Leverkusen facility, we periodically establish the amount of rent for such land lease for periods of at least two years at a time. The lease agreement provides for no formula, index or other mechanism to determine changes in the rent of such land lease; rather, any change in the rent is subject solely to periodic negotiation. As such, we will account for any change in the rent associated with such lease as a lease modification. Of the $22.5 million total lease obligations at December 31, 2023, approximately $7.4 million relates to our Leverkusen facility land lease. At December 31, 2023, we have no significant lease commitments that have not yet commenced. Land held for development. Note receivables – OPA. Under an Owner Participation Agreement (OPA) entered into by LandWell with the Redevelopment Agency of the City of Henderson, Nevada, if LandWell develops certain real property for commercial and residential purposes in a master planned community in Henderson, Nevada, the cost of certain public infrastructure may be reimbursed to us through tax increment. The maximum reimbursement under the OPA is $209 million, and is subject to, among other things, completing construction of approved qualifying public infrastructure, transferring title of such infrastructure to the City of Henderson, receiving approval from the Redevelopment Agency of the funds expended to be eligible for tax increment reimbursement and the existence of a sufficient property tax valuation base and property tax rates in order to generate tax increment reimbursement funds. We are entitled to receive 75% of the tax increment generated by the master planned community through the expiration of the Redevelopment Plan, subject to the qualifications and limitations indicated above. The OPA note receivables represent public infrastructure costs previously incurred for which the Redevelopment Agency has provided its approval for tax increment reimbursement but we have not yet received such reimbursement through tax increment receipts, and are evidenced by a promissory note issued to LandWell by the City of Henderson. During 2021, 2022 and 2023, we received approval for additional tax increment reimbursement of $15.3 million ($6.2 million in the first quarter and $9.1 million in the fourth quarter), $15.2 million ($10.0 million in the third quarter and $5.2 million in the fourth quarter), and $25.2 million ($4.8 million in the third quarter and $20.4 million in the fourth quarter), respectively, which were recognized as other income and are evidenced by a promissory note issued to LandWell by the City of Henderson. The note receivables bear interest at 6% annually and in 2021, the City of Henderson extended the Redevelopment Plan for an additional 15 years which allows us to collect any remaining amounts due under the OPA through 2051. Any unpaid balances at the end of the agreement are forfeited. See Note 13. Other. IBNR receivables relate to certain insurance liabilities, the risk of which we have reinsured with certain third-party insurance carriers. We report the insurance liabilities related to these IBNR receivables which have been reinsured as part of noncurrent accrued insurance claims and expenses. Certain of our insurance liabilities are classified as current liabilities and the related IBNR receivables are classified with prepaid expenses and other on our Consolidated Balance Sheets. See Notes 10 and 17. |
Goodwill
Goodwill | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Goodwill | Note 8 – Goodwill: We have assigned goodwill to each of our reporting units (as that term is defined in ASC Topic 350-20-20, Goodwill Operating segment Component Chemicals Products Total (In millions) Balance at December 31, 2021, 2022 and 2023 $ 352.6 $ 27.1 $ 379.7 We test for goodwill impairment at the reporting unit level. In determining the estimated fair value of the reporting units, we use appropriate valuation techniques, such as discounted cash flows and, with respect to our Chemicals Segment, we consider quoted market prices, a Level 1 input, while discounted cash flows are a Level 3 input. We also consider control premiums when assessing fair value using quoted market prices. If the carrying amount of the reporting unit’s net assets exceeds its fair value, an impairment charge is recorded for the amount by which such carrying amount exceeds the reporting unit’s fair value (not to exceed the amount of goodwill recognized). As permitted by GAAP, during 2021, 2022 and 2023 we used the qualitative assessment of ASC 350-20-35 for the Component Products security products reporting unit’s annual impairment test and determined it was not necessary to perform a quantitative goodwill impairment test. We review goodwill for each of our reporting units for impairment during the third quarter of each year. Goodwill is also evaluated for impairment at other times whenever an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. If the fair value of an evaluated asset is less than its book value, the asset is written down to fair value. In 2021, 2022 and 2023, no goodwill impairment was indicated as part of our annual impairment review of goodwill. Prior to 2021, we recorded an aggregate $16.5 million goodwill impairment, mostly with respect to our Component Products Segment. Our consolidated gross goodwill at December 31, 2023 is $396.2 million. |
Long-term debt
Long-term debt | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Long-term debt | Note 9 – Long-term debt: December 31, 2022 2023 (In millions) Valhi: Contran credit facility $ 121.4 $ 93.4 Subsidiary debt: Kronos: Kronos International, Inc. 3.75% Senior Secured Notes due 2025 424.1 440.9 LandWell: Note payable to Western Alliance Business Trust 12.9 12.2 Other 1.1 — Total subsidiary debt 438.1 453.1 Total debt 559.5 546.5 Less current maturities 1.8 .7 Total long-term debt $ 557.7 $ 545.8 Valhi – Contran credit facility – Kronos 3.75% Senior Secured Notes due 2025 – The Old Notes: ● bear interest at 3.75% per annum, payable semi-annually on March 15 and September 15 of each year, payments began on March 15, 2018 ; ● have a maturity date of September 15, 2025 . Kronos may redeem the Old Notes at 100 %, plus accrued and unpaid interest. If Kronos experiences certain specified change of control events as outlined in the indenture governing its Old Notes, it would be required to make an offer to purchase the Old Notes at 101% of the principal amount, plus accrued and unpaid interest. Kronos would also be required to make an offer to purchase a specified portion of the Old Notes at par value, plus accrued and unpaid interest, in the event that it generates a certain amount of net proceeds from the sale of assets outside the ordinary course of business, and such net proceeds are not otherwise used for specified purposes within a specified time period as described in the indenture governing its Old Notes ; ● are fully and unconditionally guaranteed , jointly and severally, on a senior secured basis by Kronos Worldwide, Inc. and each of its direct and indirect domestic, wholly-owned subsidiaries; and ● have substantially similar collateral, guarantees and covenants to the New Notes. The carrying value of the Old Notes at December 31, 2023 is stated net of unamortized debt issuance costs of $1.6 million (December 31, 2022 - $2.4 million). 9.50% Senior Secured Notes due 2029 The New Notes: ● bear interest at 9.50% per annum , payable semi-annually on March 15 and September 15 of each year, payments begin on September 15, 2024 ; ● have a maturity date of March 15, 2029 . Prior to March 15, 2026, Kronos may redeem some or all of the New Notes at a price equal to 100% of the principal amount thereof, plus an applicable premium as of the date of the redemption as described in the indenture governing its New Notes, plus accrued and unpaid interest. On or after March 15, 2026, Kronos may redeem the New Notes at redemption prices ranging from 104.750% of the principal amount, declining to 100% on or after March 15, 2028, plus accrued and unpaid interest. In addition, on or before March 15, 2026, Kronos may redeem up to 40% of the New Notes with the net proceeds of certain public or private equity offerings at 109.50% of the principal amount, plus accrued and unpaid interest, provided that following the redemption at least 50% of the New Notes remain outstanding . If Kronos or Kronos’ subsidiaries experience certain change of control events, as outlined in the indenture governing its New Notes, Kronos would be required to make an offer to purchase the New Notes at 101% of the principal amount thereof, plus accrued and unpaid interest. Kronos would also be required to make an offer to purchase a specified portion of the New Notes at par value, plus accrued and unpaid interest, in the event that Kronos and its subsidiaries generate a certain amount of net proceeds from the sale of assets outside the ordinary course of business, and such net proceeds are not otherwise used for specified purposes within a specified time period as described in the indenture governing Kronos’ New Notes ; ● are fully and unconditionally guaranteed, jointly and severally, on a senior secured basis by Kronos Worldwide, Inc. and each of its direct and indirect domestic, wholly-owned subsidiaries; ● are collateralized by a first priority lien on (i) 100 % of the common stock or other ownership interests of each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65 % of the voting common stock or other ownership interests and 100 % of the non-voting common stock or other ownership interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor; ● contain a number of covenants and restrictions which, among other things, restrict Kronos’ ability to incur or guarantee additional debt, incur liens, pay dividends or make other restricted payments, or merge or consolidate with, or sell or transfer substantially all of its assets to, another entity, and contain other provisions and restrictive covenants customary in lending transactions of this type (however, there are no ongoing financial maintenance covenants); and ● contain customary default provisions, including a default under any of Kronos’ other indebtedness in excess of $ 50.0 million. Subordinated, Unsecured Term Loan from Contran Contran Term Loan September 2029), is not subject to any amortization payments and is prepayable at par beginning in March 2026. The restrictive covenants in the Contran Term Loan are substantially similar to those contained in the indenture governing Kronos’ New Notes. In accordance with Kronos’ related party transaction policy, the audit committee of its board of directors, comprised of the independent directors, approved the terms and conditions of the new term loan from Contran. Revolving credit facility €30 million and €60 million, respectively. During 2023, Kronos had no borrowings or repayments Other – Aggregate maturities of long-term debt – Years ending December 31, Amount (In millions) Gross amounts due each year: 2024 $ .7 2025 536.7 2026 .8 2027 .8 2028 .9 2029 and thereafter 8.2 Subtotal 548.1 Less amounts representing original issue discount and debt issuance costs 1.6 Total long-term debt $ 546.5 After considering the effect of the exchange of the Old Notes and issuance of the New Notes and Contran Term Loan discussed above, our aggregate maturities of long-term debt would be: Years ending December 31, Amount (In millions) 2024 $ .7 2025 177.2 2026 .8 2027 .8 2028 .9 2029 and thereafter 369.0 Gross maturities 549.4 Less debt issuance costs 6.1 Total $ 543.3 We are in compliance with all of our debt covenants at December 31, 2023. |
Accounts payable and accrued li
Accounts payable and accrued liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Payables And Accruals [Abstract] | |
Accounts payable and accrued liabilities | Note 10 – December 31, 2022 2023 (In millions) Accounts payable: Kronos $ 177.2 $ 218.7 CompX 3.5 3.1 BMI/LandWell 18.7 6.7 Total $ 199.4 $ 228.5 Current accrued liabilities: Deferred income $ 110.7 $ 88.8 Employee benefits 34.4 36.2 Accrued sales discounts and rebates 25.6 22.5 Accrued development costs 5.6 15.1 Interest 4.9 5.1 Operating lease liabilities 3.8 3.9 Environmental remediation and related costs 3.8 3.7 Other 54.8 45.0 Total $ 243.6 $ 220.3 Noncurrent accrued liabilities: Accrued development costs $ 48.1 $ 42.3 Operating lease liabilities 17.4 18.6 Deferred income 25.9 15.5 Insurance claims and expenses 18.7 14.9 Other postretirement benefits 7.1 7.4 Employee benefits 4.8 4.9 Reserve for uncertain tax positions .3 — Other 6.7 7.8 Total $ 129.0 $ 111.4 The risks associated with certain of our accrued insurance claims and expenses have been reinsured, and the related IBNR receivables are recognized as noncurrent assets to the extent the related liability is classified as a noncurrent liability. See Note 7. Our reserve for uncertain tax positions is discussed in Note 14. |
Defined contribution and define
Defined contribution and defined benefit retirement | 12 Months Ended |
Dec. 31, 2023 | |
Compensation And Retirement Disclosure [Abstract] | |
Defined contribution and defined benefit retirement | Note 11 – Defined contribution and defined benefit retirement: Defined contribution plans. Defined benefit plans. We previously maintained a defined benefit pension plan in the United Kingdom (U.K.) related to a former disposed U.K. business unit. In accordance with applicable U.K. pension regulations, we entered into an agreement in March 2021 for the bulk annuity purchase, or “buy-in”, with a specialist insurer of defined benefit pension plans. Following the buy-in, individual policies replaced the bulk annuity policy in a “buy-out” which was completed as of May 1, 2023. The buy-out was completed with existing plan funds. At the completion of the buy-out, the assets and liabilities of the U.K. pension plan were removed from our Consolidated Financial Statements and a non-cash pension plan termination loss of $6.2 million was recognized in the second quarter of 2023. We expect to contribute the equivalent of approximately $18 million to all of our defined benefit pension plans during 2024. Benefit payments to plan participants out of plan assets are expected to be the equivalent of: Years ending December 31, Amount (In millions) 2024 $ 28.4 2025 28.3 2026 28.7 2027 31.6 2028 35.7 Next 5 years 169.5 The funded status of our U.S. defined benefit pension plans is presented in the table below. Years ended December 31, 2022 2023 (In millions) Change in projected benefit obligations (PBO): Balance at beginning of the year $ 58.0 $ 43.4 Interest cost 1.4 2.2 Actuarial losses (gains) (11.8) 1.2 Benefits paid (4.2) (4.1) Balance at end of the year $ 43.4 $ 42.7 Change in plan assets: Fair value at beginning of the year $ 52.4 $ 39.1 Actual return on plan assets (10.7) 3.7 Employer contributions 1.6 1.6 Benefits paid (4.2) (4.1) Fair value at end of the year $ 39.1 $ 40.3 Funded status $ (4.3) $ (2.4) Amounts recognized in the Consolidated Balance Sheets: Accrued pension costs: Current $ (.1) $ — Noncurrent (4.2) (2.4) Total (4.3) (2.4) Accumulated other comprehensive loss - actuarial losses 32.2 30.3 Total $ 27.9 $ 27.9 Accumulated benefit obligations (ABO) $ 43.4 $ 42.7 The total net underfunded status of our U.S. defined benefit pension plans decreased from $4.3 million at December 31, 2022 to $2.4 million at December 31, 2023 due to the change in our plan assets during 2023 exceeding the change in our PBO during 2023. The increase in our plan assets in 2023 was primarily attributable to improved returns on plan assets. The decrease in our PBO in 2023 was primarily attributable to lower actuarial gains due to the decrease in discount rates from year end 2022. The components of our net periodic defined benefit pension cost for U.S. plans are presented in the table below. The amounts shown below for the amortization of recognized actuarial losses for 2021, 2022 and 2023 were recognized as components of our accumulated other comprehensive income (loss) at December 31, 2020, 2021 and 2022, respectively, net of deferred income taxes and noncontrolling interest. Years ended December 31, 2021 2022 2023 (In millions) Net periodic pension cost for U.S. plans: Interest cost $ 1.3 $ 1.4 $ 2.2 Expected return on plan assets (2.1) (2.0) (1.9) Recognized net actuarial losses 2.1 1.9 2.0 Settlements (.5) — — Total $ .8 $ 1.3 $ 2.3 Information concerning our U.S. defined benefit pension plans (for which the ABO of all of the plans exceeds the fair value of plan assets as of the indicated date) is presented in the table below. December 31, 2022 2023 (In millions) Plans for which the ABO exceeds plan assets: Projected benefit obligations $ 43.4 $ 42.7 Accumulated benefit obligations 43.4 42.7 Fair value of plan assets 39.1 40.3 The discount rate assumptions used in determining the actuarial present value of the benefit obligation for our U.S. defined benefit pension plans as of December 31, 2022 and 2023 are 5.3% and 5.0%, respectively. The impact of assumed increases in future compensation levels does not have an effect on the benefit obligation as the plans are frozen with regards to compensation. The weighted-average rate assumptions used in determining the net periodic pension cost for our U.S. defined benefit pension plans for 2021, 2022 and 2023 are presented in the table below. The impact of assumed increases in future compensation levels does not have an effect on the periodic pension cost as the plans are frozen with regards to compensation. Years ended December 31, 2021 2022 2023 Discount rate 2.2% 2.6% 5.3% Long-term return on plan assets 4.0% 4.0% 5.0% Variances from actuarially assumed rates will result in increases or decreases in accumulated pension obligations, pension expense and funding requirements in future periods. The funded status of our non-U.S. defined benefit pension plans is presented in the table below. Years ended December 31, 2022 2023 (In millions) Change in PBO: Balance at beginning of the year $ 758.1 $ 508.6 Service cost 11.3 6.3 Interest cost 10.6 19.8 Participants’ contributions 1.7 1.8 Actuarial losses (gains) (198.6) 44.3 Settlements (1.4) (8.6) Change in currency exchange rates (51.2) 14.1 Benefits paid (21.9) (22.6) Balance at end of the year $ 508.6 $ 563.7 Change in plan assets: Fair value at beginning of the year $ 481.5 $ 390.5 Actual return on plan assets (52.5) 37.4 Employer contributions 15.0 14.7 Participants' contributions 1.7 1.8 Settlements (1.2) (8.6) Change in currency exchange rates (32.1) 9.4 Benefits paid (21.9) (22.6) Fair value at end of the year $ 390.5 $ 422.6 Funded status $ (118.1) $ (141.1) Amounts recognized in the Consolidated Balance Sheets: Noncurrent pension asset $ 9.3 $ 8.1 Noncurrent accrued pension costs (127.4) (149.2) Total (118.1) (141.1) Accumulated other comprehensive loss: Actuarial losses 90.0 106.8 Prior service cost .4 .3 Total 90.4 107.1 Total $ (27.7) $ (34.0) ABO $ 493.9 $ 549.8 The total net underfunded status of our non-U.S. defined benefit pension plans increased from $118.1 million at December 31, 2022 to $141.1 million at December 31, 2023 due to the change in our PBO during 2023 exceeding the change in plan assets during 2023. The increase in our PBO in 2023 was primarily attributable to higher actuarial losses due to the decrease in discount rates from year end 2022 and unfavorable currency fluctuations, primarily from the weakening of the U.S. dollar relative to the euro. The increase in our plan assets in 2023 was primarily attributable to positive plan asset returns in 2023 and favorable currency fluctuations (primarily from the weakening of the U.S. dollar relative to the euro) and employer contributions. The components of our net periodic pension benefit cost for our non-U.S. plans are presented in the table below. The amounts shown below for the amortization of prior service cost and recognized net actuarial losses for 2021, 2022 and 2023 were recognized as components of our accumulated other comprehensive income (loss) at December 31, 2020, 2021 and 2022, respectively, net of deferred income taxes and noncontrolling interest. Years ended December 31, 2021 2022 2023 (In millions) Net periodic pension cost for non-U.S. plans: Service cost $ 14.7 $ 11.3 $ 6.3 Interest cost 8.3 10.6 19.8 Expected return on plan assets (11.4) (11.1) (18.3) Recognized net actuarial losses 19.5 12.8 1.8 Amortization of prior service cost .2 .1 — Settlements — .4 6.5 Total $ 31.3 $ 24.1 $ 16.1 Information concerning certain of our non-U.S. defined benefit pension plans (for which the ABO exceeds the fair value of plan assets as of the indicated date) is presented in the table below. December 31, 2022 2023 (In millions) Plans for which the ABO exceeds plan assets: Projected benefit obligations $ 403.5 $ 463.1 Accumulated benefit obligations 392.4 452.9 Fair value of plan assets 276.0 313.8 The key actuarial assumptions used to determine our non-U.S. benefit obligations as of December 31, 2022 and 2023 are as follows: December 31, 2022 2023 Discount rate 3.9% 3.4% Increase in future compensation levels 2.7% 2.7% A summary of our key actuarial assumptions used to determine non-U.S. net periodic benefit cost for 2021, 2022 and 2023 are as follows: Years ended December 31, 2021 2022 2023 Discount rate 1.0% 1.5% 3.9% Increase in future compensation levels 2.6% 2.6% 2.7% Long-term return on plan assets 2.4% 2.5% 4.6% Variances from actuarially assumed rates will result in increases or decreases in accumulated pension obligations, pension expense and funding requirements in future periods. The amounts shown for all of our periodic defined benefit plans for actuarial losses and prior service cost at December 31, 2022 and 2023 have not been recognized as components of our periodic defined benefit pension cost as of those dates. These amounts will be recognized as components of our periodic defined benefit cost in future years. These amounts, net of deferred income taxes and noncontrolling interest, are recognized in our accumulated other comprehensive income (loss) at December 31, 2022 and 2023. We expect approximately $3.9 million and $.1 million of the unrecognized actuarial losses and prior service cost, respectively, will be recognized as components of our periodic defined benefit pension cost in 2024. The table below details the changes in other comprehensive income (loss) during 2021, 2022 and 2023. Years ended December 31, 2021 2022 2023 (In millions) Changes in plan assets and benefit obligations recognized in Net actuarial gains (losses) $ 50.7 $ 134.1 $ (25.5) Amortization of unrecognized: Net actuarial losses 21.6 14.7 3.8 Prior service cost .2 .1 — Settlements — .4 6.5 Total $ 72.5 $ 149.3 $ (15.2) In determining the expected long-term rate of return on plan asset assumptions, we consider the long-term asset mix (e.g. equity vs. fixed income) for the assets for each of our plans and the expected long-term rates of return for such asset components. In addition, we receive third-party advice about appropriate long-term rates of return. Such assumed asset mixes are summarized below: ● In Germany, the composition of our plan assets is established to satisfy the requirements of the German insurance commissioner. Our German pension plan assets represent an investment in a large collective investment fund established and maintained by Bayer AG in which several pension plans, including our German pension plans and Bayer’s pension plans, have invested. Our plan assets represent a very nominal portion of the total collective investment fund maintained by Bayer. These plan assets are a Level 3 in the fair value hierarchy because there is not an active market that approximates the value of our investment in the Bayer investment fund. We estimate the fair value of the Bayer plan assets based on periodic reports we receive from the managers of the Bayer fund and using a model we developed with assistance from our third-party actuary that uses estimated asset allocations and correlates such allocation to similar asset mixes in fund indexes quoted on an active market. We periodically evaluate the results of our valuation model against actual returns in the Bayer fund and adjust the model as needed. The Bayer fund periodic reports are subject to audit by the German pension regulator. ● In Canada, we currently have a plan asset target allocation of up to 10 % to equity securities and 90 – 100 % to fixed income securities. We expect the long-term rate of return for such investments to approximate the applicable equity or fixed income index. The Canadian assets are Level 1 inputs because they are traded in active markets. ● In Norway, we currently have a plan asset target allocation of 18 % to equity securities, 63 % to fixed income securities, 14 % to real estate and the remainder primarily to other investments and liquid investments such as money markets. The expected long-term rate of return for such investments is approximately 7 %, 4 %, 6 % and 7 %, respectively. The majority of Norwegian plan assets are Level 1 inputs because they are traded in active markets; however, approximately 14 % of our Norwegian plan assets are invested in real estate and other investments not actively traded and are therefore a Level 3 input. ● In the U.S. we currently have a plan asset target allocation of 33 % to equity securities, 59 % to fixed income securities and the remainder is allocated to multi-asset and other strategies. The expected long-term rate of return for our equity securities and fixed income securities is approximately 7 % and 5 %, respectively (before plan administrative expenses). Approximately 98 % of our U.S. plan assets are invested in funds that are valued at net asset value (NAV) and not subject to classification in the fair value hierarchy. ● We also have plan assets in Belgium. The Belgian plan assets are invested in certain individualized fixed income insurance contracts for the benefit of each plan participant as required by the local regulators and are therefore a Level 3 input. We had plan assets in the United Kingdom invested primarily in insurance contracts that were a Level 3 input as of December 31, 2022. During 2023, we completed a termination and buy-out of our pension plan in the United Kingdom resulting in a $6.2 million settlement loss. We regularly review our actual asset allocation for each plan, and will periodically rebalance the investments in each plan to more accurately reflect the targeted allocation and/or maximize the overall long-term return when considered appropriate. The composition of our pension plan assets by asset category and fair value level at December 31, 2022 and 2023 is shown in the tables below. Fair Value Measurements at December 31, 2022 Quoted Significant Prices in Other Significant Active Observable Unobservable Assets Markets Inputs Inputs measured Total (Level 1) (Level 2) (Level 3) at NAV (In millions) Germany $ 234.0 $ — $ — $ 234.0 $ — Canada: Local currency equities .1 .1 — — — Non local currency equities 11.0 11.0 — — — Local currency fixed income 72.9 72.9 — — — Cash and other .6 .6 — — — Norway: Local currency equities 2.3 2.3 — — — Non local currency equities 4.7 4.7 — — — Local currency fixed income 21.8 7.0 14.8 — — Non local currency fixed income 8.4 8.4 — — — Real estate 7.8 — — 7.8 — Cash and other 2.7 2.4 — .3 — U.S.: Equities 12.4 1.0 — — 11.4 Fixed income 22.9 .2 — — 22.7 Cash and other 3.8 2.8 — — 1.0 Other 24.2 1.5 — 22.7 — Total $ 429.6 $ 114.9 $ 14.8 $ 264.8 $ 35.1 Fair Value Measurements at December 31, 2023 Quoted Significant Prices in Other Significant Active Observable Unobservable Assets Markets Inputs Inputs measured Total (Level 1) (Level 2) (Level 3) at NAV (In millions) Germany $ 269.4 $ — $ — $ 269.4 $ — Canada: Non local currency equities 2.7 2.7 — — — Local currency fixed income 86.2 86.2 — — — Cash and other 1.1 1.1 — — — Norway: Local currency equities 2.4 2.4 — — — Non local currency equities 7.2 7.2 — — — Local currency fixed income 23.9 4.4 19.5 — — Non local currency fixed income 4.2 4.2 — — — Real estate 6.6 — — 6.6 — Cash and other 3.0 2.8 — .2 — U.S.: Equities 11.3 — — — 11.3 Fixed income 27.1 — — — 27.1 Cash and other 1.9 .7 — — 1.2 Other 15.9 — — 15.9 — Total $ 462.9 $ 111.7 $ 19.5 $ 292.1 $ 39.6 A rollforward of the change in fair value of Level 3 assets follows. Years ended December 31, 2022 2023 (In millions) Fair value at beginning of year $ 320.5 $ 264.8 Gain (loss) on assets held at end of year (31.0) 11.1 Gain (loss) on assets sold during the year (3.6) 14.4 Assets purchased 13.8 1.7 Assets sold (15.5) (9.3) Transfers out (.1) — Currency exchange rate fluctuations (19.3) 9.4 Fair value at end of year $ 264.8 $ 292.1 |
Disaggregation of sales
Disaggregation of sales | 12 Months Ended |
Dec. 31, 2023 | |
Disaggregation of sales | |
Disaggregation of sales | Note 12 – Disaggregation of sales: The following table disaggregates the net sales of our Chemicals Segment by place of manufacture (point of origin) and the location of the customer (point of destination), which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Years ended December 31, 2021 2022 2023 (In millions) Net sales - point of origin: United States $ 1,052.1 $ 1,226.6 $ 1,029.2 Germany 971.7 895.4 726.4 Canada 371.9 389.4 351.0 Norway 257.2 273.5 252.1 Belgium 295.7 306.5 217.1 Eliminations (1,009.2) (1,161.2) (909.3) Total $ 1,939.4 $ 1,930.2 $ 1,666.5 Net sales - point of destination: Europe $ 945.0 $ 878.3 $ 737.8 North America 645.7 695.7 618.1 Other 348.7 356.2 310.6 Total $ 1,939.4 $ 1,930.2 $ 1,666.5 The following table disaggregates the net sales of our Component Products and Real Estate Management and Development Segments by major product line, which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows for these segments are affected by economic factors. Years ended December 31, 2021 2022 2023 (In millions) Component Products: Net sales: Security products $ 105.1 $ 114.5 $ 121.2 Marine components 35.7 52.1 40.1 Total $ 140.8 $ 166.6 $ 161.3 Real Estate Management and Development: Net sales: Land sales $ 207.8 $ 120.9 $ 92.6 Utility and other 1.6 1.2 1.3 Water delivery 6.8 3.6 — Total $ 216.2 $ 125.7 $ 93.9 |
Other income, net
Other income, net | 12 Months Ended |
Dec. 31, 2023 | |
Other income, net | |
Other income, net | Note 13 – Other income, net: Years ended December 31, 2021 2022 2023 (In millions) Interest income and other: Interest and dividends $ 4.0 $ 10.9 $ 21.0 Securities transactions, net — (.5) .3 Total 4.0 10.4 21.3 Infrastructure reimbursement 15.3 16.0 25.5 Currency transactions, net 1.6 11.5 1.4 Insurance recoveries .1 2.8 3.0 Gain on land sales 16.0 — 1.5 Other, net 2.0 3.0 2.7 Total $ 39.0 $ 43.7 $ 55.4 Infrastructure reimbursement Insurance recoveries On August 24, 2020, LPC temporarily halted production due to Hurricane Laura. Although storm damage to core processing facilities was not extensive, a variety of factors, including loss of utilities and limited access and availability of employees and raw materials, prevented the resumption of operations until September 25, 2020. The majority of Kronos’ losses from property damage and its share of LPC’s lost production and other costs resulting from the disruption of operations were covered by insurance. Kronos recognized gains of $2.7 million and $2.5 million in 2022 and 2023, respectively, related to its business interruption claim. NL received $.5 million in insurance recoveries in 2023 and recoveries in each of 2021 and 2022 were nominal. Land sales |
Income taxes
Income taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income taxes Disclosure [Abstract] | |
Income taxes | Note 14 – Income taxes: Years ended December 31, 2021 2022 2023 (In millions) Pre-tax income (loss): United States $ 131.4 $ 81.4 $ 53.2 Non-U.S. subsidiaries 126.4 88.5 (72.7) Total $ 257.8 $ 169.9 $ (19.5) Expected tax expense (benefit) at U.S. federal statutory $ 54.1 $ 35.7 $ (4.1) Non-U.S. tax rates 4.5 2.0 (6.3) Incremental net tax benefit on earnings and losses of U.S. (2.0) (1.7) (13.9) Valuation allowance .9 (3.0) 2.2 Global intangible low-tax income, net 2.8 1.8 (.4) U.S. state income taxes, net 1.5 1.5 .6 Adjustment to the reserve for uncertain tax positions, net (2.6) (2.9) (.7) Nondeductible expenses 1.1 1.0 1.2 Other, net (.2) (.6) (1.0) Income tax expense (benefit) $ 60.1 $ 33.8 $ (22.4) Components of income tax expense (benefit): Currently payable: U.S. federal and state $ 29.7 $ 16.3 $ 12.6 Non-U.S. 21.5 20.1 13.5 Total 51.2 36.4 26.1 Deferred income taxes (benefit): U.S. federal and state (1.7) (3.9) (12.6) Non-U.S. 10.6 1.3 (35.9) Total 8.9 (2.6) (48.5) Income tax expense (benefit) $ 60.1 $ 33.8 $ (22.4) Comprehensive provision (benefit) for income taxes Net income (loss) $ 60.1 $ 33.8 $ (22.4) Other comprehensive income (loss): Currency translation (.8) (3.3) .4 Pension plans 29.7 60.7 (7.6) Other — .9 (.3) Total $ 89.0 $ 92.1 $ (29.9) The amount shown in the preceding table of our income tax rate reconciliation for non-U.S. tax rates represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate. The amount shown on such table for incremental net tax benefit on earnings and losses on non-U.S. and non-tax group companies includes, as applicable, (i) deferred income taxes (or deferred income tax benefits) associated with the current year earnings of all our Chemicals Segment’s non-U.S. subsidiaries, (ii) current U.S. income taxes (or current income tax benefit), including U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our Chemicals Segment’s non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current-year income (losses) of such subsidiary is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal Revenue Code, (iii) deferred income taxes associated with our direct investment in Kronos and (iv) current and deferred income taxes associated with distributions and earnings from our investment in LandWell and BMI. The components of the net deferred income taxes at December 31, 2022 and 2023 are summarized in the following table. December 31, 2022 2023 Assets Liabilities Assets Liabilities (In millions) Tax effect of temporary differences related to: Inventories $ — $ (5.3) $ 1.4 $ — Property and equipment — (62.8) — (62.9) Lease assets (liabilities) 5.3 (5.4) 5.7 (5.7) Accrued OPEB costs 2.0 — 2.1 — Accrued pension costs 22.0 — 26.9 — Accrued environmental liabilities 25.9 — 22.6 — Other deductible differences 12.0 — 14.1 — Other taxable differences — (15.8) — (15.3) Investments in subsidiaries and affiliates 6.7 (62.3) 10.5 (54.7) Tax on unremitted earnings of non-U.S. subsidiaries — (11.4) — (10.9) Tax loss and tax credit carryforwards 82.6 — 119.6 — Valuation allowance (16.5) — (18.2) — Adjusted gross deferred tax assets (liabilities) 140.0 (163.0) 184.7 (149.5) Netting of items by tax jurisdiction (99.5) 99.5 (117.7) 117.7 Net noncurrent deferred tax asset (liability) $ 40.5 $ (63.5) $ 67.0 $ (31.8) We periodically review our deferred tax assets (DTAs) to determine if a valuation allowance is required. At December 31, 2023, our Chemicals Segment has The 2017 Tax Act limited our business interest expense to the sum of our business interest income and 30% of our adjusted taxable income as defined in the Tax Act. Any business interest expense disallowed as a deduction as a result of the limitation may be carried forward indefinitely. At December 31, 2022 and December 31, 2023, we have recorded deferred tax assets of $12.5 million and $14.7 million, respectively, for the carryforwards associated with the nondeductible portion of our interest expense and have concluded we are required to recognize a valuation allowance for such deferred tax asset under the more-likely-than-not recognition criteria. During 2023 we recognized a non-cash deferred income tax expense of $2.2 million with respect to the valuation allowance recorded on additional interest expense carryforwards. Prior to the enactment of the 2017 Tax Act the undistributed earnings of our Chemicals Segment’s European subsidiaries were deemed to be permanently reinvested (we had not made a similar determination with respect to the undistributed earnings of our Chemicals Segment’s Canadian subsidiary). Pursuant to the one-time repatriation tax (Transition Tax) provisions of the 2017 Tax Act which imposed a one-time repatriation tax on post-1986 undistributed earnings, we recognized current income tax expense of $74.1 million and elected to pay such tax in annual installments over an eight-year period beginning in 2018. At December 31, 2023, the balance of our unpaid Transition Tax is $33.3 million with two remaining payments of $14.8 million due in 2024 and $18.5 million due in 2025. The payments are recorded as a current and noncurrent payable to affiliate (income taxes payable to Contran) on our Consolidated Balance Sheet at December 31, 2023. See Note 17. We recognize deferred income taxes with respect to the excess of the financial reporting carrying amount over the income tax basis of our direct investment in Kronos common stock because the exemption under GAAP to avoid such recognition of deferred income taxes is not available to us. At December 31, 2023, we have recognized a deferred income tax liability with respect to our direct investment in Kronos of $47.4 million. There is a maximum amount (or cap) of such deferred income taxes we are required to recognize with respect to our direct investment in Kronos. The maximum amount of such deferred income tax liability we would be required to have recognized (the cap) is $153.6 million. During 2023, we recognized a non-cash deferred income tax benefit with respect to our direct investment in Kronos of $6.4 million for the decrease in the deferred income taxes required to be recognized with respect to the excess of the financial reporting carrying amount over the income tax basis of our direct investment in Kronos common stock, to the extent such decrease related to our equity in Kronos’ net income during such period. We recognized a similar non-cash deferred income tax expense of $1.2 million in 2022 and $5.0 million in 2021. A portion of the net change with respect to the excess of the financial reporting carrying amount over the income tax basis of our direct investment in Kronos common stock during such periods related to our equity in Kronos’ other comprehensive income (loss) items, and the amounts shown in the table above for income tax expense (benefit) allocated to other comprehensive income (loss) items includes amounts related to our equity in Kronos’ other comprehensive income (loss) items. Tax authorities are examining certain of our U.S. and non-U.S. tax returns and may propose tax deficiencies, including penalties and interest. Because of the inherent uncertainties involved in settlement initiatives and court and tax proceedings, we cannot guarantee that these tax matters, if any, will be resolved in our favor, and therefore our potential exposure, if any, is also uncertain. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. The following table shows the changes in the amount of our uncertain tax positions (exclusive of the effect of interest and penalties) during 2021, 2022 and 2023: Years ended December 31, 2021 2022 2023 (In millions) Unrecognized tax benefits: Amount at beginning of year $ 9.6 $ 6.4 $ 3.5 Tax positions taken in current period .6 .7 .5 Lapse due to applicable statute of limitations (3.6) (3.4) (1.2) Changes in currency exchange rates (.2) (.2) — Amount at end of year $ 6.4 $ 3.5 $ 2.8 At December 31, 2023, all of our uncertain tax benefits are classified as a component of our noncurrent deferred tax asset. If our uncertain tax position at December 31, 2023 was recognized, a benefit of $2.8 million would affect our effective income tax rate. We currently estimate that our unrecognized tax benefits will not change materially during the next twelve months. We and Contran file income tax returns in U.S. federal and various state and local jurisdictions. We also file income tax returns in various foreign jurisdictions, principally in Germany, Canada, Belgium and Norway. Our U.S. income tax returns prior to 2020 are generally considered closed to examination by applicable tax authorities. Our non-U.S. income tax returns are generally considered closed to examination for years prior to: 2018 for Norway; 2018 for Canada; 2019 for Germany; and 2020 for Belgium. We accrue interest and penalties on our uncertain tax positions as a component of our provision for income taxes. We accrued interest and penalties of $.7 million during 2021, $.2 million during 2022 and nil during 2023, and at December 31, 2022 and 2023 we had $.1 million and nil, respectively, accrued for interest and penalties for our uncertain tax positions. |
Noncontrolling interest in subs
Noncontrolling interest in subsidiaries | 12 Months Ended |
Dec. 31, 2023 | |
Noncontrolling Interest [Abstract] | |
Noncontrolling interest in subsidiaries | Note 15 – Noncontrolling interest in subsidiaries: December 31, 2022 2023 (In millions) Noncontrolling interest in net assets: Kronos Worldwide $ 239.3 $ 209.0 NL Industries 79.0 76.9 CompX International 20.6 22.0 BMI 6.9 11.0 LandWell 2.4 6.8 Total $ 348.2 $ 325.7 Years ended December 31, 2021 2022 2023 (In millions) Noncontrolling interest in net income (loss) of subsidiaries: Kronos Worldwide $ 22.0 $ 20.0 $ (9.5) NL Industries 8.7 5.8 (.4) CompX International 2.2 2.6 2.9 BMI 14.7 2.8 8.2 LandWell 22.9 14.7 13.8 Total $ 70.5 $ 45.9 $ 15.0 |
Valhi stockholders' equity
Valhi stockholders' equity | 12 Months Ended |
Dec. 31, 2023 | |
Valhi stockholders' equity | |
Valhi stockholders' equity | Note 16 – Valhi stockholders’ equity: Shares of common stock Issued Treasury Outstanding (In millions) Balance at December 31, 2021, 2022 and 2023 29.6 (1.1) 28.5 Valhi share repurchases and cancellations. Treasury stock. purposes. Any unrealized gains or losses on the shares of our common stock attributable to the noncontrolling interest of Kronos and NL are recognized in the determination of each of Kronos and NL’s respective net income or loss. Under the principles of consolidation we eliminate any gains or losses associated with our common stock to the extent of our proportional ownership interest in each subsidiary. We recognized a gain of $3.3 million in 2021 2022 Valhi director stock plan. Stock plans of subsidiaries. Accumulated other comprehensive loss. Years ended December 31, 2021 2022 2023 (In millions) Accumulated other comprehensive income (loss) (net of tax and Marketable securities: Balance at beginning of year $ 1.8 $ 1.7 $ 1.6 Other comprehensive income: Unrealized gain (loss) arising during the year (.1) (.1) .1 Balance at end of year $ 1.7 $ 1.6 $ 1.7 Currency translation: Balance at beginning of year $ (67.4) $ (72.2) $ (91.5) Other comprehensive income (loss) arising during the year (4.8) (19.3) 2.7 Balance at end of year $ (72.2) $ (91.5) $ (88.8) Defined benefit pension plans: Balance at beginning of year $ (154.1) $ (120.9) $ (55.0) Other comprehensive income: Amortization of prior service cost and net losses 10.7 7.3 1.9 Net actuarial gain (loss) arising during the year 22.5 58.4 (10.0) Plan settlement — .2 4.3 Balance at end of year $ (120.9) $ (55.0) $ (58.8) OPEB plans: Balance at beginning of year $ .3 $ .1 $ 1.0 Other comprehensive income: Amortization of prior service credit and net losses (.3) (.5) (.7) Net actuarial gain arising during the year .1 1.4 .1 Balance at end of year $ .1 $ 1.0 $ .4 Total accumulated other comprehensive loss: Balance at beginning of year $ (219.4) $ (191.3) $ (143.9) Other comprehensive income (loss) 28.1 47.4 (1.6) Balance at end of year $ (191.3) $ (143.9) $ (145.5) See Note 11 for amounts related to our defined benefit pension plans and Note 10 for amounts related to our OPEB plans. |
Related party transactions
Related party transactions | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related party transactions | Note 17 – Related party transactions: We may be deemed to be controlled by Ms. Simmons and the Family Trust. See Note 1. Corporations that may be deemed to be controlled by or affiliated with such individuals sometimes engage in (a) intercorporate transactions such as guarantees, management and expense sharing arrangements, shared fee arrangements, joint ventures, partnerships, loans, options, advances of funds on open account, and sales, leases and exchanges of assets, including securities issued by both related and unrelated parties and (b) common investment and acquisition strategies, business combinations, reorganizations, recapitalizations, securities repurchases, and purchases and sales (and other acquisitions and dispositions) of subsidiaries, divisions or other business units, which transactions have involved both related and unrelated parties and have included transactions which resulted in the acquisition by one related party of a publicly-held noncontrolling interest in another related party. While no transactions of the type described above are planned or proposed with respect to us other than as set forth in these financial statements, we continuously consider, review and evaluate, and understand that Contran and related entities consider, review and evaluate such transactions. Depending upon the business, tax and other objectives then relevant, it is possible that we might be a party to one or more such transactions in the future. From time to time, we may have loans and advances outstanding between us and various related parties, including Contran, pursuant to term and demand notes. We generally enter into these loans and advances for cash management purposes. When we loan funds to related parties, we are generally able to earn a higher rate of return on the loan than we would earn if we invested the funds in other instruments. While certain of these loans may be of a lesser credit quality than cash equivalent instruments otherwise available to us, we believe we have evaluated the credit risks involved and appropriately reflect those credit risks in the terms of the applicable loans. When we borrow from related parties, we are generally able to pay a lower rate of interest than we would pay if we borrowed from unrelated parties. We paid Contran $10.4 million, $9.2 million and $10.3 million in interest on borrowings and unused commitment fees under Valhi’s Contran credit facility in 2021, 2022 and 2023, respectively. In February 2024, Kronos entered into a $53.7 million subordinated, unsecured term loan with Contran. See Note 9 for more information on the Kronos term loan with Contran and the Valhi credit facility with Contran. Under the terms of various intercorporate services agreements (ISAs) we enter into with Contran, employees of Contran provide us certain management, tax planning, financial and administrative services on a fee basis. Such fees are based on the compensation of individual Contran employees providing services for us and/or estimates of the time devoted to our affairs by such persons. Because of the number of companies affiliated with Contran, we believe we benefit from cost savings and economies of scale gained by not having certain management, financial and administrative staffs duplicated at all of our subsidiaries, thus allowing certain Contran employees to provide services to multiple companies but only be compensated by Contran. We negotiate fees annually, and agreements renew quarterly. The net ISA fees charged to us by Contran aggregated $41.0 million in 2021, $41.2 million in 2022 and $37.8 million in 2023. At December 31, 2023, we had an aggregate 16.7 million shares of our Kronos common stock pledged as collateral for certain debt obligations of Contran. We receive a fee from Contran for pledging these Kronos shares, determined by a formula based on the market value of the shares pledged. We received $1.5 million in 2021, $1.2 million in 2022 and $.8 million in 2023 from Contran for this pledge. Contran and certain of its subsidiaries and affiliates, including us, purchase certain of their insurance policies and risk management services as a group, with the costs of the jointly-owned policies and services being apportioned among the participating companies. Tall Pines Insurance Company, our subsidiary, underwrites certain insurance policies for Contran and certain of its subsidiaries and affiliates, including us. Tall Pines purchases reinsurance from highly rated (as determined by A.M. Best or other internationally recognized ratings agency) third-party insurance carriers for substantially all of the risks it underwrites. Consistent with insurance industry practices, Tall Pines receives commissions from the reinsurance underwriters and/or assesses fees for certain of the policies that it underwrites. The aggregate amount paid under the group insurance program by us, our subsidiaries and our joint venture in 2021, 2022 and 2023 was $27.1 million, $25.2 million and $29.3 million, respectively, which amounts principally represent insurance premiums. The aggregate amounts paid under the group insurance program also include payments to insurers or reinsurers for the reimbursement of claims within our applicable deductible or retention ranges that such insurers and reinsurers paid to third parties on our behalf, as well as amounts for claims and risk management services and various other third-party fees and expenses incurred by the program. We expect these relationships will continue in 2024. With respect to certain of such jointly-owned policies, it is possible that unusually large losses incurred by one or more insureds during a given policy period could leave the other participating companies without adequate coverage under that policy for the balance of the policy period. As a result, and in the event that the available coverage under a particular policy would become exhausted by one or more claims, Contran and certain of its subsidiaries and affiliates, including us, have entered into a loss sharing agreement under which any uninsured loss arising because the available coverage had been exhausted by one or more claims will be shared ratably amongst those entities that had submitted claims under the relevant policy. We believe the benefits in the form of reduced premiums and broader coverage associated with the group coverage for such policies justify the risk associated with the potential for any uninsured loss. Contran and certain of its subsidiaries participate in a combined information technology data services program that Contran provides for primary data processing and failover. The program apportions its costs among the participating companies. The aggregate amount Kronos paid Contran for such services was $.3 million in each of 2021 and 2022 and $.4 million in 2023. Under the terms of a sublease agreement between Contran and Kronos, Kronos leases certain office space from Contran. Kronos paid Contran $.4 million in 2021, $.5 million in 2022 and $.6 million in 2023 for such rent and related ancillary services. We expect that these relationships with Contran will continue in 2024. Receivables from and payables to affiliates are summarized in the table below. December 31, 2022 2023 (In millions) Current receivables from affiliates: LPC $ — $ 16.9 Contran - trade items .2 .2 Other 2.7 .4 Total $ 2.9 $ 17.5 Current payables to affiliates: LPC $ 17.1 $ 19.9 Contran - income taxes 5.8 10.2 Total $ 22.9 $ 30.1 Noncurrent payable to affiliates: Contran - income taxes $ 33.4 $ 18.5 Payables to affiliate included in long-term debt: Valhi - Contran credit facility $ 121.4 $ 93.4 Amounts payable to LPC are generally for the purchase of TiO 2 , while amounts receivable from LPC are generally from the sale of TiO 2 feedstock. See Note 7. Purchases of TiO 2 from LPC were $188.6 million in 2021, $225.6 million in 2022 and $231.7 million in 2023. Sales of feedstock to LPC were $85.4 million in 2021, $106.9 million in 2022 and $135.1 million in 2023. The noncurrent payable to Contran for income taxes is discussed in Note 14. |
Commitments and contingencies
Commitments and contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments and contingencies | Note 18 – Commitments and contingencies: Lead pigment litigation NL’s former operations included the manufacture of lead pigments for use in paint and lead-based paint. NL, other former manufacturers of lead pigments for use in paint and lead-based paint (together, the “former pigment manufacturers”), and the Lead Industries Association (LIA), which discontinued business operations in 2002, have been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions have been filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others have been asserted as class actions. These lawsuits seek recovery under a variety of theories, including public and private nuisance, negligent product design, negligent failure to warn, strict liability, breach of warranty, conspiracy/concert of action, aiding and abetting, enterprise liability, market share or risk contribution liability, intentional tort, fraud and misrepresentation, violations of state consumer protection statutes, supplier negligence and similar claims. The plaintiffs in these actions generally seek to impose on the defendants responsibility for lead paint abatement and health concerns associated with the use of lead-based paints, including damages for personal injury, contribution and/or indemnification for medical expenses, medical monitoring expenses and costs for educational programs. To the extent the plaintiffs seek compensatory or punitive damages in these actions, such damages are generally unspecified. In some cases, the damages are unspecified pursuant to the requirements of applicable state law. A number of cases are inactive or have been dismissed or withdrawn. Most of the remaining cases are in various pre-trial stages. Some are on appeal following dismissal or summary judgment rulings or a trial verdict in favor of either the defendants or the plaintiffs. NL believes it has substantial defenses to these actions and NL intends to continue to deny all allegations of wrongdoing and liability and to defend against all actions vigorously. We do not believe it is probable we have incurred any liability with respect to pending lead pigment litigation cases to which NL is a party, and with respect to all such lead pigment litigation cases to which NL is a party, we believe liability to NL that may result, if any, in this regard cannot be reasonably estimated, because: ● NL has never settled any of the market share, intentional tort, fraud, nuisance, supplier negligence, breach of warranty, conspiracy, misrepresentation, aiding and abetting, enterprise liability, or statutory cases (other than the Santa Clara case discussed below), ● no final, non-appealable adverse judgments have ever been entered against NL, and ● NL has never ultimately been found liable with respect to any such litigation matters, including over 100 cases over a thirty-year period for which NL was previously a party and for which NL has been dismissed without any finding of liability. Accordingly, we have not accrued any amounts for any of the pending lead pigment and lead-based paint litigation cases filed by or on behalf of states, counties, cities or their public housing authorities and school districts, or those asserted as class actions. In addition, we have determined that liability to NL which may result, if any, cannot be reasonably estimated at this time because there is no prior history of a loss of this nature on which an estimate could be made and there is no substantive information available upon which an estimate could be based. In the matter titled County of Santa Clara v. Atlantic Richfield Company, et al Under the terms of the global settlement agreement, each defendant must pay an aggregate $101.7 million to the plaintiffs as follows: $25.0 million within sixty days of the court’s approval of the settlement and dismissal of the case, and the remaining $76.7 million in six annual installments beginning on the first anniversary of the initial payment ($12.0 million first five installments For financial reporting purposes, using a discount rate of 1.9% per annum, we discounted the aggregate $101.7 million settlement to the estimated net present value of $96.3 million. NL made the initial $25.0 million payment in September 2019 and the first, second, third and fourth annual installment payments of $12.0 million each in September 2020, 2021, 2022 and 2023. We recognized an aggregate accretion expense of $1.1 million, $.9 million and $.7 million in 2021, 2022, and 2023, respectively. New cases may continue to be filed against us. We do not know if we will incur liability in the future in respect of any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. In the future, if new information regarding such matters becomes available to us (such as a final, non-appealable adverse verdict against us or otherwise ultimately being found liable with respect to such matters), at that time we would consider such information in evaluating any remaining cases then-pending against us as to whether it might then have become probable we have incurred liability with respect to these matters, and whether such liability, if any, could have become reasonably estimable. The resolution of any of these cases could result in the recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity. Environmental matters and litigation Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. Our businesses have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance. From time to time, our businesses may be subject to environmental regulatory enforcement under U.S. and non-U.S. statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe all of our facilities are in substantial compliance with applicable environmental laws. Certain properties and facilities used in our former operations (primarily NL’s former operations), including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws and common law. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (PRP) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization Act (CERCLA), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities that we or our predecessors and NL or its predecessors, subsidiaries or their predecessors currently or previously owned, operated or used, certain of which are on the United States Environmental Protection Agency’s (EPA) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases NL is only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are occasionally named as a party in a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations. Obligations associated with environmental remediation and related matters are difficult to assess and estimate for numerous reasons including the: ● complexity and differing interpretations of governmental regulations, ● number of PRPs and their ability or willingness to fund such allocation of costs, ● financial capabilities of the PRPs and the allocation of costs among them, ● solvency of other PRPs, ● multiplicity of possible solutions, ● number of years of investigatory, remedial and monitoring activity required, ● uncertainty over the extent, if any, to which our former operations might have contributed to the conditions allegedly giving rise to such personal injury, property damage, natural resource and related claims, and ● number of years between former operations and notice of claims and lack of information and documents about the former operations. In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or the allocation of costs among PRPs, solvency of other PRPs, the results of future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. Actual costs could exceed accrued amounts or the upper end of the range for sites for which estimates have been made, and costs may be incurred for sites where no estimates presently can be made. Further, additional environmental and related matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our consolidated financial statements, results of operations and liquidity. We record liabilities related to environmental remediation and related matters (including costs associated with damages for personal injury or property damage and/or damages for injury to natural resources) when estimated future expenditures are probable and reasonably estimable. We adjust such accruals as further information becomes available to us or as circumstances change. Unless the amounts and timing of such estimated future expenditures are fixed and reasonably determinable, we generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the payout. We recognize recoveries of costs from other parties, if any, as assets when their receipt is deemed probable. At December 31, 2022 and December 31, 2023, we had not recognized any material receivables for recoveries. We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental and related costs. The timing of payments depends upon a number of factors, including but not limited to the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of the accrued environmental and related costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability. The table below presents a summary of the activity in our accrued environmental costs during 2021, 2022, and 2023. Years ended December 31, 2021 2022 2023 (In millions) Balance at the beginning of the year $ 98.6 $ 97.6 $ 97.3 Additions charged to expense, net 1.6 1.7 2.5 Payments, net (2.5) (2.0) (2.9) Changes in currency exchange rates and other (.1) — — Balance at the end of the year $ 97.6 $ 97.3 $ 96.9 Amounts recognized in the Consolidated Balance Sheet at the Current liabilities $ 3.5 $ 3.8 $ 3.7 Noncurrent liabilities 94.1 93.5 93.2 Total $ 97.6 $ 97.3 $ 96.9 NL. NL believes that it is not reasonably possible to estimate the range of costs for certain sites. At December 31, 2023, there were approximately five sites for which NL is not currently able to reasonably estimate a range of costs. For these sites, generally the investigation is in the early stages, and NL is unable to determine whether or not NL actually had any association with the site, the nature of its responsibility, if any, for the contamination at the site, if any, and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of NL’s control, such as when the party alleging liability provides information to NL. At certain of these previously inactive sites, NL has received general and special notices of liability from the EPA and/or state agencies alleging that NL, sometimes with other PRPs, are liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that NL, along with any other alleged PRPs, are liable for past and/or future clean-up costs. As further information becomes available to us for any of these sites which would allow us to estimate a range of costs, we would at that time adjust our accruals. Any such adjustment could result in the recognition of an accrual that would have a material effect on our consolidated financial statements, results of operations and liquidity. Other. Insurance coverage claims We are involved in certain legal proceedings with a number of our former insurance carriers regarding the nature and extent of the carriers’ obligations to us under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether insurance coverage for defense costs or indemnity or both will be found to exist for our lead pigment and asbestos litigation depends upon a variety of factors and we cannot assure you that such insurance coverage will be available. We have agreements with certain of our former insurance carriers pursuant to which the carriers reimburse us for a portion of our future lead pigment litigation defense costs, and one such carrier reimburses us for a portion of our future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. While we continue to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, we recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery. Other litigation In addition to the litigation described above, we and our affiliates are involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect additional material insurance coverage for our environmental matters. We currently believe that the disposition of all of these various other claims and disputes (including asbestos-related claims), individually or in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided. Other matters Concentrations of credit risk – Sales of TiO 2 accounted for approximately 92% of our Chemicals Segment’s sales in each of 2021 and 2022 and 90% in 2023. The remaining sales result from the sale of ilmenite ore (a raw material used in the sulfate pigment production process), and the manufacture and sale of iron-based water treatment chemicals and certain titanium chemical products (derived from co-products of the TiO 2 production processes). TiO 2 is generally sold to the paint, plastics and paper industries. Such markets are generally considered “quality-of-life” markets whose demand for TiO 2 is influenced by the relative economic well-being of the various geographic regions. Our Chemicals Segment sells TiO 2 to approximately 3,000 customers, with the top ten customers approximating 32% of our Chemicals Segment’s net sales in 2021, 33% in 2022 and 35% in 2023. One customer accounted for approximately 10% of our Chemicals Segment’s net sales in 2022 and 12% in 2023. Our Chemicals Segment did not have sales to a single customer comprising 10% or more of its net sales in 2021. The table below shows the approximate percentage of our Chemicals Segment’s TiO 2 sales by volume for its significant markets, Europe and North America, for the last three years. 2021 2022 2023 Europe 46% 45% 44% North America 37% 39% 41% Our Component Products Segment’s products are sold primarily in North America to original equipment manufacturers. The ten largest customers related to our Component Product’s Segment accounted for approximately 51% of our Component Products Segment’s sales in 2021 and 52% in each of 2022 and 2023. One customer of the security products reporting unit accounted for approximately 16% of the Component Products Segment’s total sales in 2021, 14% in 2022 and 24% in 2023 (of which 11% relates to a pilot project). One customer of the marine components reporting unit accounted for 12% of the Component Products Segment’s total sales in 2022. Our Real Estate Management and Development Segment’s revenues are land sales income and water (through September 2022) and electric delivery fees (prior to December 2023). During 2021, we had sales to three customers two customers Long-term contracts – Our Chemicals Segment has long-term supply contracts that provide for certain of its TiO 2 feedstock requirements through 2026. The agreements require Kronos to purchase certain minimum quantities of feedstock with minimum purchase commitments aggregating approximately $ 583 million over the life of the contracts in years subsequent to December 31, 2023 (including approximately $465 million committed to be purchased in 2024). In addition, our Chemicals Segment has other long-term supply and service contracts that provide for various raw materials and services. These agreements require Kronos to purchase certain minimum quantities or services with minimum purchase commitments aggregating approximately $72 million at December 31, 2023 (including $38 million committed to be purchased in 2024). Income taxes – We are a party to a tax sharing agreement with Contran providing for the allocation of tax liabilities and tax payments as described in Note 1. Under applicable law, we, as well as every other member of the Contran Tax Group, are each jointly and severally liable for the aggregate federal income tax liability of Contran and the other companies included in the Contran Tax Group for all periods in which we are included in the Contran Tax Group. Contran has agreed, however, to indemnify us for any liability for income taxes of the Contran Tax Group in excess of our tax liability computed in accordance with the tax sharing agreement. |
Financial instruments
Financial instruments | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Financial instruments | Note 19 – Financial instruments: See Note 6 for information on how we determine the fair value of our marketable securities. The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure as of December 31, 2022 and 2023: December 31, 2022 December 31, 2023 Carrying Fair Carrying Fair amount value amount value (In millions) Cash, cash equivalents and restricted cash equivalents $ 562.0 $ 562.0 $ 462.0 $ 462.0 Long-term debt: Kronos 3.75% Senior Secured Notes due 2025 424.1 374.2 440.9 424.5 Valhi credit facility with Contran 121.4 121.4 93.4 93.4 LandWell bank note payable 12.9 12.9 12.2 12.2 At December 31, 2023, the estimated market price of Kronos’ 3.75% Senior Secured Notes due 2025 was €959 per €1,000 principal amount. The fair value of Kronos’ 3.75% Senior Secured Notes due 2025 was based on quoted market prices; however, these quoted market prices represent Level 2 inputs because the markets in which the 3.75% Senior Secured Notes due 2025 trade were not active. Fair values of variable interest rate debt and other fixed-rate debt are deemed to approximate book value. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value. See Notes 4 and 10. |
Restructuring costs
Restructuring costs | 12 Months Ended |
Dec. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring costs | Note 20 – Restructuring costs: As part of overall cost saving measures to improve Kronos’ long-term cost structure, during the third quarter of 2023 Kronos began implementing certain voluntary and involuntary workforce reductions. A substantial portion of Kronos’ workforce reductions were accomplished through voluntary programs for which eligible workforce reduction costs are recognized at the time both the employee and employer are irrevocably committed to the terms of the separation. These workforce reductions impacted approximately 100 individuals and are substantially completed. Kronos recognized a total of approximately $6 million in selling, general and administrative expense related to these workforce reductions in 2023. by the first quarter of 2024 and are included in accrued liabilities – other on our Consolidated Balance Sheet. See Note 10. A summary of the activity in Kronos’ accrued workforce reduction costs for 2023 is shown in the table below (in millions): Accrued workforce reduction costs as of January 1, 2023 $ — Workforce reduction costs accrued 5.8 Workforce reduction costs paid (.9) Currency translation adjustments, net .1 Accrued workforce reduction costs at December 31, 2023 $ 5.0 Amounts recognized in the balance sheet: Current liability $ 5.0 Noncurrent liability — $ 5.0 |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Changes And Error Corrections [Abstract] | |
Recent Accounting Pronouncements | Note 21 – Recent Accounting Pronouncements: In November 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures |
Summary of significant accoun_2
Summary of significant accounting policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Summary of significant accounting policies | |
Nature of our business | Nature of our business. |
Organization | Organization. Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Valhi, Inc. and its subsidiaries, taken as a whole. |
Management's estimates | Management’s estimates. |
Principles of consolidation | Principles of consolidation. |
Foreign currency translation | Foreign currency translation. |
Derivatives and hedging activities | Derivatives and hedging activities. |
Cash and cash equivalents | Cash and cash equivalents. |
Restricted cash and cash equivalents | Restricted cash and cash equivalents. |
Marketable securities and securities transactions | Marketable securities and securities transactions. Fair Value Measurements and Disclosures ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the assets or liability; and ● Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable. We classify all of our marketable securities as available-for-sale. Any unrealized gains or losses on our marketable equity securities are recognized in other income, net on our Consolidated Statements of Operations. We accumulate unrealized gains and losses on marketable debt securities as part of accumulated other comprehensive income (loss), net of related deferred income taxes. See Notes 6, 11 and 13. We base realized gains and losses upon the specific identification of the securities sold. |
Accounts receivable | Accounts receivable. |
Inventories and cost of sales | Inventories and cost of sales. |
Land held for development | Land held for development. identification, relative sales value, square footage or a combination of these methods. All sales and marketing activities and general overhead are charged to selling, general and administrative expense as incurred. |
Investment in TiO2 manufacturing joint venture | Investment in TiO 2 manufacturing joint venture. |
Leases | Leases. We determine if an arrangement is a lease (including leases embedded in another type of contract) at inception. All of our leases are classified as operating leases. Operating leases are included in operating lease right-of-use assets, current operating lease liabilities and noncurrent operating lease liabilities in our Consolidated Balance Sheets. See Notes 7 and 10. As permitted by ASC Topic 842, Leases Right-of-use assets represent our right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease. The right-of-use operating lease assets and liabilities are recognized based on the estimated present value of lease payments over the lease term as of the respective lease commencement dates. We use an estimated incremental borrowing rate to determine the present value of lease payments (unless we can determine the rate implicit in the lease, which is generally not the case). Our incremental borrowing rate for each of our leases is derived from available information, including our current debt and credit facilities and U.S. and European yield curves as well as publicly available data for instruments with similar characteristics, adjusted for factors such as collateralization and term. Our leases generally do not include termination or purchase options. Certain of our leases include an option to renew the lease after expiration of the initial lease term, but we have not included such renewal periods in our lease term because it is not reasonably certain that we would exercise the renewal option. Our leases generally have fixed lease payments, with no contingent or incentive payments. Certain of our leases include variable lease payments that depend on a specified index or rate. Our lease agreements do not contain any residual value guarantees. |
Goodwill and other intangible assets; amortization expense | Goodwill and other intangible assets; amortization expense. |
Property and equipment; depreciation expense | Property and equipment; depreciation expense. Asset Useful lives Buildings and improvements 10 Machinery and equipment 3 Mine development costs Units-of-production We use accelerated depreciation methods for income tax purposes, as permitted. Upon the sale or retirement of an asset, we remove the related cost and accumulated depreciation from the accounts and recognize any gain or loss in income currently. We expense expenditures for maintenance, repairs and minor renewals as incurred that do not improve or extend the life of the assets, including planned major maintenance. We have a governmental concession with an unlimited term to operate our ilmenite mine in Norway. Mining properties consist of buildings and equipment used in our Norwegian ilmenite mining operations. While we own the land and ilmenite reserves associated with the mining operations, such land and reserves were acquired for nominal value and we have no material asset recognized for the land and reserves related to our mining operations. We perform impairment tests when events or changes in circumstances indicate the carrying value may not be recoverable. We consider all relevant factors. We perform the impairment test by comparing the estimated future undiscounted cash flows (exclusive of interest expense) associated with the asset or asset group to the asset’s net carrying value to determine if a write-down to fair value is required. During the fourth quarter of 2023, our Chemicals Segment recorded a fixed asset impairment of $3.8 million related to the write-off of certain costs resulting from a capital project termination. Excluding this project, we did not evaluate any long-lived assets for impairment during 2023 because no such impairment indicators were present. During the preparation of our second quarter 2023 interim financial statements, we identified a prior period misclassification related to the presentation of the gross value of the classes of property and equipment and accumulated depreciation and amortization. This misclassification had no impact to net property and equipment; however, total gross property and equipment increased $19.1 million (a decrease of $5.3 million and $45.8 million in land and equipment, respectively, and an increase of $5.1 million and $65.1 million in buildings and mining properties, respectively), and accumulated depreciation and amortization increased by the same amount. Property and equipment presented on the December 31, 2022 Consolidated Balance Sheet has been revised to reflect these changes. We have evaluated the misclassifications and determined the related changes are not material to any previously issued annual or interim financial statements. |
Long-term debt | Long-term debt. |
Employee benefit plans | Employee benefit plans. |
Income taxes | Income taxes. We recognize deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the income tax and financial reporting carrying amounts of assets and liabilities, including investments in our subsidiaries and affiliates who are not members of the Contran Tax Group and undistributed earnings of our Chemicals Segment’s non-U.S. subsidiaries which are not deemed to be permanently reinvested. At December 31, 2023, we continue to assert indefinite reinvestment as it relates to our outside basis difference attributable to our Chemicals Segment’s investments in non-U.S. subsidiaries, other than post-1986 undistributed earnings of our Chemicals Segment’s European subsidiaries and all undistributed earnings of our Chemicals Segment’s Canadian subsidiary, which are not subject to permanent reinvestment plans. It is not practical for us to determine the amount of the unrecognized deferred income tax liability related to our investments in our Chemicals Segment’s non-U.S. subsidiaries which are permanently reinvested due to the complexities associated with our organizational structure, changes in the Tax Cuts and Jobs Act (2017 Tax Act) and the U.S. taxation of such investments in the states in which we operate. Deferred income tax assets and liabilities for each tax-paying jurisdiction in which we operate are netted and presented as either a noncurrent deferred income tax asset or liability, as applicable. We periodically evaluate our deferred tax assets in the various taxing jurisdictions in which we operate and adjust any related valuation allowance based on the estimate of the amount of such deferred tax assets that we believe does not meet the more-likely-than-not recognition criteria. The U.S. Federal tax code imposes a tax on global intangible low-tax income (GILTI). We record GILTI tax as a current period expense when incurred under the period cost method. While our future global operations depend on a number of different factors, we do expect to have future U.S. inclusions in taxable income related to GILTI. We account for the tax effects of a change in tax law as a component of the income tax provision related to continuing operations in the period of enactment, including the tax effects of any deferred income taxes originally established through a financial statement component other than continuing operations (i.e. other comprehensive income). Changes in applicable income tax rates over time as a result of changes in tax law, or times in which a deferred income tax asset valuation allowance is initially recognized in one year and subsequently reversed in a later year, can give rise to “stranded” tax effects in accumulated other comprehensive income in which the net accumulated income tax (benefit) remaining in accumulated other comprehensive income does not correspond to the then-applicable income tax rate applied to the pre-tax amount which resides in accumulated other comprehensive income. As permitted by GAAP, our accounting policy is to remove any such stranded tax effect remaining in accumulated other comprehensive income, by recognizing an offset to our provision for income taxes related to continuing operations, only at the time when there is no remaining pre-tax amount in accumulated other comprehensive income. For accumulated other comprehensive income related to currency translation, this would occur only upon the sale or complete liquidation of one of our Chemicals Segment’s non-U.S. subsidiaries. For defined pension benefit plans and OPEB plans, this would occur whenever one of our subsidiaries which previously sponsored a defined benefit pension or OPEB plan had terminated such a plan and had no future obligation or plan asset associated with such a plan. We record a reserve for uncertain tax positions where we believe it is more-likely-than-not our position will not prevail with the applicable tax authorities. The amount of the benefit associated with our uncertain tax positions that we recognize is limited to the largest amount for which we believe the likelihood of realization is greater than 50%. We accrue penalties and interest on the difference between tax positions taken on our tax returns and the amount of benefit recognized for financial reporting purposes. We classify our reserves for uncertain tax positions in a separate current or noncurrent liability, depending on the nature of the tax position. See Note 14. |
Environmental remediation and related costs | Environmental remediation and related costs. |
Revenue recognition | Revenue recognition. Chemicals and Component Products Segments – Revenue from Contracts with Customers to our customers by transferring control of our products to them, which generally occurs at point of shipment or upon delivery. Such transfer of control is also evidenced by transfer of legal title and other risks and rewards of ownership (giving the customer the ability to direct the use of, and obtain substantially all of the benefits of, the product), and our customers becoming obligated to pay us and it is probable we will receive payment. In certain arrangements we provide shipping and handling activities after the transfer of control to our customer (e.g. when control transfers prior to delivery). In such arrangements shipping and handling are considered fulfillment activities, and accordingly, such costs are accrued when the related revenue is recognized. Revenue is recorded in an amount that reflects the net consideration we expect to receive in exchange for our products. Prices for our products are based on terms specified in published list prices and purchase orders, which generally do not include financing components, noncash consideration or consideration paid to our customers. As our standard payment terms are less than one year, we have elected the practical expedient under ASC 606 and we have not assessed whether a contract has a significant financing component. We state sales net of price, early payment and distributor discounts as well as volume rebates (collectively, variable consideration). Variable consideration, to the extent present, is recognized as the amount to which we are most-likely to be entitled, using all information (historical, current and forecasted) that is reasonably available to us, and only to the extent that a significant reversal in the amount of the cumulative revenue recognized is not probable of occurring in a future period. Differences, if any, between estimates of the amount of variable consideration to which we will be entitled and the actual amount of such variable consideration have not been material in the past. We occasionally receive partial or full consideration from our customers prior to the completion of our performance obligation (shipment of product). We record estimated deferred revenue on the amount to which we are most-likely to be entitled and deferred revenue is recognized into revenue as our performance obligation has been satisfied. Deferred revenue has not been material in the past. We report any tax assessed by a governmental authority that we collect from our customers that is both imposed on and concurrent with our revenue-producing activities (such as sales, use, value added and excise taxes) on a net basis (meaning we do not recognize these taxes either in our revenues or in our costs and expenses). Frequently, we receive orders for products to be delivered over dates that may extend across reporting periods. We invoice for each delivery upon shipment and recognize revenue for each distinct shipment when all sales recognition criteria for that shipment have been satisfied. As scheduled delivery dates for these orders are within a one year period, under the optional exemption provided by ASC 606, we do not disclose sales allocated to future shipments of partially completed contracts. Real Estate Management and Development Segment – Our revenues also are related to efforts to develop certain real estate in Henderson, Nevada, including approximately 2,100 acres zoned for residential/planned community purposes. Contracts for land sales are negotiated on an individual basis, involve single performance obligations, and generally require us to complete property development and improvements after title passes to the buyer and we have received all or a substantial portion of the selling price. We recognize land sales revenue associated with the residential/planned community over time using cost-based input methods. Land sales associated with the residential/planned community have variable consideration components which are based on a percentage of the builder’s ultimate selling price of a residential housing unit to their customer (ranging from 2.5% to 3.5% of such sales price). The amount we recognize when a parcel is sold to a home builder is the amount to which we are most-likely to be entitled, using all information (historical, current and forecasted) that is reasonably available to us, and only to the extent that a significant reversal in the amount of the cumulative revenue recognized is not probable of occurring in a future period. By recognizing revenue over time using cost-based input methods, revenues (including variable consideration) and profits are recognized in the same proportion of our progress towards completion of our contractual obligations, with our progress measured by costs incurred as a percentage of total costs estimated to be incurred relative to the parcels sold. Estimates of total costs expected to be incurred require significant management judgment, and the amount of revenue and profits that have been recognized to date are subject to revisions throughout the development period. The impact on the amount of revenue recognized resulting from any future change in the estimate of total costs estimated to be incurred would be accounted for prospectively in accordance with GAAP. We record estimated deferred revenue on the amount to which we are most-likely to be entitled and deferred revenue is recognized into revenue as the housing units are sold. |
Selling, general and administrative expenses; shipping and handling costs; advertising costs; research and development costs | Selling, general and administrative expenses; shipping and handling costs; advertising costs; research and development costs. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Summary of significant accounting policies | |
Schedule of estimated useful lives of the assets | Asset Useful lives Buildings and improvements 10 Machinery and equipment 3 Mine development costs Units-of-production |
Business and geographic segme_2
Business and geographic segments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Business and geographic segments | |
Holding Percentage of Subsidiaries | % controlled at Business segment Entity December 31, 2023 Chemicals Kronos 81% Component products CompX 87% Real estate management and development BMI and LandWell 63% - 77% |
Segment Operating Performance | Years ended December 31, 2021 2022 2023 (In millions) Net sales: Chemicals $ 1,939.4 $ 1,930.2 $ 1,666.5 Component products 140.8 166.6 161.3 Real estate management and development 216.2 125.7 93.9 Total net sales $ 2,296.4 $ 2,222.5 $ 1,921.7 Cost of sales: Chemicals $ 1,494.5 $ 1,540.2 $ 1,502.7 Component products 98.1 117.8 112.1 Real estate management and development 123.6 74.1 61.7 Total cost of sales $ 1,716.2 $ 1,732.1 $ 1,676.5 Gross margin: Chemicals $ 444.9 $ 390.0 $ 163.8 Component products 42.7 48.8 49.2 Real estate management and development 92.6 51.6 32.2 Total gross margin $ 580.2 $ 490.4 $ 245.2 Operating income (loss): Chemicals $ 200.8 $ 174.6 $ (41.1) Component products 20.5 25.4 25.4 Real estate management and development 97.3 39.4 49.9 Total operating income 318.6 239.4 34.2 General corporate items: Interest income and other 4.0 10.4 21.3 Gain on land sales 16.0 — 1.5 Other components of net periodic pension and OPEB expense (17.0) (13.9) (11.8) Changes in market value of Valhi common stock held by subsidiaries 3.3 (1.6) (1.7) General expenses, net (34.6) (36.5) (34.7) Interest expense (32.5) (27.9) (28.3) Income (loss) before income taxes $ 257.8 $ 169.9 $ (19.5) Years ended December 31, 2021 2022 2023 (In millions) Depreciation and amortization: Chemicals $ 52.8 $ 53.1 $ 49.9 Component products 3.8 4.0 4.0 Real estate management and development 2.7 1.4 .2 Total $ 59.3 $ 58.5 $ 54.1 Capital expenditures: Chemicals $ 58.6 $ 63.2 $ 47.4 Component products 4.1 3.7 1.1 Real estate management and development 1.4 .7 — Total $ 64.1 $ 67.6 $ 48.5 |
Total Assets Held by Business Segments | December 31, 2021 2022 2023 (In millions) Total assets: Operating segments: Chemicals $ 2,373.1 $ 2,293.5 $ 2,196.8 Component products 146.4 131.3 141.5 Real estate management and development 259.3 219.2 200.9 Corporate and eliminations 226.4 191.7 197.8 Total $ 3,005.2 $ 2,835.7 $ 2,737.0 |
Net Sales by Point of Origin and Point of Destination | Years ended December 31, 2021 2022 2023 (In millions) Net sales - point of origin: United States $ 1,409.1 $ 1,518.9 $ 1,284.4 Germany 971.7 895.4 726.4 Canada 371.9 389.4 351.0 Norway 257.2 273.5 252.1 Belgium 295.7 306.5 217.1 Eliminations (1,009.2) (1,161.2) (909.3) Total $ 2,296.4 $ 2,222.5 $ 1,921.7 Net sales - point of destination: North America $ 999.7 $ 985.4 $ 871.0 Europe 945.7 879.0 738.5 Other 351.0 358.1 312.2 Total $ 2,296.4 $ 2,222.5 $ 1,921.7 |
Net Property and Equipment by Segment | December 31, 2021 2022 2023 (In millions) Net property and equipment: United States $ 63.6 $ 45.8 $ 40.0 Germany 214.8 204.7 213.0 Belgium 107.7 101.4 98.5 Norway 86.4 83.6 83.5 Canada 91.1 88.3 82.3 Total $ 563.6 $ 523.8 $ 517.3 |
Accounts and other receivable_2
Accounts and other receivables, net (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounts and other receivables, net | |
Components of Accounts and Other Receivables | December 31, 2022 2023 (In millions) Trade accounts receivable: Kronos $ 220.3 $ 273.6 CompX 17.9 17.1 BMI/LandWell 2.3 1.2 VAT and other receivables 35.4 33.4 Allowance for doubtful accounts (4.9) (4.2) Total $ 271.0 $ 321.1 |
Inventories, net (Tables)
Inventories, net (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Inventories, net | |
Inventories, Net | December 31, 2022 2023 (In millions) Raw materials: Chemicals $ 145.3 $ 188.3 Component products 6.2 5.7 Total raw materials 151.5 194.0 Work in process: Chemicals 32.0 30.8 Component products 20.0 19.1 Total in-process products 52.0 49.9 Finished products: Chemicals 350.7 250.4 Component products 5.1 5.9 Total finished products 355.8 256.3 Supplies (chemicals) 81.5 95.9 Total $ 640.8 $ 596.1 |
Marketable securities (Tables)
Marketable securities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Marketable securities | |
Schedule of Marketable Securities | Cost or amortized Unrealized Market value cost loss, net (In millions) December 31, 2022: Current assets $ 75.1 $ 75.7 $ (.6) Noncurrent assets $ 1.2 $ 1.2 $ — December 31, 2023: Current assets $ 56.1 $ 56.1 $ — Noncurrent assets $ 4.8 $ 5.0 $ (.2) |
Schedule of Marketable Securities and Fair Value Measurements | Fair Value Measurements Quoted Significant Prices in Other Active Observable Markets Inputs Total (Level 1) (Level 2) (In millions) December 31, 2022: Current assets: Fixed income securities $ 73.3 $ — $ 73.3 Mutual funds 1.8 1.8 — Total $ 75.1 $ 1.8 $ 73.3 Noncurrent assets - fixed income securities $ 1.2 $ — $ 1.2 December 31, 2023: Current assets - fixed income securities $ 56.1 $ — $ 56.1 Noncurrent assets: Fixed income securities $ 2.6 $ — $ 2.6 Mutual funds 2.2 2.2 — Total $ 4.8 $ 2.2 $ 2.6 |
Investment in TiO2 manufactur_2
Investment in TiO2 manufacturing joint venture and other assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Other Assets | December 31, 2022 2023 (In millions) Other assets: Restricted cash and cash equivalents $ 37.2 $ 32.4 Note receivables - OPA 49.3 69.1 Operating lease right-of-use assets 21.5 22.7 Land held for development 29.7 19.4 IBNR receivables 16.8 13.4 Other 24.3 16.7 Total $ 178.8 $ 173.7 |
Schedule of Maturities of Operating Lease Liabilities | Years ending December 31, Amount (In millions) 2024 $ 4.6 2025 3.6 2026 3.3 2027 2.2 2028 2.0 2029 and thereafter 17.0 Total remaining lease payments 32.7 Less imputed interest 10.2 Total lease obligations 22.5 Less current obligations 3.9 Long term lease obligations $ 18.6 |
Louisiana Pigment Company | |
Summary of Net Distributions, Balance Sheets and Income Statements | Years ended December 31, 2021 2022 2023 (In millions) Distributions from LPC $ 28.5 $ 58.3 $ 52.8 Contributions to LPC (24.7) (68.8) (49.7) Net distributions (contributions) $ 3.8 $ (10.5) $ 3.1 Summary balance sheets of LPC are shown below: December 31, 2022 2023 (In millions) ASSETS Current assets $ 122.2 $ 118.5 Property and equipment, net 147.4 148.4 Total assets $ 269.6 $ 266.9 LIABILITIES AND PARTNERS' EQUITY Other liabilities, primarily current $ 41.2 $ 42.1 Partners' equity 228.4 224.8 Total liabilities and partners' equity $ 269.6 $ 266.9 Summary income statements of LPC are shown below: Years ended December 31, 2021 2022 2023 (In millions) Revenues and other income: Kronos $ 188.6 $ 225.6 $ 231.7 Venator Investments 189.6 225.9 231.7 Total 378.2 451.5 463.4 Cost and expenses: Cost of sales 377.8 451.1 463.0 General and administrative .4 .4 .4 Total 378.2 451.5 463.4 Net income $ — $ — $ — |
Goodwill (Tables)
Goodwill (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Changes in Carrying Amount of Goodwill | Operating segment Component Chemicals Products Total (In millions) Balance at December 31, 2021, 2022 and 2023 $ 352.6 $ 27.1 $ 379.7 |
Long-term debt (Tables)
Long-term debt (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Long-Term Debt | December 31, 2022 2023 (In millions) Valhi: Contran credit facility $ 121.4 $ 93.4 Subsidiary debt: Kronos: Kronos International, Inc. 3.75% Senior Secured Notes due 2025 424.1 440.9 LandWell: Note payable to Western Alliance Business Trust 12.9 12.2 Other 1.1 — Total subsidiary debt 438.1 453.1 Total debt 559.5 546.5 Less current maturities 1.8 .7 Total long-term debt $ 557.7 $ 545.8 |
Aggregate maturities of long-term debt | Years ending December 31, Amount (In millions) Gross amounts due each year: 2024 $ .7 2025 536.7 2026 .8 2027 .8 2028 .9 2029 and thereafter 8.2 Subtotal 548.1 Less amounts representing original issue discount and debt issuance costs 1.6 Total long-term debt $ 546.5 After considering the effect of the exchange of the Old Notes and issuance of the New Notes and Contran Term Loan discussed above, our aggregate maturities of long-term debt would be: Years ending December 31, Amount (In millions) 2024 $ .7 2025 177.2 2026 .8 2027 .8 2028 .9 2029 and thereafter 369.0 Gross maturities 549.4 Less debt issuance costs 6.1 Total $ 543.3 |
Accounts payable and accrued _2
Accounts payable and accrued liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Payables And Accruals [Abstract] | |
Schedule of Accounts Payable and Accrued Liabilities | December 31, 2022 2023 (In millions) Accounts payable: Kronos $ 177.2 $ 218.7 CompX 3.5 3.1 BMI/LandWell 18.7 6.7 Total $ 199.4 $ 228.5 Current accrued liabilities: Deferred income $ 110.7 $ 88.8 Employee benefits 34.4 36.2 Accrued sales discounts and rebates 25.6 22.5 Accrued development costs 5.6 15.1 Interest 4.9 5.1 Operating lease liabilities 3.8 3.9 Environmental remediation and related costs 3.8 3.7 Other 54.8 45.0 Total $ 243.6 $ 220.3 Noncurrent accrued liabilities: Accrued development costs $ 48.1 $ 42.3 Operating lease liabilities 17.4 18.6 Deferred income 25.9 15.5 Insurance claims and expenses 18.7 14.9 Other postretirement benefits 7.1 7.4 Employee benefits 4.8 4.9 Reserve for uncertain tax positions .3 — Other 6.7 7.8 Total $ 129.0 $ 111.4 |
Defined contribution and defi_2
Defined contribution and defined benefit retirement (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Defined Benefit Plan Disclosure [Line Items] | |
Composition of Pension Plan Assets | The composition of our pension plan assets by asset category and fair value level at December 31, 2022 and 2023 is shown in the tables below. Fair Value Measurements at December 31, 2022 Quoted Significant Prices in Other Significant Active Observable Unobservable Assets Markets Inputs Inputs measured Total (Level 1) (Level 2) (Level 3) at NAV (In millions) Germany $ 234.0 $ — $ — $ 234.0 $ — Canada: Local currency equities .1 .1 — — — Non local currency equities 11.0 11.0 — — — Local currency fixed income 72.9 72.9 — — — Cash and other .6 .6 — — — Norway: Local currency equities 2.3 2.3 — — — Non local currency equities 4.7 4.7 — — — Local currency fixed income 21.8 7.0 14.8 — — Non local currency fixed income 8.4 8.4 — — — Real estate 7.8 — — 7.8 — Cash and other 2.7 2.4 — .3 — U.S.: Equities 12.4 1.0 — — 11.4 Fixed income 22.9 .2 — — 22.7 Cash and other 3.8 2.8 — — 1.0 Other 24.2 1.5 — 22.7 — Total $ 429.6 $ 114.9 $ 14.8 $ 264.8 $ 35.1 Fair Value Measurements at December 31, 2023 Quoted Significant Prices in Other Significant Active Observable Unobservable Assets Markets Inputs Inputs measured Total (Level 1) (Level 2) (Level 3) at NAV (In millions) Germany $ 269.4 $ — $ — $ 269.4 $ — Canada: Non local currency equities 2.7 2.7 — — — Local currency fixed income 86.2 86.2 — — — Cash and other 1.1 1.1 — — — Norway: Local currency equities 2.4 2.4 — — — Non local currency equities 7.2 7.2 — — — Local currency fixed income 23.9 4.4 19.5 — — Non local currency fixed income 4.2 4.2 — — — Real estate 6.6 — — 6.6 — Cash and other 3.0 2.8 — .2 — U.S.: Equities 11.3 — — — 11.3 Fixed income 27.1 — — — 27.1 Cash and other 1.9 .7 — — 1.2 Other 15.9 — — 15.9 — Total $ 462.9 $ 111.7 $ 19.5 $ 292.1 $ 39.6 A rollforward of the change in fair value of Level 3 assets follows. Years ended December 31, 2022 2023 (In millions) Fair value at beginning of year $ 320.5 $ 264.8 Gain (loss) on assets held at end of year (31.0) 11.1 Gain (loss) on assets sold during the year (3.6) 14.4 Assets purchased 13.8 1.7 Assets sold (15.5) (9.3) Transfers out (.1) — Currency exchange rate fluctuations (19.3) 9.4 Fair value at end of year $ 264.8 $ 292.1 |
Defined Benefit Pension Plans | |
Defined Benefit Plan Disclosure [Line Items] | |
Schedule of Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss) | The table below details the changes in other comprehensive income (loss) during 2021, 2022 and 2023. Years ended December 31, 2021 2022 2023 (In millions) Changes in plan assets and benefit obligations recognized in Net actuarial gains (losses) $ 50.7 $ 134.1 $ (25.5) Amortization of unrecognized: Net actuarial losses 21.6 14.7 3.8 Prior service cost .2 .1 — Settlements — .4 6.5 Total $ 72.5 $ 149.3 $ (15.2) |
Schedule of Rollforward of Change in Fair Value of Level 3 Assets | Fair Value Measurements at December 31, 2023 Quoted Significant Prices in Other Significant Active Observable Unobservable Assets Markets Inputs Inputs measured Total (Level 1) (Level 2) (Level 3) at NAV (In millions) Germany $ 269.4 $ — $ — $ 269.4 $ — Canada: Non local currency equities 2.7 2.7 — — — Local currency fixed income 86.2 86.2 — — — Cash and other 1.1 1.1 — — — Norway: Local currency equities 2.4 2.4 — — — Non local currency equities 7.2 7.2 — — — Local currency fixed income 23.9 4.4 19.5 — — Non local currency fixed income 4.2 4.2 — — — Real estate 6.6 — — 6.6 — Cash and other 3.0 2.8 — .2 — U.S.: Equities 11.3 — — — 11.3 Fixed income 27.1 — — — 27.1 Cash and other 1.9 .7 — — 1.2 Other 15.9 — — 15.9 — Total $ 462.9 $ 111.7 $ 19.5 $ 292.1 $ 39.6 A rollforward of the change in fair value of Level 3 assets follows. Years ended December 31, 2022 2023 (In millions) Fair value at beginning of year $ 320.5 $ 264.8 Gain (loss) on assets held at end of year (31.0) 11.1 Gain (loss) on assets sold during the year (3.6) 14.4 Assets purchased 13.8 1.7 Assets sold (15.5) (9.3) Transfers out (.1) — Currency exchange rate fluctuations (19.3) 9.4 Fair value at end of year $ 264.8 $ 292.1 |
Defined Benefit Pension Plans | United States | |
Defined Benefit Plan Disclosure [Line Items] | |
Schedule of Defined Benefit Plan Expected Future Payments | Years ending December 31, Amount (In millions) 2024 $ 28.4 2025 28.3 2026 28.7 2027 31.6 2028 35.7 Next 5 years 169.5 |
Schedule of Funded Status | The funded status of our U.S. defined benefit pension plans is presented in the table below. Years ended December 31, 2022 2023 (In millions) Change in projected benefit obligations (PBO): Balance at beginning of the year $ 58.0 $ 43.4 Interest cost 1.4 2.2 Actuarial losses (gains) (11.8) 1.2 Benefits paid (4.2) (4.1) Balance at end of the year $ 43.4 $ 42.7 Change in plan assets: Fair value at beginning of the year $ 52.4 $ 39.1 Actual return on plan assets (10.7) 3.7 Employer contributions 1.6 1.6 Benefits paid (4.2) (4.1) Fair value at end of the year $ 39.1 $ 40.3 Funded status $ (4.3) $ (2.4) Amounts recognized in the Consolidated Balance Sheets: Accrued pension costs: Current $ (.1) $ — Noncurrent (4.2) (2.4) Total (4.3) (2.4) Accumulated other comprehensive loss - actuarial losses 32.2 30.3 Total $ 27.9 $ 27.9 Accumulated benefit obligations (ABO) $ 43.4 $ 42.7 |
Components of Net Periodic Defined Benefit Cost | The components of our net periodic defined benefit pension cost for U.S. plans are presented in the table below. The amounts shown below for the amortization of recognized actuarial losses for 2021, 2022 and 2023 were recognized as components of our accumulated other comprehensive income (loss) at December 31, 2020, 2021 and 2022, respectively, net of deferred income taxes and noncontrolling interest. Years ended December 31, 2021 2022 2023 (In millions) Net periodic pension cost for U.S. plans: Interest cost $ 1.3 $ 1.4 $ 2.2 Expected return on plan assets (2.1) (2.0) (1.9) Recognized net actuarial losses 2.1 1.9 2.0 Settlements (.5) — — Total $ .8 $ 1.3 $ 2.3 |
Schedule of Plans for which Accumulated Benefit Obligations Exceeds Plan Assets | Information concerning our U.S. defined benefit pension plans (for which the ABO of all of the plans exceeds the fair value of plan assets as of the indicated date) is presented in the table below. December 31, 2022 2023 (In millions) Plans for which the ABO exceeds plan assets: Projected benefit obligations $ 43.4 $ 42.7 Accumulated benefit obligations 43.4 42.7 Fair value of plan assets 39.1 40.3 |
Summary of Actuarial Assumptions Used to Determine the Benefit Obligation and Net Benefit Cost | The weighted-average rate assumptions used in determining the net periodic pension cost for our U.S. defined benefit pension plans for 2021, 2022 and 2023 are presented in the table below. The impact of assumed increases in future compensation levels does not have an effect on the periodic pension cost as the plans are frozen with regards to compensation. Years ended December 31, 2021 2022 2023 Discount rate 2.2% 2.6% 5.3% Long-term return on plan assets 4.0% 4.0% 5.0% |
Defined Benefit Pension Plans | Non U.S. | |
Defined Benefit Plan Disclosure [Line Items] | |
Schedule of Funded Status | The funded status of our non-U.S. defined benefit pension plans is presented in the table below. Years ended December 31, 2022 2023 (In millions) Change in PBO: Balance at beginning of the year $ 758.1 $ 508.6 Service cost 11.3 6.3 Interest cost 10.6 19.8 Participants’ contributions 1.7 1.8 Actuarial losses (gains) (198.6) 44.3 Settlements (1.4) (8.6) Change in currency exchange rates (51.2) 14.1 Benefits paid (21.9) (22.6) Balance at end of the year $ 508.6 $ 563.7 Change in plan assets: Fair value at beginning of the year $ 481.5 $ 390.5 Actual return on plan assets (52.5) 37.4 Employer contributions 15.0 14.7 Participants' contributions 1.7 1.8 Settlements (1.2) (8.6) Change in currency exchange rates (32.1) 9.4 Benefits paid (21.9) (22.6) Fair value at end of the year $ 390.5 $ 422.6 Funded status $ (118.1) $ (141.1) Amounts recognized in the Consolidated Balance Sheets: Noncurrent pension asset $ 9.3 $ 8.1 Noncurrent accrued pension costs (127.4) (149.2) Total (118.1) (141.1) Accumulated other comprehensive loss: Actuarial losses 90.0 106.8 Prior service cost .4 .3 Total 90.4 107.1 Total $ (27.7) $ (34.0) ABO $ 493.9 $ 549.8 |
Components of Net Periodic Defined Benefit Cost | The components of our net periodic pension benefit cost for our non-U.S. plans are presented in the table below. Years ended December 31, 2021 2022 2023 (In millions) Net periodic pension cost for non-U.S. plans: Service cost $ 14.7 $ 11.3 $ 6.3 Interest cost 8.3 10.6 19.8 Expected return on plan assets (11.4) (11.1) (18.3) Recognized net actuarial losses 19.5 12.8 1.8 Amortization of prior service cost .2 .1 — Settlements — .4 6.5 Total $ 31.3 $ 24.1 $ 16.1 |
Schedule of Plans for which Accumulated Benefit Obligations Exceeds Plan Assets | Information concerning certain of our non-U.S. defined benefit pension plans (for which the ABO exceeds the fair value of plan assets as of the indicated date) is presented in the table below. December 31, 2022 2023 (In millions) Plans for which the ABO exceeds plan assets: Projected benefit obligations $ 403.5 $ 463.1 Accumulated benefit obligations 392.4 452.9 Fair value of plan assets 276.0 313.8 |
Summary of Actuarial Assumptions Used to Determine the Benefit Obligation and Net Benefit Cost | The key actuarial assumptions used to determine our non-U.S. benefit obligations as of December 31, 2022 and 2023 are as follows: December 31, 2022 2023 Discount rate 3.9% 3.4% Increase in future compensation levels 2.7% 2.7% A summary of our key actuarial assumptions used to determine non-U.S. net periodic benefit cost for 2021, 2022 and 2023 are as follows: Years ended December 31, 2021 2022 2023 Discount rate 1.0% 1.5% 3.9% Increase in future compensation levels 2.6% 2.6% 2.7% Long-term return on plan assets 2.4% 2.5% 4.6% |
Disaggregation of sales (Tables
Disaggregation of sales (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disaggregation of sales | |
Schedule of Disaggregates of Net Sales | The following table disaggregates the net sales of our Chemicals Segment by place of manufacture (point of origin) and the location of the customer (point of destination), which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Years ended December 31, 2021 2022 2023 (In millions) Net sales - point of origin: United States $ 1,052.1 $ 1,226.6 $ 1,029.2 Germany 971.7 895.4 726.4 Canada 371.9 389.4 351.0 Norway 257.2 273.5 252.1 Belgium 295.7 306.5 217.1 Eliminations (1,009.2) (1,161.2) (909.3) Total $ 1,939.4 $ 1,930.2 $ 1,666.5 Net sales - point of destination: Europe $ 945.0 $ 878.3 $ 737.8 North America 645.7 695.7 618.1 Other 348.7 356.2 310.6 Total $ 1,939.4 $ 1,930.2 $ 1,666.5 The following table disaggregates the net sales of our Component Products and Real Estate Management and Development Segments by major product line, which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows for these segments are affected by economic factors. Years ended December 31, 2021 2022 2023 (In millions) Component Products: Net sales: Security products $ 105.1 $ 114.5 $ 121.2 Marine components 35.7 52.1 40.1 Total $ 140.8 $ 166.6 $ 161.3 Real Estate Management and Development: Net sales: Land sales $ 207.8 $ 120.9 $ 92.6 Utility and other 1.6 1.2 1.3 Water delivery 6.8 3.6 — Total $ 216.2 $ 125.7 $ 93.9 |
Other income, net (Tables)
Other income, net (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Other income, net | |
Schedule of Components of Other Income | Years ended December 31, 2021 2022 2023 (In millions) Interest income and other: Interest and dividends $ 4.0 $ 10.9 $ 21.0 Securities transactions, net — (.5) .3 Total 4.0 10.4 21.3 Infrastructure reimbursement 15.3 16.0 25.5 Currency transactions, net 1.6 11.5 1.4 Insurance recoveries .1 2.8 3.0 Gain on land sales 16.0 — 1.5 Other, net 2.0 3.0 2.7 Total $ 39.0 $ 43.7 $ 55.4 |
Income taxes (Tables)
Income taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income taxes Disclosure [Abstract] | |
Component of Income Taxes Expenses | Years ended December 31, 2021 2022 2023 (In millions) Pre-tax income (loss): United States $ 131.4 $ 81.4 $ 53.2 Non-U.S. subsidiaries 126.4 88.5 (72.7) Total $ 257.8 $ 169.9 $ (19.5) Expected tax expense (benefit) at U.S. federal statutory $ 54.1 $ 35.7 $ (4.1) Non-U.S. tax rates 4.5 2.0 (6.3) Incremental net tax benefit on earnings and losses of U.S. (2.0) (1.7) (13.9) Valuation allowance .9 (3.0) 2.2 Global intangible low-tax income, net 2.8 1.8 (.4) U.S. state income taxes, net 1.5 1.5 .6 Adjustment to the reserve for uncertain tax positions, net (2.6) (2.9) (.7) Nondeductible expenses 1.1 1.0 1.2 Other, net (.2) (.6) (1.0) Income tax expense (benefit) $ 60.1 $ 33.8 $ (22.4) Components of income tax expense (benefit): Currently payable: U.S. federal and state $ 29.7 $ 16.3 $ 12.6 Non-U.S. 21.5 20.1 13.5 Total 51.2 36.4 26.1 Deferred income taxes (benefit): U.S. federal and state (1.7) (3.9) (12.6) Non-U.S. 10.6 1.3 (35.9) Total 8.9 (2.6) (48.5) Income tax expense (benefit) $ 60.1 $ 33.8 $ (22.4) Comprehensive provision (benefit) for income taxes Net income (loss) $ 60.1 $ 33.8 $ (22.4) Other comprehensive income (loss): Currency translation (.8) (3.3) .4 Pension plans 29.7 60.7 (7.6) Other — .9 (.3) Total $ 89.0 $ 92.1 $ (29.9) |
Components of Net Deferred Tax Asset (Liability) | The components of the net deferred income taxes at December 31, 2022 and 2023 are summarized in the following table. December 31, 2022 2023 Assets Liabilities Assets Liabilities (In millions) Tax effect of temporary differences related to: Inventories $ — $ (5.3) $ 1.4 $ — Property and equipment — (62.8) — (62.9) Lease assets (liabilities) 5.3 (5.4) 5.7 (5.7) Accrued OPEB costs 2.0 — 2.1 — Accrued pension costs 22.0 — 26.9 — Accrued environmental liabilities 25.9 — 22.6 — Other deductible differences 12.0 — 14.1 — Other taxable differences — (15.8) — (15.3) Investments in subsidiaries and affiliates 6.7 (62.3) 10.5 (54.7) Tax on unremitted earnings of non-U.S. subsidiaries — (11.4) — (10.9) Tax loss and tax credit carryforwards 82.6 — 119.6 — Valuation allowance (16.5) — (18.2) — Adjusted gross deferred tax assets (liabilities) 140.0 (163.0) 184.7 (149.5) Netting of items by tax jurisdiction (99.5) 99.5 (117.7) 117.7 Net noncurrent deferred tax asset (liability) $ 40.5 $ (63.5) $ 67.0 $ (31.8) |
Changes in Uncertain Tax Positions | Years ended December 31, 2021 2022 2023 (In millions) Unrecognized tax benefits: Amount at beginning of year $ 9.6 $ 6.4 $ 3.5 Tax positions taken in current period .6 .7 .5 Lapse due to applicable statute of limitations (3.6) (3.4) (1.2) Changes in currency exchange rates (.2) (.2) — Amount at end of year $ 6.4 $ 3.5 $ 2.8 |
Noncontrolling interest in su_2
Noncontrolling interest in subsidiaries (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Noncontrolling Interest [Abstract] | |
Noncontrolling Interest in Net Assets of Subsidiaries | December 31, 2022 2023 (In millions) Noncontrolling interest in net assets: Kronos Worldwide $ 239.3 $ 209.0 NL Industries 79.0 76.9 CompX International 20.6 22.0 BMI 6.9 11.0 LandWell 2.4 6.8 Total $ 348.2 $ 325.7 |
Schedule of Noncontrolling interest in net income (loss) of subsidiaries | December 31, 2022 2023 (In millions) Noncontrolling interest in net assets: Kronos Worldwide $ 239.3 $ 209.0 NL Industries 79.0 76.9 CompX International 20.6 22.0 BMI 6.9 11.0 LandWell 2.4 6.8 Total $ 348.2 $ 325.7 Years ended December 31, 2021 2022 2023 (In millions) Noncontrolling interest in net income (loss) of subsidiaries: Kronos Worldwide $ 22.0 $ 20.0 $ (9.5) NL Industries 8.7 5.8 (.4) CompX International 2.2 2.6 2.9 BMI 14.7 2.8 8.2 LandWell 22.9 14.7 13.8 Total $ 70.5 $ 45.9 $ 15.0 |
Valhi stockholders equity (Tabl
Valhi stockholders equity (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Schedule of Common Stock Outstanding | Shares of common stock Issued Treasury Outstanding (In millions) Balance at December 31, 2021, 2022 and 2023 29.6 (1.1) 28.5 |
Accumulated Other Comprehensive Loss (Loss) | Years ended December 31, 2021 2022 2023 (In millions) Accumulated other comprehensive income (loss) (net of tax and Marketable securities: Balance at beginning of year $ 1.8 $ 1.7 $ 1.6 Other comprehensive income: Unrealized gain (loss) arising during the year (.1) (.1) .1 Balance at end of year $ 1.7 $ 1.6 $ 1.7 Currency translation: Balance at beginning of year $ (67.4) $ (72.2) $ (91.5) Other comprehensive income (loss) arising during the year (4.8) (19.3) 2.7 Balance at end of year $ (72.2) $ (91.5) $ (88.8) Defined benefit pension plans: Balance at beginning of year $ (154.1) $ (120.9) $ (55.0) Other comprehensive income: Amortization of prior service cost and net losses 10.7 7.3 1.9 Net actuarial gain (loss) arising during the year 22.5 58.4 (10.0) Plan settlement — .2 4.3 Balance at end of year $ (120.9) $ (55.0) $ (58.8) OPEB plans: Balance at beginning of year $ .3 $ .1 $ 1.0 Other comprehensive income: Amortization of prior service credit and net losses (.3) (.5) (.7) Net actuarial gain arising during the year .1 1.4 .1 Balance at end of year $ .1 $ 1.0 $ .4 Total accumulated other comprehensive loss: Balance at beginning of year $ (219.4) $ (191.3) $ (143.9) Other comprehensive income (loss) 28.1 47.4 (1.6) Balance at end of year $ (191.3) $ (143.9) $ (145.5) |
Related party transactions (Tab
Related party transactions (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Receivables from and Payables to Affiliates | December 31, 2022 2023 (In millions) Current receivables from affiliates: LPC $ — $ 16.9 Contran - trade items .2 .2 Other 2.7 .4 Total $ 2.9 $ 17.5 Current payables to affiliates: LPC $ 17.1 $ 19.9 Contran - income taxes 5.8 10.2 Total $ 22.9 $ 30.1 Noncurrent payable to affiliates: Contran - income taxes $ 33.4 $ 18.5 Payables to affiliate included in long-term debt: Valhi - Contran credit facility $ 121.4 $ 93.4 |
Commitments and contingencies (
Commitments and contingencies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Commitments And Contingencies Disclosure [Abstract] | |
Change in Accrued Environmental Remediation and Related Costs | Years ended December 31, 2021 2022 2023 (In millions) Balance at the beginning of the year $ 98.6 $ 97.6 $ 97.3 Additions charged to expense, net 1.6 1.7 2.5 Payments, net (2.5) (2.0) (2.9) Changes in currency exchange rates and other (.1) — — Balance at the end of the year $ 97.6 $ 97.3 $ 96.9 Amounts recognized in the Consolidated Balance Sheet at the Current liabilities $ 3.5 $ 3.8 $ 3.7 Noncurrent liabilities 94.1 93.5 93.2 Total $ 97.6 $ 97.3 $ 96.9 |
Approximate Percentage of TiO2 Sales by Volume for Segments | 2021 2022 2023 Europe 46% 45% 44% North America 37% 39% 41% |
Financial instruments (Tables)
Financial instruments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Financial Instruments not Carried at Fair Value | December 31, 2022 December 31, 2023 Carrying Fair Carrying Fair amount value amount value (In millions) Cash, cash equivalents and restricted cash equivalents $ 562.0 $ 562.0 $ 462.0 $ 462.0 Long-term debt: Kronos 3.75% Senior Secured Notes due 2025 424.1 374.2 440.9 424.5 Valhi credit facility with Contran 121.4 121.4 93.4 93.4 LandWell bank note payable 12.9 12.9 12.2 12.2 |
Restructuring costs (Tables)
Restructuring costs (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring costs | A summary of the activity in Kronos’ accrued workforce reduction costs for 2023 is shown in the table below (in millions): Accrued workforce reduction costs as of January 1, 2023 $ — Workforce reduction costs accrued 5.8 Workforce reduction costs paid (.9) Currency translation adjustments, net .1 Accrued workforce reduction costs at December 31, 2023 $ 5.0 Amounts recognized in the balance sheet: Current liability $ 5.0 Noncurrent liability — $ 5.0 |
Summary of significant accoun_4
Summary of significant accounting policies - Additional Information (Detail) | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2023 USD ($) a | Jun. 30, 2022 USD ($) | Dec. 31, 2023 USD ($) a | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Capitalized interest costs on property and equipment | $ 1,900,000 | $ 1,700,000 | $ 1,400,000 | ||
Fixed asset impairment | $ 3,800,000 | $ 16,400,000 | $ 3,800,000 | ||
Percentage of likelihood for recognition of uncertain tax positions | 50% | ||||
Recognition of receivables for recoveries | $ 0 | $ 0 | 0 | ||
Standard payment terms | less than one year | ||||
Shipping and handling costs | $ 1,676,500,000 | 1,732,100,000 | 1,716,200,000 | ||
Advertising costs | 2,000,000 | 2,000,000 | 1,000,000 | ||
Research, development and certain sales technical support costs | $ 18,000,000 | 16,000,000 | 17,000,000 | ||
Louisiana Pigment Company | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Percentage owned manufacturing joint venture under equity method investment | 50% | 50% | |||
Revision of Prior Period, Reclassification, Adjustment | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Property, Plant and Equipment, Gross, Period Increase (Decrease) | $ 19,100,000 | ||||
Revision of Prior Period, Reclassification, Adjustment | Land | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Property, Plant and Equipment, Gross, Period Increase (Decrease) | (5,300,000) | ||||
Revision of Prior Period, Reclassification, Adjustment | Equipment | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Property, Plant and Equipment, Gross, Period Increase (Decrease) | (45,800,000) | ||||
Revision of Prior Period, Reclassification, Adjustment | Building | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Property, Plant and Equipment, Gross, Period Increase (Decrease) | 5,100,000 | ||||
Revision of Prior Period, Reclassification, Adjustment | Mining properties | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Property, Plant and Equipment, Gross, Period Increase (Decrease) | 65,100,000 | ||||
Chemicals | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Shipping and handling costs | $ 1,502,700,000 | 1,540,200,000 | 1,494,500,000 | ||
Chemicals | Louisiana Pigment Company | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Percentage owned manufacturing joint venture under equity method investment | 50% | 50% | |||
Shipping and Handling | Chemicals | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Shipping and handling costs | $ 101,000,000 | 122,000,000 | 132,000,000 | ||
Residential/Planned Community | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Area of real estate property | a | 2,100 | 2,100 | |||
Residential Housing Unit | Minimum | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Percentage of sales price | 2.50% | ||||
Residential Housing Unit | Maximum | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Percentage of sales price | 3.50% | ||||
Contran | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Net cash payments received from/paid to tax group parent | $ 14,200,000 | $ 17,500,000 | $ 25,500,000 | ||
Contran | Valhi Incorporation | |||||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||||
Parent company ownership interest | 91% | 91% |
Summary of significant accoun_5
Summary of significant accounting policies - Computation of Depreciation of Property and Equipment (Detail) | Dec. 31, 2023 |
Buildings and improvements | Minimum [Member] | |
Property Plant And Equipment [Line Items] | |
Property and equipment useful life | 10 years |
Buildings and improvements | Maximum [Member] | |
Property Plant And Equipment [Line Items] | |
Property and equipment useful life | 40 years |
Machinery and equipment | Minimum [Member] | |
Property Plant And Equipment [Line Items] | |
Property and equipment useful life | 3 years |
Machinery and equipment | Maximum [Member] | |
Property Plant And Equipment [Line Items] | |
Property and equipment useful life | 20 years |
Mine development costs | |
Property Plant And Equipment [Line Items] | |
Property and equipment useful life | us-gaap:UnitsOfProductionDepreciationMethodMember |
Summary of significant accoun_6
Summary of significant accounting policies - Revenue Recognition Period (Detail) | Dec. 31, 2023 |
Maximum [Member] | Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]: 2024-01-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Revenue recognition period | 1 year |
Business and geographic segme_3
Business and geographic segments - Holding Percentage of Subsidiaries (Detail) | Dec. 31, 2023 |
Chemicals | |
Segment Reporting Information [Line Items] | |
Controlling interest in subsidiary | 81% |
Component products | |
Segment Reporting Information [Line Items] | |
Controlling interest in subsidiary | 87% |
Real estate management and development | BMI | |
Segment Reporting Information [Line Items] | |
Controlling interest in subsidiary | 63% |
Real estate management and development | LandWell | Aggregate General And Limited Interests | |
Segment Reporting Information [Line Items] | |
Controlling interest in subsidiary | 77% |
Business and geographic segme_4
Business and geographic segments - Additional Information (Detail) $ in Millions | 3 Months Ended | 12 Months Ended | ||
Dec. 01, 2023 USD ($) | Sep. 30, 2022 USD ($) | Dec. 31, 2023 USD ($) segment | Dec. 31, 2022 USD ($) | |
Segment Reporting Information [Line Items] | ||||
Loss on deconsolidation of Basic Water Company (BWC) | $ (2) | |||
Loss on sale of Basic Power Company (BPC) | $ 2.6 | |||
Number of operating segments | segment | 3 | |||
Non-U.S. subsidiaries | ||||
Segment Reporting Information [Line Items] | ||||
Net assets of non-U.S. subsidiaries | $ 653 | $ 699 | ||
Kronos Worldwide, Inc. | Valhi Incorporation | ||||
Segment Reporting Information [Line Items] | ||||
Direct ownership percentage by parent | 50% | |||
Kronos Worldwide, Inc. | NL | ||||
Segment Reporting Information [Line Items] | ||||
Indirect controlling interest in subsidiary | 31% | |||
NL | Valhi Incorporation | ||||
Segment Reporting Information [Line Items] | ||||
Direct ownership percentage by parent | 83% | |||
LandWell | Valhi Incorporation | ||||
Segment Reporting Information [Line Items] | ||||
Direct ownership percentage by parent | 27% | |||
LandWell | BMI | ||||
Segment Reporting Information [Line Items] | ||||
Indirect controlling interest in subsidiary | 50% | |||
BMI | ||||
Segment Reporting Information [Line Items] | ||||
Loss on deconsolidation of Basic Water Company (BWC) | $ 2 | |||
Bad debt expense recognized | $ 1.3 | |||
BMI | Valhi Incorporation | ||||
Segment Reporting Information [Line Items] | ||||
Direct ownership percentage by parent | 63% |
Business and geographic segme_5
Business and geographic segments - Segment Operating Performance (Detail) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2023 | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2021 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | ||||||||||||
Net sales | $ 1,921.7 | $ 2,222.5 | $ 2,296.4 | |||||||||
Cost of sales | 1,676.5 | 1,732.1 | 1,716.2 | |||||||||
Gross margin | 245.2 | 490.4 | 580.2 | |||||||||
Operating income | 34.2 | 239.4 | 318.6 | |||||||||
Interest income and other | 21.3 | 10.4 | 4 | |||||||||
Gain on land sales | $ 10.4 | $ 5.6 | $ 1.5 | 1.5 | 16 | |||||||
Other components of net periodic pension and OPEB expense | (11.8) | (13.9) | (17) | |||||||||
Changes in market value of Valhi common stock held by subsidiaries | (1.7) | (1.6) | 3.3 | |||||||||
General expenses, net | (34.7) | (36.5) | (34.6) | |||||||||
Interest expense | (28.3) | (27.9) | (32.5) | |||||||||
Income (loss) before income taxes | (19.5) | 169.9 | 257.8 | |||||||||
Restructuring Costs | $ 5.8 | |||||||||||
Insurance recoveries | 3 | 2.8 | 0.1 | |||||||||
Fixed asset impairment | $ 3.8 | $ 16.4 | 3.8 | |||||||||
Chemicals | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Net sales | 1,666.5 | 1,930.2 | 1,939.4 | |||||||||
Cost of sales | 1,502.7 | 1,540.2 | 1,494.5 | |||||||||
Gross margin | 163.8 | 390 | 444.9 | |||||||||
Operating income | (41.1) | 174.6 | 200.8 | |||||||||
Insurance recoveries | $ 2.5 | $ 2.5 | $ 2.5 | $ 2.7 | ||||||||
Component products | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Net sales | 161.3 | 166.6 | 140.8 | |||||||||
Cost of sales | 112.1 | 117.8 | 98.1 | |||||||||
Gross margin | 49.2 | 48.8 | 42.7 | |||||||||
Operating income | 25.4 | 25.4 | 20.5 | |||||||||
Real estate management and development | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Net sales | 93.9 | 125.7 | 216.2 | |||||||||
Cost of sales | 61.7 | 74.1 | 123.6 | |||||||||
Gross margin | 32.2 | 51.6 | 92.6 | |||||||||
Operating income | $ 49.9 | $ 39.4 | $ 97.3 |
Business and Geographic Segme_6
Business and Geographic Segments - Total Assets Held by Business Segments (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Total assets | $ 2,737 | $ 2,835.7 | $ 3,005.2 |
Depreciation And Amortization | 54.1 | 58.5 | 59.3 |
Capital expenditures | 48.5 | 67.6 | 64.1 |
Corporate and eliminations | |||
Segment Reporting Information [Line Items] | |||
Total assets | 197.8 | 191.7 | 226.4 |
Chemicals | Operating Segment | |||
Segment Reporting Information [Line Items] | |||
Total assets | 2,196.8 | 2,293.5 | 2,373.1 |
Depreciation And Amortization | 49.9 | 53.1 | 52.8 |
Capital expenditures | 47.4 | 63.2 | 58.6 |
Component products | Operating Segment | |||
Segment Reporting Information [Line Items] | |||
Total assets | 141.5 | 131.3 | 146.4 |
Depreciation And Amortization | 4 | 4 | 3.8 |
Capital expenditures | 1.1 | 3.7 | 4.1 |
Real estate management and development | Operating Segment | |||
Segment Reporting Information [Line Items] | |||
Total assets | 200.9 | 219.2 | 259.3 |
Depreciation And Amortization | $ 0.2 | 1.4 | 2.7 |
Capital expenditures | $ 0.7 | $ 1.4 |
Business and Geographic Segme_7
Business and Geographic Segments - Net Sales by Point of Origin and Point of Destination (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Net sales | $ 1,921.7 | $ 2,222.5 | $ 2,296.4 |
Operating Segment | Point Of Origin | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,921.7 | 2,222.5 | 2,296.4 |
Operating Segment | Point Of Destination | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,921.7 | 2,222.5 | 2,296.4 |
Operating Segment | United States | Point Of Origin | |||
Segment Reporting Information [Line Items] | |||
Net sales | 1,284.4 | 1,518.9 | 1,409.1 |
Operating Segment | Germany | Point Of Origin | |||
Segment Reporting Information [Line Items] | |||
Net sales | 726.4 | 895.4 | 971.7 |
Operating Segment | Canada | Point Of Origin | |||
Segment Reporting Information [Line Items] | |||
Net sales | 351 | 389.4 | 371.9 |
Operating Segment | Norway | Point Of Origin | |||
Segment Reporting Information [Line Items] | |||
Net sales | 252.1 | 273.5 | 257.2 |
Operating Segment | Belgium | Point Of Origin | |||
Segment Reporting Information [Line Items] | |||
Net sales | 217.1 | 306.5 | 295.7 |
Operating Segment | North America | Point Of Destination | |||
Segment Reporting Information [Line Items] | |||
Net sales | 871 | 985.4 | 999.7 |
Operating Segment | Europe | Point Of Destination | |||
Segment Reporting Information [Line Items] | |||
Net sales | 738.5 | 879 | 945.7 |
Operating Segment | Asia and other | Point Of Destination | |||
Segment Reporting Information [Line Items] | |||
Net sales | 312.2 | 358.1 | 351 |
Eliminations | Point Of Origin | |||
Segment Reporting Information [Line Items] | |||
Net sales | $ (909.3) | $ (1,161.2) | $ (1,009.2) |
Business and Geographic Segme_8
Business and Geographic Segments - Net Property and Equipment by Segment (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Net property and equipment: | |||
Net property and equipment | $ 517.3 | $ 523.8 | $ 563.6 |
United States | |||
Net property and equipment: | |||
Net property and equipment | 40 | 45.8 | 63.6 |
Germany | |||
Net property and equipment: | |||
Net property and equipment | 213 | 204.7 | 214.8 |
Belgium | |||
Net property and equipment: | |||
Net property and equipment | 98.5 | 101.4 | 107.7 |
Norway | |||
Net property and equipment: | |||
Net property and equipment | 83.5 | 83.6 | 86.4 |
Canada | |||
Net property and equipment: | |||
Net property and equipment | $ 82.3 | $ 88.3 | $ 91.1 |
Business combinations and relat
Business combinations and related transactions (Detail) $ in Millions | 3 Months Ended | 12 Months Ended | |||
Jun. 30, 2022 USD ($) item shares | Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2021 USD ($) shares | Dec. 31, 2020 shares | |
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Loss on sale of Basic Power Company (BPC) | $ | $ 2.6 | ||||
Shares Repurchased from Affiliates | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Number of affiliates | item | 2 | ||||
Number of private transactions | item | 2 | ||||
Kronos Worldwide, Inc. | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Repurchase of common stock | 2,000,000 | ||||
Shares available for purchase | 1,017,518 | ||||
CompX International Inc. | Class A Common [Member] | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Common stock, Repurchased | 0 | ||||
Shares available for purchase | 523,647 | ||||
NL Industries, Inc. | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Common stock, Repurchased | 2,000 | ||||
Treasury stock | Kronos Worldwide, Inc. | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Common stock, Repurchased | 313,814 | 217,778 | 14,409 | ||
Stock repurchase, aggregate purchase price | $ | $ 2.8 | $ 2.5 | $ 0.2 | ||
Treasury stock | CompX International Inc. | Shares Repurchased in Market Transaction | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Common stock, Repurchased | 70,000 | ||||
Treasury stock | CompX International Inc. | Shares Repurchased from Affiliates | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Common stock, Repurchased | 8,900 | ||||
Treasury stock | CompX International Inc. | Class A Common [Member] | |||||
Business Combinations Discontinued Operations And Related Transactions [Line Items] | |||||
Common stock, Repurchased | 78,900 | 75,000 | |||
Stock repurchase, aggregate purchase price | $ | $ 1.7 | $ 1.3 |
Accounts and other receivable_3
Accounts and other receivables, net - Components of Accounts and Other Receivables (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Trade accounts receivable: | ||
VAT and other receivables | $ 33.4 | $ 35.4 |
Allowance for doubtful accounts | (4.2) | (4.9) |
Total | 321.1 | 271 |
Trade Accounts Receivable | Kronos | ||
Trade accounts receivable: | ||
Trade Accounts receivable | 273.6 | 220.3 |
Trade Accounts Receivable | CompX | ||
Trade accounts receivable: | ||
Trade Accounts receivable | 17.1 | 17.9 |
Trade Accounts Receivable | BMI/LandWell | ||
Trade accounts receivable: | ||
Trade Accounts receivable | $ 1.2 | $ 2.3 |
Inventories, net (Detail)
Inventories, net (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Inventory [Line Items] | ||
Raw materials | $ 194 | $ 151.5 |
Work in process | 49.9 | 52 |
Finished products | 256.3 | 355.8 |
Supplies (chemicals) | 95.9 | 81.5 |
Total | 596.1 | 640.8 |
Chemicals | ||
Inventory [Line Items] | ||
Raw materials | 188.3 | 145.3 |
Work in process | 30.8 | 32 |
Finished products | 250.4 | 350.7 |
Component products | ||
Inventory [Line Items] | ||
Raw materials | 5.7 | 6.2 |
Work in process | 19.1 | 20 |
Finished products | $ 5.9 | $ 5.1 |
Marketable securities - Schedul
Marketable securities - Schedule of Marketable Securities (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Marketable Securities [Line Items] | ||
Market value, current | $ 56.1 | $ 75.1 |
Market value, noncurrent | 4.8 | 1.2 |
Current Assets | ||
Marketable Securities [Line Items] | ||
Market value, current | 56.1 | 75.1 |
Cost or amortized cost | 56.1 | 75.7 |
Unrealized loss, net | (0.6) | |
Non Current Assets | ||
Marketable Securities [Line Items] | ||
Market value, noncurrent | 4.8 | 1.2 |
Cost or amortized cost | 5 | $ 1.2 |
Unrealized loss, net | $ (0.2) |
Marketable Securities - Sched_2
Marketable Securities - Schedule of Marketable Securities and Fair Value Measurements (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, current | $ 56.1 | $ 75.1 |
Marketable securities, noncurrent | 4.8 | 1.2 |
Fixed Income Securities | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, current | 56.1 | 73.3 |
Marketable securities, noncurrent | 2.6 | 1.2 |
Mutual Fund | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, current | 1.8 | |
Marketable securities, noncurrent | 2.2 | |
Quoted Prices in Active Markets (Level 1) | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, current | 1.8 | |
Marketable securities, noncurrent | 2.2 | |
Quoted Prices in Active Markets (Level 1) | Mutual Fund | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, current | 1.8 | |
Marketable securities, noncurrent | 2.2 | |
Significant Other Observable Inputs (Level 2) | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, current | 73.3 | |
Marketable securities, noncurrent | 2.6 | |
Significant Other Observable Inputs (Level 2) | Fixed Income Securities | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, current | 56.1 | 73.3 |
Marketable securities, noncurrent | $ 2.6 | $ 1.2 |
Investment in TiO2 Manufactur_3
Investment in TiO2 Manufacturing Joint Venture and Other Assets - Other Noncurrent Assets (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Other assets: | ||
Restricted cash and cash equivalents | $ 32.4 | $ 37.2 |
Note receivables - OPA | 69.1 | 49.3 |
Operating lease right-of-use assets | $ 22.7 | $ 21.5 |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Total | Total |
Restricted Cash and Cash Equivalents, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Total | Total |
Land held for development | $ 19.4 | $ 29.7 |
IBNR receivables | 13.4 | 16.8 |
Other | 16.7 | 24.3 |
Total | $ 173.7 | $ 178.8 |
Investment in TiO2 Manufactur_4
Investment in TiO2 Manufacturing Joint Venture and Other Assets - Additional Information (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | |||||||
Dec. 31, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Dec. 31, 2021 | Mar. 31, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Other Assets Non Current [Line Items] | |||||||||
Operating lease expense | $ 5,600,000 | $ 5,500,000 | $ 7,700,000 | ||||||
Operating lease, right-of-use asset | $ 4,600,000 | $ 6,600,000 | $ 3,800,000 | $ 4,600,000 | $ 6,600,000 | 3,800,000 | |||
Weighted average remaining lease term | 14 years | 15 years | 14 years | 15 years | |||||
Weighted average discount rate associated with leases | 5% | 5% | 5% | 5% | |||||
Operating lease liability | $ 22,500,000 | $ 22,500,000 | |||||||
Operating lease not yet commenced, description | At December 31, 2023, we have no significant lease commitments that have not yet commenced. | ||||||||
Infrastructure reimbursement | $ 25,500,000 | $ 16,000,000 | $ 15,300,000 | ||||||
Additional term for redevelopment plan | 15 years | ||||||||
City of Henderson Redevelopment Agency | Tax Increment Reimbursement, Quarter One | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Infrastructure reimbursement | $ 6,200,000 | ||||||||
City of Henderson Redevelopment Agency | Tax Increment Reimbursement, Quarter Three | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Infrastructure reimbursement | $ 4,800,000 | $ 10,000,000 | |||||||
City of Henderson Redevelopment Agency | Tax Increment Reimbursement, Quarter Four | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Infrastructure reimbursement | 20,400,000 | $ 5,200,000 | $ 9,100,000 | ||||||
City Of Henderson [Member] | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Annual interest rate | 6% | ||||||||
OPA | City of Henderson Redevelopment Agency | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Tax increment reimbursement percentage | 75% | ||||||||
OPA | City of Henderson Redevelopment Agency | OtherIncome | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Infrastructure reimbursement | $ 25,200,000 | $ 15,200,000 | $ 15,300,000 | ||||||
OPA | Maximum [Member] | City of Henderson Redevelopment Agency | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Reimbursement revenue | 209,000,000 | 209,000,000 | |||||||
Chemicals | Leverkusen TiO2 production facility | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Operating lease liability | $ 7,400,000 | $ 7,400,000 | |||||||
Louisiana Pigment Company | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Percentage owned manufacturing joint venture under equity method investment | 50% | 50% | |||||||
Income (loss) from equity investments | $ 0 | ||||||||
Louisiana Pigment Company | Chemicals | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Percentage owned manufacturing joint venture under equity method investment | 50% | 50% | |||||||
Venator Materials PLC | Tioxide Group | Louisiana Pigment Company | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Parent company ownership interest | 50% | 50% | |||||||
Venator Materials PLC | Venator Investments LLC | |||||||||
Other Assets Non Current [Line Items] | |||||||||
Parent company ownership interest | 100% | 100% |
Investment in TiO2 Manufactur_5
Investment in TiO2 Manufacturing Joint Venture and Other Assets - Components of Net Distributions from LPC (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Investment in TiO2 manufacturing joint venture and other assets | |||
Distributions from LPC | $ 52.8 | $ 58.3 | $ 28.5 |
Contributions to LPC | (49.7) | (68.8) | (24.7) |
Net distributions (contributions) | $ 3.1 | $ (10.5) | $ 3.8 |
Investment in TiO2 Manufactur_6
Investment in TiO2 Manufacturing Joint Venture and Other Assets - Summary of Financial Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Financial Information [Line Items] | |||
Current assets | $ 1,475.4 | $ 1,589.5 | |
Property and equipment, net | 517.3 | 523.8 | $ 563.6 |
Total assets | 2,737 | 2,835.7 | 3,005.2 |
Other liabilities, primarily current | 30.1 | 22.9 | |
Total liabilities and equity | 2,737 | 2,835.7 | |
Net sales | 1,977.1 | 2,266.2 | 2,335.4 |
Cost of sales | 1,676.5 | 1,732.1 | 1,716.2 |
General and administrative | 277.4 | 304 | 311.9 |
Total costs and expenses | 1,996.6 | 2,096.3 | 2,077.6 |
Net income | 2.9 | 136.1 | 197.7 |
Louisiana Pigment Company | |||
Financial Information [Line Items] | |||
Current assets | 118.5 | 122.2 | |
Property and equipment, net | 148.4 | 147.4 | |
Total assets | 266.9 | 269.6 | |
Other liabilities, primarily current | 42.1 | 41.2 | |
Partners' equity | 224.8 | 228.4 | |
Total liabilities and equity | 266.9 | 269.6 | |
Net sales | 463.4 | 451.5 | 378.2 |
Cost of sales | 463 | 451.1 | 377.8 |
General and administrative | 0.4 | 0.4 | 0.4 |
Total costs and expenses | 463.4 | 451.5 | 378.2 |
Louisiana Pigment Company | Kronos | |||
Financial Information [Line Items] | |||
Net sales | 231.7 | 225.6 | 188.6 |
Louisiana Pigment Company | Venator Investments LLC | |||
Financial Information [Line Items] | |||
Net sales | $ 231.7 | $ 225.9 | $ 189.6 |
Investment in TiO2 Manufactur_7
Investment in TiO2 Manufacturing Joint Venture and Other Assets - Schedule of Maturities of Operating Lease Liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Gross amounts due each year: | ||
2024 | $ 4.6 | |
2025 | 3.6 | |
2026 | 3.3 | |
2027 | 2.2 | |
2028 | 2 | |
2029 and thereafter | 17 | |
Total remaining lease payments | 32.7 | |
Less imputed interest | 10.2 | |
Total lease obligations | 22.5 | |
Less current obligations | $ 3.9 | $ 3.8 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | Accrued liabilities | Accrued liabilities |
Operating lease liabilities | $ 18.6 | $ 17.4 |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | Other liabilities | Other liabilities |
Goodwill - Changes in Carrying
Goodwill - Changes in Carrying Amount of Goodwill (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Goodwill [Line Items] | |||
Goodwill | $ 379.7 | $ 379.7 | $ 379.7 |
Chemicals | |||
Goodwill [Line Items] | |||
Goodwill | 352.6 | 352.6 | 352.6 |
Component Products [Member] | |||
Goodwill [Line Items] | |||
Goodwill | $ 27.1 | $ 27.1 | $ 27.1 |
Goodwill - Additional Informati
Goodwill - Additional Information (Detail) - USD ($) | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill [Line Items] | ||||
Aggregate goodwill impairment | $ 0 | $ 0 | $ 0 | |
Consolidated gross goodwill | $ 396,200,000 | |||
Component Products [Member] | ||||
Goodwill [Line Items] | ||||
Aggregate goodwill impairment | $ 16,500,000 |
Long-term debt (Detail)
Long-term debt (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Long-term debt | ||
Total debt | $ 546.5 | $ 559.5 |
Less current maturities | 0.7 | 1.8 |
Total long-term debt | 545.8 | 557.7 |
VALHI, INC. | Contran Credit Facility | ||
Long-term debt | ||
Total debt | 93.4 | 121.4 |
Kronos Worldwide, Inc. | 3.75% Senior Secured Notes due September 15, 2025 | Kronos International, Inc | ||
Long-term debt | ||
Total debt | 440.9 | 424.1 |
LandWell | Unsecured Debt | Western Alliance Bank | ||
Long-term debt | ||
Total debt | 12.2 | 12.9 |
Other Subsidiary | Other | ||
Long-term debt | ||
Total debt | 1.1 | |
Subsidiary | ||
Long-term debt | ||
Total debt | $ 453.1 | $ 438.1 |
Long-term debt - Valhi Contran
Long-term debt - Valhi Contran Credit Facility - Additional Information (Detail) - VALHI, INC. - Contran Credit Facility $ in Millions | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Debt Instrument [Line Items] | |
Borrowings of credit facility | $ 0 |
Repayments of credit facility | $ 28 |
Debt instrument, Interest rate at period end | 9.50% |
Line of credit maximum borrowing capacity | $ 150 |
Interest rate on outstanding borrowings | 1% |
Debt due date, start date | Dec. 31, 2025 |
Amount available for borrowing | $ 56.6 |
Debt instrument, interest rate during period | 9.20% |
Long-term debt - Kronos 3.75 Se
Long-term debt - Kronos 3.75 Senior Secured Notes - Additional Information (Detail) - Kronos Worldwide, Inc. - Kronos International, Inc € in Millions, $ in Millions | 12 Months Ended | ||||
Feb. 12, 2024 USD ($) | Sep. 13, 2017 EUR (€) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Sep. 13, 2017 USD ($) | |
Debt Instrument [Line Items] | |||||
Maximum amount of other indebtedness default before triggering customary default provisions | $ 50 | ||||
Collateral Pledged | Direct Domestic Subsidiary of KII and Guarantors | |||||
Debt Instrument [Line Items] | |||||
Parent company ownership interest | 100% | ||||
Collateral Pledged | Foreign Subsidiary Directly Owned by KII or any Guarantor | |||||
Debt Instrument [Line Items] | |||||
Parent company ownership interest | 65% | ||||
Non-voting Common Stock | Collateral Pledged | Foreign Subsidiary Directly Owned by KII or any Guarantor | |||||
Debt Instrument [Line Items] | |||||
Parent company ownership interest | 100% | ||||
3.75% Senior Secured Notes due September 15, 2025 | |||||
Debt Instrument [Line Items] | |||||
Debt instrument interest rate | 3.75% | 3.75% | 3.75% | ||
Debt instrument maturity date | Sep. 15, 2025 | ||||
Debt instrument principal amount | € 400 | $ 477.6 | |||
Unamortized debt issuance costs | $ 1.6 | $ 2.4 | |||
Debt instrument, payment terms | bear interest at 3.75% per annum, | ||||
Frequency of debt instrument payment | semi-annually | ||||
Debt Instrument, date of first required semi-annual payment | Mar. 15, 2018 | ||||
Debt instrument redemption price percent if experiences certain specified change of control events | 101% | ||||
3.75% Senior Secured Notes due September 15, 2025 | Redeem the Old Notes | |||||
Debt Instrument [Line Items] | |||||
Debt instrument, redemption price percentage | 100% |
Long-term debt - Kronos 9.50 Se
Long-term debt - Kronos 9.50 Senior Secured Notes - Additional Information (Detail) - Kronos Worldwide, Inc. - Kronos International, Inc $ in Millions | 12 Months Ended | |||
Feb. 12, 2024 EUR (€) | Sep. 13, 2017 EUR (€) | Dec. 31, 2023 | Sep. 13, 2017 USD ($) | |
9.50% Senior Secured Notes due March 15, 2029 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument interest rate | 9.50% | |||
Principal amount | € 325,000,000 | |||
Debt instrument principal amount | 276,174,000 | |||
Cash consideration | € 50,000,000 | |||
Debt instrument, payment terms | bear interest at 9.50% per annum | |||
Frequency of debt instrument payment | semi-annually | |||
Debt Instrument, date of first required semi-annual payment | Sep. 15, 2024 | |||
Debt instrument maturity date | Mar. 15, 2029 | |||
Debt instrument, redemption, description | have a maturity date of March 15, 2029. Prior to March 15, 2026, Kronos may redeem some or all of the New Notes at a price equal to 100% of the principal amount thereof, plus an applicable premium as of the date of the redemption as described in the indenture governing its New Notes, plus accrued and unpaid interest. On or after March 15, 2026, Kronos may redeem the New Notes at redemption prices ranging from 104.750% of the principal amount, declining to 100% on or after March 15, 2028, plus accrued and unpaid interest. In addition, on or before March 15, 2026, Kronos may redeem up to 40% of the New Notes with the net proceeds of certain public or private equity offerings at 109.50% of the principal amount, plus accrued and unpaid interest, provided that following the redemption at least 50% of the New Notes remain outstanding. If Kronos or Kronos’ subsidiaries experience certain change of control events, as outlined in the indenture governing its New Notes, Kronos would be required to make an offer to purchase the New Notes at 101% of the principal amount thereof, plus accrued and unpaid interest. Kronos would also be required to make an offer to purchase a specified portion of the New Notes at par value, plus accrued and unpaid interest, in the event that Kronos and its subsidiaries generate a certain amount of net proceeds from the sale of assets outside the ordinary course of business, and such net proceeds are not otherwise used for specified purposes within a specified time period as described in the indenture governing Kronos’ New Notes | |||
Debt Instrument Exchanged, Principal Amount of Each Instrument | € 850 | |||
Debt Instrument Exchanged, Cash Paid For Each Instrument | 150 | |||
Debt Instrument Not Exchanged, Dace Amount | € 75,000,000 | |||
9.50% Senior Secured Notes due March 15, 2029 | Prior to March 15, 2026 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, redemption price percentage | 100% | |||
9.50% Senior Secured Notes due March 15, 2029 | On or After March 15, 2026 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, redemption price percentage | 104.75% | |||
9.50% Senior Secured Notes due March 15, 2029 | On or After March 15, 2028 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, redemption price percentage | 100% | |||
9.50% Senior Secured Notes due March 15, 2029 | On or Before March 15, 2026 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, redemption price percentage | 109.50% | |||
Debt instrument, percentage of debt that may be redeemed | 40% | |||
Minimum redemption outstanding debt percentage | 50% | |||
9.50% Senior Secured Notes due March 15, 2029 | Certain Change Of control events | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, redemption price percentage | 101% | |||
3.75% Senior Secured Notes due September 15, 2025 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument interest rate | 3.75% | 3.75% | 3.75% | |
Debt instrument principal amount | € 400,000,000 | $ 477.6 | ||
Debt instrument, payment terms | bear interest at 3.75% per annum, | |||
Frequency of debt instrument payment | semi-annually | |||
Debt Instrument, date of first required semi-annual payment | Mar. 15, 2018 | |||
Debt instrument maturity date | Sep. 15, 2025 | |||
Debt instrument, redemption, description | have a maturity date of September 15, 2025. Kronos may redeem the Old Notes at 100%, plus accrued and unpaid interest. If Kronos experiences certain specified change of control events as outlined in the indenture governing its Old Notes, it would be required to make an offer to purchase the Old Notes at 101% of the principal amount, plus accrued and unpaid interest. Kronos would also be required to make an offer to purchase a specified portion of the Old Notes at par value, plus accrued and unpaid interest, in the event that it generates a certain amount of net proceeds from the sale of assets outside the ordinary course of business, and such net proceeds are not otherwise used for specified purposes within a specified time period as described in the indenture governing its Old Notes | |||
Debt instrument, par value | € 1,000 | |||
3.75% Senior Secured Notes due September 15, 2025 | On or After March 15, 2028 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, redemption price percentage | 100% |
Long-term debt - Subordinated,
Long-term debt - Subordinated, Unsecured Term Loan from Contran (Details) - Kronos Worldwide, Inc. - Subordinated, unsecured term loan from Contran € in Millions, $ in Millions | Feb. 12, 2024 USD ($) | Feb. 12, 2024 EUR (€) | Feb. 06, 2024 USD ($) |
Debt Instrument [Line Items] | |||
Proceeds from Issuance of Unsecured Debt | $ 53.7 | € 50 | |
Line of credit maximum borrowing capacity | $ 225 | ||
Long-term promissory note fixed interest rate | 11.50% |
Long-term debt - Revolving Cred
Long-term debt - Revolving Credit Facility - Additional Information (Detail) - Kronos Worldwide, Inc. € in Millions, $ in Millions | 12 Months Ended | ||
Apr. 20, 2021 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2023 EUR (€) | |
Global Revolver Credit Facility | |||
Line Of Credit Facility [Line Items] | |||
Borrowings on credit facilities | $ 0 | ||
Line of credit maximum borrowing capacity | $ 225 | ||
Line of credit, maturity month and year | 2026-04 | ||
Repayment of credit facility | 0 | ||
Amount available for borrowing | $ 225 | ||
Fixed charge coverage ratio, minimum value | 100% | ||
Global Revolver Credit Facility | Minimum | Variable Rate | |||
Line Of Credit Facility [Line Items] | |||
Interest rate on outstanding borrowings | 1.50% | ||
Global Revolver Credit Facility | Minimum | Base Rate Option | |||
Line Of Credit Facility [Line Items] | |||
Interest rate on outstanding borrowings | 0.50% | ||
Global Revolver Credit Facility | Maximum | Variable Rate | |||
Line Of Credit Facility [Line Items] | |||
Interest rate on outstanding borrowings | 2% | ||
Global Revolver Credit Facility | Maximum | Base Rate Option | |||
Line Of Credit Facility [Line Items] | |||
Interest rate on outstanding borrowings | 2% | ||
Canadian Subsidiary Revolving Borrowings Maximum | |||
Line Of Credit Facility [Line Items] | |||
Line of credit maximum borrowing capacity | $ 25 | ||
Belgian Subsidiary Revolving Borrowings Maximum | |||
Line Of Credit Facility [Line Items] | |||
Line of credit maximum borrowing capacity | € | € 30 | ||
German Subsidiary Revolving Borrowings Maximum | |||
Line Of Credit Facility [Line Items] | |||
Line of credit maximum borrowing capacity | € | € 60 |
Long-Term Debt - Notes Payable
Long-Term Debt - Notes Payable Landwell - Additional Information (Detail) - Land Well [Member] - Western Alliance Business Trust - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2019 | |
Debt Instrument [Line Items] | ||
Interest rate terms | The agreement requires semi-annual payments of principal and interest on April 15 and October 15 aggregating $1.3 million annually beginning on April 15, 2020 through the maturity date in April 2036 and is payable from the tax increment reimbursement funds received under the OPA. | |
Frequency of debt instrument payment | semi-annual | |
Long-term promissory note fixed interest rate | 4.76% | |
Principal amount of loan agreement | $ 15 | |
Periodic principal and interest payments | $ 1.3 | |
Loans maturity period | 2036-04 |
Long-Term Debt - Aggregate Matu
Long-Term Debt - Aggregate Maturities of Long-Term Debt (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
2024 | $ 0.7 | |
2025 | 536.7 | |
2026 | 0.8 | |
2027 | 0.8 | |
2028 | 0.9 | |
2029 and thereafter | 8.2 | |
Subtotal | 548.1 | |
Less amounts representing original issue discount and debt issuance costs | 1.6 | |
Total debt | 546.5 | $ 559.5 |
After the effect of the exchange of Old Notes and issuance of New notes and Contran Term Loan | ||
Debt Instrument [Line Items] | ||
2024 | 0.7 | |
2025 | 177.2 | |
2026 | 0.8 | |
2027 | 0.8 | |
2028 | 0.9 | |
2029 and thereafter | 369 | |
Subtotal | 549.4 | |
Less amounts representing original issue discount and debt issuance costs | 6.1 | |
Total debt | $ 543.3 |
Accounts payable and accrued _3
Accounts payable and accrued liabilities - Schedule of Accounts Payable and Accrued Liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Accounts payable: | |||
Accounts payable | $ 228.5 | $ 199.4 | |
Current accrued liabilities: | |||
Deferred income | 88.8 | 110.7 | |
Employee benefits | 36.2 | 34.4 | |
Accrued sales discounts and rebates | 22.5 | 25.6 | |
Accrued development costs | 15.1 | 5.6 | |
Interest | 5.1 | 4.9 | |
Operating lease liabilities | $ 3.9 | $ 3.8 | |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Total | Total | |
Environmental remediation and related costs | $ 3.7 | $ 3.8 | $ 3.5 |
Environmental Loss Contingency, Current, Statement of Financial Position [Extensible Enumeration] | Total | Total | |
Other | $ 45 | $ 54.8 | |
Total | 220.3 | 243.6 | |
Noncurrent accrued liabilities: | |||
Accrued development costs | 42.3 | 48.1 | |
Deferred income | 15.5 | 25.9 | |
Insurance claims and expenses | 14.9 | 18.7 | |
Operating lease liabilities | $ 18.6 | $ 17.4 | |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Total | Total | |
Other postretirement benefits | $ 7.4 | $ 7.1 | |
Employee benefits | 4.9 | 4.8 | |
Reserve for uncertain tax positions | 0.3 | ||
Other | 7.8 | 6.7 | |
Total | 111.4 | 129 | |
Kronos Worldwide, Inc. | |||
Accounts payable: | |||
Accounts payable | 218.7 | 177.2 | |
CompX | |||
Accounts payable: | |||
Accounts payable | 3.1 | 3.5 | |
BMI/LandWell | |||
Accounts payable: | |||
Accounts payable | $ 6.7 | $ 18.7 |
Defined contribution and defi_3
Defined contribution and defined benefit retirement - Additional Information (Detail) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |||
Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2024 | |
Defined Benefit Plan Disclosure [Line Items] | |||||
Non cash defined benefit plan termination loss | $ 6.2 | ||||
Defined contribution plan expense | 8.2 | $ 8 | $ 7.8 | ||
Defined Benefit Pension Plans | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Non cash defined benefit plan termination loss | $ 6.2 | ||||
Expected contribution | $ 18 | ||||
Defined benefit fair value of plan assets | 462.9 | 429.6 | |||
Expect to recognize unrecognized actuarial gains (losses) | 3.9 | 0.1 | |||
Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3) | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Defined benefit fair value of plan assets | 292.1 | 264.8 | 320.5 | ||
Defined Benefit Pension Plans | Non U.S. | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Defined benefit plan benefit obligation | 563.7 | 508.6 | 758.1 | ||
Defined benefit fair value of plan assets | 422.6 | 390.5 | $ 481.5 | ||
Net underfunded status | $ 141.1 | $ 118.1 | |||
Discount rate | 3.40% | 3.90% | |||
Long-term return on plan assets | 4.60% | 2.50% | 2.40% | ||
Defined Benefit Pension Plans | Canada | Equity Securities | Minimum [Member] | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Percentage of plan asset allocation | 10% | ||||
Defined Benefit Pension Plans | Canada | Fixed Income Funds | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Percentage of plan asset allocation | 98% | ||||
Defined Benefit Pension Plans | Canada | Fixed Income Funds | Minimum [Member] | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Percentage of plan asset allocation | 90% | ||||
Defined Benefit Pension Plans | Canada | Fixed Income Funds | Maximum [Member] | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Percentage of plan asset allocation | 100% | ||||
Defined Benefit Pension Plans | Norway | Significant Unobservable Inputs (Level 3) | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Percentage of plan asset allocation | 14% | ||||
Defined Benefit Pension Plans | Norway | Equity Securities | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Long-term return on plan assets | 7% | ||||
Percentage of plan asset allocation | 18% | ||||
Defined Benefit Pension Plans | Norway | Fixed Income Funds | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Long-term return on plan assets | 4% | ||||
Percentage of plan asset allocation | 63% | ||||
Defined Benefit Pension Plans | Norway | Real Estate. | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Defined benefit fair value of plan assets | $ 6.6 | $ 7.8 | |||
Long-term return on plan assets | 6% | ||||
Percentage of plan asset allocation | 14% | ||||
Defined Benefit Pension Plans | Norway | Real Estate. | Significant Unobservable Inputs (Level 3) | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Defined benefit fair value of plan assets | $ 6.6 | 7.8 | |||
Defined Benefit Pension Plans | Norway | Other Investments And Liquid Funds | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Long-term return on plan assets | 7% | ||||
Defined Benefit Pension Plans | United States | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Defined benefit plan benefit obligation | $ 42.7 | 43.4 | $ 58 | ||
Defined benefit fair value of plan assets | 40.3 | 39.1 | $ 52.4 | ||
Net underfunded status | $ 2.4 | $ 4.3 | |||
Discount rate | 5% | 5.30% | |||
Long-term return on plan assets | 5% | 4% | 4% | ||
Defined Benefit Pension Plans | United States | Equity Securities | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Long-term return on plan assets | 7% | ||||
Percentage of plan asset allocation | 33% | ||||
Defined Benefit Pension Plans | United States | Fixed Income Funds | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Long-term return on plan assets | 5% | ||||
Percentage of plan asset allocation | 59% |
Defined contribution and defi_4
Defined contribution and defined benefit retirement - Schedule of Funded Status (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Amounts recognized in the Consolidated Balance Sheets: | |||
Pension asset | $ 8.1 | $ 9.3 | |
Noncurrent | (151.6) | (131.6) | |
Pension Plans Defined Benefit [Member] | |||
Change in plan assets: | |||
Fair value at beginning of the year | 429.6 | ||
Fair value at end of the year | 462.9 | 429.6 | |
Pension Plans Defined Benefit [Member] | United States | |||
Change in benefit obligation: | |||
Balance at beginning of the year | 43.4 | 58 | |
Interest cost | 2.2 | 1.4 | $ 1.3 |
Actuarial losses (gains) | 1.2 | (11.8) | |
Benefits paid | (4.1) | (4.2) | |
Balance at end of the year | 42.7 | 43.4 | 58 |
Change in plan assets: | |||
Fair value at beginning of the year | 39.1 | 52.4 | |
Actual return on plan assets | 3.7 | (10.7) | |
Employer contributions | 1.6 | 1.6 | |
Benefits paid | (4.1) | (4.2) | |
Fair value at end of the year | 40.3 | 39.1 | 52.4 |
Funded status | (2.4) | (4.3) | |
Amounts recognized in the Consolidated Balance Sheets: | |||
Current | (0.1) | ||
Noncurrent | (2.4) | (4.2) | |
Total recognized in balance sheet | (2.4) | (4.3) | |
Accumulated other comprehensive (income) loss: | |||
Accumulated other comprehensive loss Actuarial losses | 30.3 | 32.2 | |
Total amount recognized in balance sheet and AOCI | 27.9 | 27.9 | |
Accumulated benefit obligations ("ABO") | $ 42.7 | $ 43.4 | |
Defined Benefit Plan, Funding Status [Extensible List] | us-gaap:FundedPlanMember | us-gaap:FundedPlanMember | |
Pension Plans Defined Benefit [Member] | Non U.S. | |||
Change in benefit obligation: | |||
Balance at beginning of the year | $ 508.6 | $ 758.1 | |
Service cost | 6.3 | 11.3 | 14.7 |
Interest cost | 19.8 | 10.6 | 8.3 |
Participants' contributions | 1.8 | 1.7 | |
Actuarial losses (gains) | 44.3 | (198.6) | |
Settlements | (8.6) | (1.4) | |
Change in currency exchange rates | 14.1 | (51.2) | |
Benefits paid | (22.6) | (21.9) | |
Balance at end of the year | 563.7 | 508.6 | 758.1 |
Change in plan assets: | |||
Fair value at beginning of the year | 390.5 | 481.5 | |
Actual return on plan assets | 37.4 | (52.5) | |
Employer contributions | 14.7 | 15 | |
Participants' contributions | 1.8 | 1.7 | |
Settlements | (8.6) | (1.2) | |
Change in currency exchange rates | 9.4 | (32.1) | |
Benefits paid | (22.6) | (21.9) | |
Fair value at end of the year | 422.6 | 390.5 | $ 481.5 |
Funded status | (141.1) | (118.1) | |
Amounts recognized in the Consolidated Balance Sheets: | |||
Pension asset | 8.1 | 9.3 | |
Noncurrent | (149.2) | (127.4) | |
Total recognized in balance sheet | (141.1) | (118.1) | |
Accumulated other comprehensive (income) loss: | |||
Accumulated other comprehensive loss Actuarial losses | 106.8 | 90 | |
Accumulated other comprehensive (income) loss - Prior service credit | 0.3 | 0.4 | |
Accumulated other comprehensive loss, Total | 107.1 | 90.4 | |
Total amount recognized in balance sheet and AOCI | (34) | (27.7) | |
Accumulated benefit obligations ("ABO") | $ 549.8 | $ 493.9 | |
Defined Benefit Plan, Funding Status [Extensible List] | us-gaap:FundedPlanMember | us-gaap:FundedPlanMember |
Defined contribution and defi_5
Defined contribution and defined benefit retirement - Components of Net Periodic Defined Benefit Pension Benefit Cost (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
U.K. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Settlements | $ 6.2 | ||
Pension Plans Defined Benefit [Member] | United States | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Interest cost | 2.2 | $ 1.4 | $ 1.3 |
Expected return on plan assets | (1.9) | (2) | (2.1) |
Recognized net actuarial losses | 2 | 1.9 | 2.1 |
Settlements | (0.5) | ||
Total | 2.3 | 1.3 | 0.8 |
Pension Plans Defined Benefit [Member] | Non U.S. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | 6.3 | 11.3 | 14.7 |
Interest cost | 19.8 | 10.6 | 8.3 |
Expected return on plan assets | (18.3) | (11.1) | (11.4) |
Amortization of prior service cost | 0.1 | 0.2 | |
Recognized net actuarial losses | 1.8 | 12.8 | 19.5 |
Settlements | 6.5 | 0.4 | |
Total | $ 16.1 | $ 24.1 | $ 31.3 |
Defined contribution and defi_6
Defined contribution and defined benefit retirement - Schedule of Defined Benefit Plan Expected Future Payments (Detail) - Pension Plans Defined Benefit [Member] $ in Millions | Dec. 31, 2023 USD ($) |
Pension Plans Postretirement And Other Employee Benefits [Line Items] | |
2024 | $ 28.4 |
2025 | 28.3 |
2026 | 28.7 |
2027 | 31.6 |
2028 | 35.7 |
Next 5 years | $ 169.5 |
Defined contribution and defi_7
Defined contribution and defined benefit retirement - Schedule of Plans for which Accumulated Benefit Obligations Exceeds Plan Assets (Detail) - Pension Plans Defined Benefit [Member] - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
United States | ||
Plans for which the ABO exceeds plan assets: | ||
Projected benefit obligations | $ 42.7 | $ 43.4 |
Accumulated benefit obligations | 42.7 | 43.4 |
Fair value of plan assets | 40.3 | 39.1 |
Non U.S. | ||
Plans for which the ABO exceeds plan assets: | ||
Projected benefit obligations | 463.1 | 403.5 |
Accumulated benefit obligations | 452.9 | 392.4 |
Fair value of plan assets | $ 313.8 | $ 276 |
Defined contribution and defi_8
Defined contribution and defined benefit retirement - Summary of Actuarial Assumptions Used to Determine Net Periodic Benefit Cost (Credit) (Detail) - Pension Plans Defined Benefit [Member] | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
United States | |||
Pension Plans Postretirement And Other Employee Benefits [Line Items] | |||
Discount rate | 5.30% | 2.60% | 2.20% |
Long-term return on plan assets | 5% | 4% | 4% |
Non U.S. | |||
Pension Plans Postretirement And Other Employee Benefits [Line Items] | |||
Discount rate | 3.90% | 1.50% | 1% |
Increase in future compensation levels | 2.70% | 2.60% | 2.60% |
Long-term return on plan assets | 4.60% | 2.50% | 2.40% |
Defined contribution and defi_9
Defined contribution and defined benefit retirement - Summary of Actuarial Assumptions Used to Benefit Obligations (Detail) - Pension Plans Defined Benefit [Member] - Non U.S. | Dec. 31, 2023 | Dec. 31, 2022 |
Pension Plans Postretirement And Other Employee Benefits [Line Items] | ||
Discount rate | 3.40% | 3.90% |
Increase in future compensation levels | 2.70% | 2.70% |
Defined contribution and def_10
Defined contribution and defined benefit retirement - Schedule of Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss) (Detail) - Pension Plans Defined Benefit [Member] - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pension Plans Postretirement And Other Employee Benefits [Line Items] | |||
Net actuarial gains | $ (25.5) | $ 134.1 | $ 50.7 |
Amortization of unrecognized net actuarial losses | 3.8 | 14.7 | 21.6 |
Amortization of unrecognized prior service cost (credit) | 0.1 | 0.2 | |
Settlements | 6.5 | 0.4 | |
Total | $ (15.2) | $ 149.3 | $ 72.5 |
Defined contribution and def_11
Defined contribution and defined benefit retirement - Composition of Pension Plan Assets (Detail) - Pension Plans Defined Benefit [Member] - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 462.9 | $ 429.6 | |
Quoted Prices in Active Markets (Level 1) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 111.7 | 114.9 | |
Significant Other Observable Inputs (Level 2) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 19.5 | 14.8 | |
Significant Unobservable Inputs (Level 3) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 292.1 | 264.8 | $ 320.5 |
Assets measured at NAV | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 39.6 | 35.1 | |
Non U.S. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 422.6 | $ 390.5 | $ 481.5 |
Long-term return on plan assets | 4.60% | 2.50% | 2.40% |
Germany | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 269.4 | $ 234 | |
Germany | Significant Unobservable Inputs (Level 3) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 269.4 | 234 | |
Canada | Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 0.1 | ||
Canada | Non Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 2.7 | 11 | |
Canada | Local Currency Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 86.2 | 72.9 | |
Canada | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 1.1 | 0.6 | |
Canada | Quoted Prices in Active Markets (Level 1) | Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 0.1 | ||
Canada | Quoted Prices in Active Markets (Level 1) | Non Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 2.7 | 11 | |
Canada | Quoted Prices in Active Markets (Level 1) | Local Currency Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 86.2 | 72.9 | |
Canada | Quoted Prices in Active Markets (Level 1) | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 1.1 | 0.6 | |
Norway | Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 2.4 | 2.3 | |
Norway | Non Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 7.2 | 4.7 | |
Norway | Local Currency Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 23.9 | 21.8 | |
Norway | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 3 | 2.7 | |
Norway | Non Local Currency Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 4.2 | 8.4 | |
Norway | Real Estate. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 6.6 | 7.8 | |
Long-term return on plan assets | 6% | ||
Norway | Quoted Prices in Active Markets (Level 1) | Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 2.4 | 2.3 | |
Norway | Quoted Prices in Active Markets (Level 1) | Non Local Currency Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 7.2 | 4.7 | |
Norway | Quoted Prices in Active Markets (Level 1) | Local Currency Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 4.4 | 7 | |
Norway | Quoted Prices in Active Markets (Level 1) | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 2.8 | 2.4 | |
Norway | Quoted Prices in Active Markets (Level 1) | Non Local Currency Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 4.2 | 8.4 | |
Norway | Significant Other Observable Inputs (Level 2) | Local Currency Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 19.5 | 14.8 | |
Norway | Significant Unobservable Inputs (Level 3) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Percentage of plan asset allocation | 14% | ||
Norway | Significant Unobservable Inputs (Level 3) | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 0.2 | 0.3 | |
Norway | Significant Unobservable Inputs (Level 3) | Real Estate. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 6.6 | 7.8 | |
Other. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 15.9 | 24.2 | |
Other. | Quoted Prices in Active Markets (Level 1) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 1.5 | ||
Other. | Significant Unobservable Inputs (Level 3) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 15.9 | 22.7 | |
United States | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 40.3 | $ 39.1 | $ 52.4 |
Long-term return on plan assets | 5% | 4% | 4% |
United States | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 1.9 | $ 3.8 | |
United States | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 11.3 | 12.4 | |
United States | Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 27.1 | 22.9 | |
United States | Quoted Prices in Active Markets (Level 1) | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 0.7 | 2.8 | |
United States | Quoted Prices in Active Markets (Level 1) | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 1 | ||
United States | Quoted Prices in Active Markets (Level 1) | Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 0.2 | ||
United States | Assets measured at NAV | Cash and Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 1.2 | 1 | |
United States | Assets measured at NAV | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | 11.3 | 11.4 | |
United States | Assets measured at NAV | Fixed Income | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Plan assets | $ 27.1 | $ 22.7 |
Defined contribution and def_12
Defined contribution and defined benefit retirement- Schedule of Rollforward of Change in Fair Value of Level 3 Assets (Detail) - Pension Plans Defined Benefit [Member] - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule Of Reconciliation Of Changes In Fair Value Of Assets And Liabilities [Line Items] | ||
Fair value at beginning of the year | $ 429.6 | |
Fair value at end of the year | 462.9 | $ 429.6 |
Significant Unobservable Inputs (Level 3) | ||
Schedule Of Reconciliation Of Changes In Fair Value Of Assets And Liabilities [Line Items] | ||
Fair value at beginning of the year | 264.8 | 320.5 |
Gain (loss) on assets held at end of year | 11.1 | (31) |
Gain (loss) on assets sold during the year | 14.4 | (3.6) |
Assets purchased | 1.7 | 13.8 |
Assets sold | (9.3) | (15.5) |
Transfers in (out) | (0.1) | |
Currency exchange rate fluctuations | 9.4 | (19.3) |
Fair value at end of the year | $ 292.1 | $ 264.8 |
Disaggregation of sales - Sched
Disaggregation of sales - Schedule of Disaggregates of Net Sales of our Chemicals Segment (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation Of Revenue [Line Items] | |||
Net sales | $ 1,921.7 | $ 2,222.5 | $ 2,296.4 |
Point Of Origin | Operating Segment | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 1,921.7 | 2,222.5 | 2,296.4 |
Point Of Origin | Operating Segment | United States | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 1,284.4 | 1,518.9 | 1,409.1 |
Point Of Origin | Operating Segment | Germany | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 726.4 | 895.4 | 971.7 |
Point Of Origin | Operating Segment | Canada | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 351 | 389.4 | 371.9 |
Point Of Origin | Operating Segment | Belgium | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 217.1 | 306.5 | 295.7 |
Point Of Origin | Operating Segment | Norway | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 252.1 | 273.5 | 257.2 |
Point Of Origin | Eliminations | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | (909.3) | (1,161.2) | (1,009.2) |
Point Of Destination | Operating Segment | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 1,921.7 | 2,222.5 | 2,296.4 |
Point Of Destination | Operating Segment | Europe | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 738.5 | 879 | 945.7 |
Point Of Destination | Operating Segment | North America | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 871 | 985.4 | 999.7 |
Chemicals | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 1,666.5 | 1,930.2 | 1,939.4 |
Chemicals | Point Of Origin | Operating Segment | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 1,666.5 | 1,930.2 | 1,939.4 |
Chemicals | Point Of Origin | Operating Segment | United States | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 1,029.2 | 1,226.6 | 1,052.1 |
Chemicals | Point Of Origin | Operating Segment | Germany | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 726.4 | 895.4 | 971.7 |
Chemicals | Point Of Origin | Operating Segment | Canada | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 351 | 389.4 | 371.9 |
Chemicals | Point Of Origin | Operating Segment | Belgium | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 217.1 | 306.5 | 295.7 |
Chemicals | Point Of Origin | Operating Segment | Norway | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 252.1 | 273.5 | 257.2 |
Chemicals | Point Of Origin | Eliminations | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | (909.3) | (1,161.2) | (1,009.2) |
Chemicals | Point Of Destination | Operating Segment | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 1,666.5 | 1,930.2 | 1,939.4 |
Chemicals | Point Of Destination | Operating Segment | Europe | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 737.8 | 878.3 | 945 |
Chemicals | Point Of Destination | Operating Segment | North America | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 618.1 | 695.7 | 645.7 |
Chemicals | Point Of Destination | Operating Segment | Other | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | $ 310.6 | $ 356.2 | $ 348.7 |
Disaggregation of sales - Sch_2
Disaggregation of sales - Schedule of Disaggregates of Net Sales of our Component Products and Real Estate Management and Development Segments (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation Of Revenue [Line Items] | |||
Net sales | $ 1,921.7 | $ 2,222.5 | $ 2,296.4 |
Component products | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 161.3 | 166.6 | 140.8 |
Component products | Security Products | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 121.2 | 114.5 | 105.1 |
Component products | Marine Components | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 40.1 | 52.1 | 35.7 |
Real estate management and development | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 93.9 | 125.7 | 216.2 |
Real estate management and development | Land Sales | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | 92.6 | 120.9 | 207.8 |
Real estate management and development | Utility and Other | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | $ 1.3 | 1.2 | 1.6 |
Real estate management and development | Water Delivery | |||
Disaggregation Of Revenue [Line Items] | |||
Net sales | $ 3.6 | $ 6.8 |
Other income, net - Schedule of
Other income, net - Schedule of Components of Other Income (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Interest income and other: | |||
Interest and dividends | $ 21 | $ 10.9 | $ 4 |
Securities transactions, net | 0.3 | (0.5) | |
Total | 21.3 | 10.4 | 4 |
Infrastructure reimbursement | 25.5 | 16 | 15.3 |
Currency transactions, net | 1.4 | 11.5 | 1.6 |
Insurance recoveries | 3 | 2.8 | 0.1 |
Gain on land sales | 1.5 | 16 | |
Other, net | 2.7 | 3 | 2 |
Total | $ 55.4 | $ 43.7 | $ 39 |
Other income, net - Additional
Other income, net - Additional Information (Detail) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
Sep. 30, 2023 | Jun. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2021 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Other Income Net Additional Information Detail [Line Items] | ||||||||
Insurance recoveries | $ 3 | $ 2.8 | $ 0.1 | |||||
Pre-tax gain on sale of land | $ 10.4 | $ 5.6 | $ 1.5 | 1.5 | 16 | |||
Net proceeds | $ 15 | $ 8.4 | $ 1.8 | 1.8 | 23.4 | |||
Infrastructure reimbursement | 25.5 | 16 | $ 15.3 | |||||
Kronos Worldwide, Inc. | ||||||||
Disclosure Other Income Net Additional Information Detail [Line Items] | ||||||||
Insurance recoveries | 2.5 | $ 2.7 | ||||||
Land Well [Member] | ||||||||
Disclosure Other Income Net Additional Information Detail [Line Items] | ||||||||
Infrastructure reimbursement | $ 0.3 | $ 0.8 | ||||||
N L Industries Inc | ||||||||
Disclosure Other Income Net Additional Information Detail [Line Items] | ||||||||
Insurance recoveries | $ 0.5 |
Income Taxes - Components of Co
Income Taxes - Components of Comprehensive Provision for Income Taxes Allocation (Detail) (Imported) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Schedule Of Income Tax [Line Items] | |||
United States | $ 53.2 | $ 81.4 | $ 131.4 |
Non-U.S. subsidiaries | (72.7) | 88.5 | 126.4 |
Income (loss) before income taxes | (19.5) | 169.9 | 257.8 |
Expected tax expense (benefit) at U.S. federal statutory income tax rate of 21% | $ (4.1) | $ 35.7 | $ 54.1 |
U.S. federal statutory income tax rate | 21% | 21% | 21% |
Non-U.S. tax rates | $ (6.3) | $ 2 | $ 4.5 |
Incremental net tax (benefit) on earnings and losses of U.S. and non-U.S. tax group companies | (13.9) | (1.7) | (2) |
Valuation allowance | 2.2 | (3) | 0.9 |
Global intangible low-tax income, net | (0.4) | 1.8 | 2.8 |
U.S. state income taxes and other, net | 0.6 | 1.5 | 1.5 |
Adjustment to the reserve for uncertain tax positions, net | (0.7) | (2.9) | (2.6) |
Nondeductible expenses | 1.2 | 1 | 1.1 |
Other, net | (1) | (0.6) | (0.2) |
Income tax expense | (22.4) | 33.8 | 60.1 |
Comprehensive provision (benefit) for income taxes allocable to: | |||
Income tax expense (benefit) | (22.4) | 33.8 | 60.1 |
Other comprehensive income (loss): | |||
Currency translation | 0.4 | (3.3) | (0.8) |
Total | (29.9) | 92.1 | 89 |
Pension Plans Defined Benefit [Member] | |||
Other comprehensive income (loss): | |||
Defined benefit plans | (7.6) | 60.7 | $ 29.7 |
Other Postretirement Benefit Plans Defined Benefit [Member] | |||
Other comprehensive income (loss): | |||
Defined benefit plans | $ (0.3) | $ 0.9 |
Income taxes - Component of Inc
Income taxes - Component of Income Taxes Expenses (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Currently payable: | |||
U.S. federal and state | $ 12.6 | $ 16.3 | $ 29.7 |
Non-U.S. | 13.5 | 20.1 | 21.5 |
Total | 26.1 | 36.4 | 51.2 |
Deferred income taxes (benefit): | |||
U.S. federal and state | (12.6) | (3.9) | (1.7) |
Non-U.S. | (35.9) | 1.3 | 10.6 |
Total | (48.5) | (2.6) | 8.9 |
Income tax expense | $ (22.4) | $ 33.8 | $ 60.1 |
Income taxes - Components of Ne
Income taxes - Components of Net Deferred Tax Asset (Liability) (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Tax effect of temporary differences related to: | ||
Inventories | $ 1.4 | |
Lease assets | 5.7 | $ 5.3 |
Accrued OPEB costs | 2.1 | 2 |
Accrued pension costs | 26.9 | 22 |
Accrued environmental liabilities | 22.6 | 25.9 |
Other deductible differences | 14.1 | 12 |
Investments in subsidiaries and affiliates | 10.5 | 6.7 |
Tax loss and tax credit carryforwards | 119.6 | 82.6 |
Valuation allowance | (18.2) | (16.5) |
Adjusted gross deferred tax assets | 184.7 | 140 |
Netting of items by tax jurisdiction, assets | (117.7) | (99.5) |
Net noncurrent deferred tax asset (liability) | 67 | 40.5 |
Tax effect of temporary differences related to: | ||
Inventories | (5.3) | |
Property and equipment | (62.9) | (62.8) |
Lease liabilities | (5.7) | (5.4) |
Other taxable differences | (15.3) | (15.8) |
Investments in subsidiaries and affiliates | (54.7) | (62.3) |
Tax on unremitted earnings of non-U.S. subsidiaries | (10.9) | (11.4) |
Adjusted gross deferred tax liabilities | (149.5) | (163) |
Netting of items by tax jurisdiction, liabilities | 117.7 | 99.5 |
Net noncurrent deferred tax asset (liability) | $ (31.8) | $ (63.5) |
Income taxes - Additional Infor
Income taxes - Additional Information (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2017 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2018 | |
Income Taxes Disclosure [Line Items] | |||||
Nondeductible Portion of Interest Carryforwards | $ 14,700,000 | $ 12,500,000 | |||
Unpaid Transition Tax | $ 33,300,000 | ||||
Transition Tax, Number Of Payments | 2 | ||||
Transition Tax, due in 2024 | $ 14,800,000 | ||||
Transition Tax, due in 2025 | 18,500,000 | ||||
Income tax expense (benefit) | (22,400,000) | 33,800,000 | $ 60,100,000 | ||
Deferred income taxes | $ 67,000,000 | 40,500,000 | |||
Period For Which Opertaing Loss Carryforward is Utilized | 3 years | ||||
Business interest income, adjusted taxable income | 30% | ||||
Current income taxes expense (benefit) | $ 26,100,000 | 36,400,000 | 51,200,000 | ||
Deferred income taxes expense (benefit) | (48,500,000) | (2,600,000) | 8,900,000 | ||
Deferred income taxes | 31,800,000 | 63,500,000 | |||
Unrecognized tax benefits impact on effective tax rate | 2,800,000 | ||||
Accrued interest and penalties during the period | 0 | 200,000 | 700,000 | ||
Accrued interest and penalties end of the period | 0 | 100,000 | |||
Contran | |||||
Income Taxes Disclosure [Line Items] | |||||
Income taxes payable current | 10,200,000 | 5,800,000 | |||
Chemicals | |||||
Income Taxes Disclosure [Line Items] | |||||
Deferred income taxes expense (benefit) | $ 2,200,000 | ||||
Canada | |||||
Income Taxes Disclosure [Line Items] | |||||
Operating Loss Carryforwards, Expiration Period | 20 years | ||||
European Subsidiaries | Chemicals | Transition Tax | |||||
Income Taxes Disclosure [Line Items] | |||||
Current income tax expense provisional pursuant to transition tax | $ 74,100,000 | ||||
Income tax liability payable period | 8 years | ||||
Corporate Tax Purposes | Germany | |||||
Income Taxes Disclosure [Line Items] | |||||
Net operating loss carryforwards | $ 75,800,000 | ||||
Net operating loss carryforwards | 478,700,000 | ||||
Corporate Tax Purposes | Belgium | |||||
Income Taxes Disclosure [Line Items] | |||||
Net operating loss carryforwards | 11,800,000 | ||||
Net operating loss carryforwards | 47,000,000 | ||||
Corporate Tax Purposes | Canada | |||||
Income Taxes Disclosure [Line Items] | |||||
Net operating loss carryforwards | 4,700,000 | ||||
Net operating loss carryforwards | 31,500,000 | ||||
Trade Tax Purposes | Germany | |||||
Income Taxes Disclosure [Line Items] | |||||
Net operating loss carryforwards | 5,900,000 | ||||
Net operating loss carryforwards | 54,500,000 | ||||
Provincial Tax Purposes | Canada | |||||
Income Taxes Disclosure [Line Items] | |||||
Net operating loss carryforwards | 4,000,000 | ||||
Net operating loss carryforwards | 34,900,000 | ||||
Direct Investment in Subsidiary | Kronos | |||||
Income Taxes Disclosure [Line Items] | |||||
Deferred income taxes expense (benefit) | 6,400,000 | $ (1,200,000) | $ 5,000,000 | ||
Deferred income taxes | 47,400,000 | ||||
Direct Investment in Subsidiary | Kronos | Maximum [Member] | |||||
Income Taxes Disclosure [Line Items] | |||||
Deferred income taxes | $ 153,600,000 |
Income taxes - Changes in Uncer
Income taxes - Changes in Uncertain Tax Positions (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Unrecognized tax benefits: | |||
Amount at beginning of year | $ 3.5 | $ 6.4 | $ 9.6 |
Net increase (decrease): | |||
Tax positions taken in current period | 0.5 | 0.7 | 0.6 |
Lapse due to applicable statute of limitations | (1.2) | (3.4) | (3.6) |
Changes in currency exchange rates | (0.2) | (0.2) | |
Amount at end of year | $ 2.8 | $ 3.5 | $ 6.4 |
Noncontrolling interest in su_3
Noncontrolling interest in subsidiaries - Noncontrolling Interest in Net Assets of Subsidiaries (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Noncontrolling interest in net assets: | ||
Noncontrolling interest in subsidiaries | $ 325.7 | $ 348.2 |
Kronos Worldwide, Inc. | ||
Noncontrolling interest in net assets: | ||
Noncontrolling interest in subsidiaries | 209 | 239.3 |
NL Industries, Inc. | ||
Noncontrolling interest in net assets: | ||
Noncontrolling interest in subsidiaries | 76.9 | 79 |
CompX International Inc. | ||
Noncontrolling interest in net assets: | ||
Noncontrolling interest in subsidiaries | 22 | 20.6 |
BMI | ||
Noncontrolling interest in net assets: | ||
Noncontrolling interest in subsidiaries | 11 | 6.9 |
LandWell | ||
Noncontrolling interest in net assets: | ||
Noncontrolling interest in subsidiaries | $ 6.8 | $ 2.4 |
Noncontrolling interest in su_4
Noncontrolling interest in subsidiaries - Schedule of Noncontrolling Interest in Net Income of Subsidiaries (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Noncontrolling interest in net income (loss) of subsidiaries: | |||
Noncontrolling interest in net income of subsidiaries | $ 15 | $ 45.9 | $ 70.5 |
Kronos Worldwide, Inc. | |||
Noncontrolling interest in net income (loss) of subsidiaries: | |||
Noncontrolling interest in net income of subsidiaries | (9.5) | 20 | 22 |
NL | |||
Noncontrolling interest in net income (loss) of subsidiaries: | |||
Noncontrolling interest in net income of subsidiaries | (0.4) | 5.8 | 8.7 |
CompX | |||
Noncontrolling interest in net income (loss) of subsidiaries: | |||
Noncontrolling interest in net income of subsidiaries | 2.9 | 2.6 | 2.2 |
BMI | |||
Noncontrolling interest in net income (loss) of subsidiaries: | |||
Noncontrolling interest in net income of subsidiaries | 8.2 | 2.8 | 14.7 |
LandWell | |||
Noncontrolling interest in net income (loss) of subsidiaries: | |||
Noncontrolling interest in net income of subsidiaries | $ 13.8 | $ 14.7 | $ 22.9 |
Valhi Stockholders' Equity - Sc
Valhi Stockholders' Equity - Schedule of Common Stock Outstanding (Detail) - shares shares in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Schedule Of Stockholders Equity [Line Items] | |||
Common stock, shares issued | 29.6 | 29.6 | 29.6 |
Shares of common stock, Treasury | (1.1) | (1.1) | (1.1) |
Common stock, shares outstanding | 29.6 | 29.6 | |
Excluding Stock Ownership By Subsidiary Considered To Be Held In Treasury | |||
Schedule Of Stockholders Equity [Line Items] | |||
Common stock, shares outstanding | 28.5 | 28.5 | 28.5 |
Valhi Stockholders' Equity - Ad
Valhi Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions | 12 Months Ended | ||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2021 | Dec. 31, 2019 | |
Schedule Of Stockholders Equity [Line Items] | |||||
Common stock, par value | $ 0.01 | $ 0.01 | |||
Treasury stock, shares | 1,100,000 | 1,100,000 | 1,100,000 | ||
Percentage of shares held by majority-owned subsidiary that has to be considered for voting purpose | 100% | ||||
Preferred stock, par value | $ 0.01 | $ 0.01 | |||
Director Stock Plan | |||||
Schedule Of Stockholders Equity [Line Items] | |||||
Number of shares authorized | 100,000 | 200,000 | |||
Shares awarded under plan | 9,000 | 2,400 | |||
Common stock available for future grant | 84,600 | ||||
N L Industries Inc | |||||
Schedule Of Stockholders Equity [Line Items] | |||||
Treasury stock, shares | 1,200,000 | 1,200,000 | |||
Unrealized gain (loss) on sale of shares attributable to noncontrolling interest | $ 1.6 | $ 3.3 | |||
N L Industries Inc | Director Stock Plan | |||||
Schedule Of Stockholders Equity [Line Items] | |||||
Common stock available for future grant | 200,000 | ||||
Kronos | |||||
Schedule Of Stockholders Equity [Line Items] | |||||
Shares available for purchase | 1,017,518 | ||||
Treasury stock, shares | 100,000 | 100,000 | |||
Unrealized gain (loss) on sale of shares attributable to noncontrolling interest | $ 1.7 | $ 1.6 | $ 3.3 | ||
Kronos | Director Stock Plan | |||||
Schedule Of Stockholders Equity [Line Items] | |||||
Common stock available for future grant | 97,100 | ||||
Comp X | Director Stock Plan | |||||
Schedule Of Stockholders Equity [Line Items] | |||||
Common stock available for future grant | 124,450 | ||||
Common Stock | |||||
Schedule Of Stockholders Equity [Line Items] | |||||
Shares available for purchase | 334,000 | 833,333 |
Valhi stockholders' equity - Ac
Valhi stockholders' equity - Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accumulated other comprehensive income (loss) (net of tax and noncontrolling interest): | |||
Balance at beginning of period | $ 958.6 | ||
Other comprehensive income (loss) | (1.6) | $ 47.4 | $ 28.1 |
Plan settlement | 4.3 | 0.2 | |
Balance at end of period | 935.8 | 958.6 | |
Marketable Securities | |||
Accumulated other comprehensive income (loss) (net of tax and noncontrolling interest): | |||
Balance at beginning of period | 1.6 | 1.7 | 1.8 |
Other comprehensive income (loss) | 0.1 | (0.1) | (0.1) |
Balance at end of period | 1.7 | 1.6 | 1.7 |
Currency Translation | |||
Accumulated other comprehensive income (loss) (net of tax and noncontrolling interest): | |||
Balance at beginning of period | (91.5) | (72.2) | (67.4) |
Other comprehensive income (loss) | 2.7 | (19.3) | (4.8) |
Balance at end of period | (88.8) | (91.5) | (72.2) |
Accumulated Defined Benefit Plans Adjustment | Defined Benefit Pension Plans | |||
Accumulated other comprehensive income (loss) (net of tax and noncontrolling interest): | |||
Balance at beginning of period | (55) | (120.9) | (154.1) |
Other comprehensive income (loss) | 1.9 | 7.3 | 10.7 |
Net actuarial gain (loss) arising during the year | (10) | 58.4 | 22.5 |
Balance at end of period | (58.8) | (55) | (120.9) |
Accumulated Defined Benefit Plans Adjustment | OPEB | |||
Accumulated other comprehensive income (loss) (net of tax and noncontrolling interest): | |||
Balance at beginning of period | 1 | 0.1 | 0.3 |
Other comprehensive income (loss) | (0.7) | (0.5) | (0.3) |
Net actuarial gain (loss) arising during the year | 0.1 | 1.4 | 0.1 |
Balance at end of period | 0.4 | 1 | 0.1 |
Total Accumulated Other Comprehensive Loss | |||
Accumulated other comprehensive income (loss) (net of tax and noncontrolling interest): | |||
Balance at beginning of period | (143.9) | (191.3) | (219.4) |
Balance at end of period | $ (145.5) | $ (143.9) | $ (191.3) |
Related party transactions - Ad
Related party transactions - Additional Information (Detail) € in Millions, shares in Millions, $ in Millions | 1 Months Ended | 12 Months Ended | ||||
Feb. 12, 2024 USD ($) | Feb. 12, 2024 EUR (€) | Feb. 29, 2024 USD ($) | Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Kronos | Subordinated, unsecured term loan from Contran | ||||||
Related Party Transaction [Line Items] | ||||||
Subordinated, Unsecured Term Loan from Contran | $ 53.7 | € 50 | ||||
Contran | Intercorporate Services Agreements Fees | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction | $ 37.8 | $ 41.2 | $ 41 | |||
Contran | Combined Information Technology Data Recovery Program | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction | 0.4 | 0.3 | 0.3 | |||
Contran | Pledge Fee Received | ||||||
Related Party Transaction [Line Items] | ||||||
Revenue and other income from related party transactions | 0.8 | 1.2 | 1.5 | |||
Contran | Kronos | Sublease Agreement | ||||||
Related Party Transaction [Line Items] | ||||||
Payment for sublease rent and related ancillary services | $ 0.6 | 0.5 | 0.4 | |||
Contran | Kronos | Stock Pledged as Collateral | ||||||
Related Party Transaction [Line Items] | ||||||
Stock pledged as collateral | shares | 16.7 | |||||
Contran | Contran Credit Facility | ||||||
Related Party Transaction [Line Items] | ||||||
Interest on borrowings and unused commitment fees under credit facilities | $ 10.3 | 9.2 | 10.4 | |||
Contran and Other Affiliates | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction cash paid for insurance premium | 29.3 | 25.2 | 27.1 | |||
LPC | ||||||
Related Party Transaction [Line Items] | ||||||
Purchase of Ti02 from LPC | 231.7 | 225.6 | 188.6 | |||
Sales of feedstock ore to LPC | $ 135.1 | $ 106.9 | $ 85.4 | |||
Related Party [Member] | Kronos | Subordinated, unsecured term loan from Contran | Contran | ||||||
Related Party Transaction [Line Items] | ||||||
Subordinated, Unsecured Term Loan from Contran | $ 53.7 |
Related party transactions - Re
Related party transactions - Receivables from and Payables to Affiliates (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Related Party Transaction [Line Items] | ||
Other liabilities, primarily current | $ 30.1 | $ 22.9 |
Current receivables from affiliates | 17.5 | 2.9 |
Payables to affiliate included in long-term debt | 111.4 | 129 |
Current receivables from affiliates: | ||
Current receivables from affiliates | 17.5 | 2.9 |
Current payables to affiliates | 30.1 | 22.9 |
Payables to affiliate included in long-term debt | 111.4 | 129 |
Related Party [Member] | ||
Related Party Transaction [Line Items] | ||
Other liabilities, primarily current | 30.1 | 22.9 |
Current receivables from affiliates | 17.5 | 2.9 |
Current receivables from affiliates: | ||
Current receivables from affiliates | 17.5 | 2.9 |
Current payables to affiliates | 30.1 | 22.9 |
Contran | ||
Related Party Transaction [Line Items] | ||
Contran trade items | 0.2 | 0.2 |
Contran income taxes | 10.2 | 5.8 |
Contran | Contran | ||
Related Party Transaction [Line Items] | ||
Contran - income taxes | 18.5 | 33.4 |
Louisiana Pigment Company | ||
Related Party Transaction [Line Items] | ||
Other liabilities, primarily current | 19.9 | 17.1 |
Current receivables from affiliates | 16.9 | |
Current receivables from affiliates: | ||
Current receivables from affiliates | 16.9 | |
Current payables to affiliates | 19.9 | 17.1 |
VALHI, INC. | Contran | Credit Facility. | ||
Related Party Transaction [Line Items] | ||
Payables to affiliate included in long-term debt | 93.4 | 121.4 |
Current receivables from affiliates: | ||
Payables to affiliate included in long-term debt | 93.4 | 121.4 |
Other Affiliates | ||
Related Party Transaction [Line Items] | ||
Current receivables from affiliates | 0.4 | 2.7 |
Current receivables from affiliates: | ||
Current receivables from affiliates | $ 0.4 | $ 2.7 |
Commitments and contingencies -
Commitments and contingencies - Lead Pigment Litigation-NL and Environmental Matters and Litigation - Additional Information (Detail) | 1 Months Ended | 12 Months Ended | |||||||||
Jul. 24, 2019 USD ($) installment defendant | Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2020 USD ($) | Dec. 31, 2023 USD ($) case site | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | Sep. 30, 2019 USD ($) | Jul. 25, 2019 USD ($) | |
Commitments And Contingent Liabilities [Line Items] | |||||||||||
Litigation settlement | $ 11,800,000 | $ 11,800,000 | |||||||||
Litigation settlement net present value | 16,100,000 | 27,400,000 | |||||||||
Current insurance recovery receivable | 0 | 0 | |||||||||
Accrual for reasonably estimable environmental remediation and related matters | 96,900,000 | 97,300,000 | $ 97,600,000 | $ 98,600,000 | |||||||
Other Environmental Cleanup Matters | |||||||||||
Commitments And Contingent Liabilities [Line Items] | |||||||||||
Accrual for reasonably estimable environmental remediation and related matters | 6,000,000 | ||||||||||
NL | Environmental Remediation Sites NL Named As PRP Or Defendant | |||||||||||
Commitments And Contingent Liabilities [Line Items] | |||||||||||
Accrual for reasonably estimable environmental remediation and related matters | $ 91,000,000 | ||||||||||
Number of sites associated with remediation and related costs | site | 33 | ||||||||||
Number of sites for which NL not currently able to reasonably estimate range of costs | 5 | ||||||||||
NL | Maximum | Environmental Remediation Sites NL Named As PRP Or Defendant | |||||||||||
Commitments And Contingent Liabilities [Line Items] | |||||||||||
Upper end range, estimate costs for remediation and related matters | $ 118,000,000 | ||||||||||
Lead Pigment Litigation | NL | |||||||||||
Commitments And Contingent Liabilities [Line Items] | |||||||||||
Number of cases settled and dismissed and found not liable | case | 100 | ||||||||||
Period by which loss contingency claims settled and dismissed | 30 years | ||||||||||
C A Lead Paint Litigation | NL | |||||||||||
Commitments And Contingent Liabilities [Line Items] | |||||||||||
Description of defendants | July 24, 2019, an order approving a global settlement agreement entered into among all of the plaintiffs and the three defendants remaining in the case (the Sherwin Williams Company, ConAgra Grocery Products and NL) was entered by the court and the case was dismissed with prejudice. The global settlement agreement provides that an aggregate $305 million will be paid collectively by the three co-defendants in full satisfaction of all claims resulting in a dismissal of the case with prejudice and the resolution of (i) all pending and future claims by the plaintiffs in the case, and (ii) all potential claims for contribution or indemnity between NL and its co-defendants in respect to the case. | ||||||||||
Number of Defendant | defendant | 3 | ||||||||||
Settlement amount | $ 305,000,000 | ||||||||||
Litigation settlement | 101,700,000 | ||||||||||
Litigation settlement charge upon approval of settlement terms | 25,000,000 | ||||||||||
Remaining litigation settlement charge | $ 76,700,000 | $ 101,700,000 | |||||||||
Number of annual installment payments | installment | 6 | ||||||||||
Litigation payment | $ 12,000,000 | $ 12,000,000 | $ 12,000,000 | $ 12,000,000 | |||||||
Remaining litigation settlement charge due in first installment | $ 12,000,000 | ||||||||||
Remaining litigation settlement charge due in second installment | 12,000,000 | ||||||||||
Remaining litigation settlement charge due in third installment | 12,000,000 | ||||||||||
Remaining litigation settlement charge due in fourth installment | 12,000,000 | ||||||||||
Remaining litigation settlement charge due in fifth installment | 12,000,000 | ||||||||||
Remaining litigation settlement charge due in sixth installment | $ 16,700,000 | ||||||||||
Litigation settlement net present value | $ 96,300,000 | ||||||||||
Discounted rate for estimated present value of remaining litigation amount | 1.90% | ||||||||||
Litigation settlement accrual payments | $ 25,000,000 | ||||||||||
Accretion expense | $ 700,000 | $ 900,000 | $ 1,100,000 | ||||||||
C A Lead Paint Litigation | NL | Other Assets | |||||||||||
Commitments And Contingent Liabilities [Line Items] | |||||||||||
Escrow deposit | $ 9,000,000 |
Commitments and contingencies_2
Commitments and contingencies - Changes in Accrued Environmental Remediation and Related Costs (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Environmental Remediation Obligations [Abstract] | |||
Balance at the beginning of the period | $ 97.3 | $ 97.6 | $ 98.6 |
Additions charged to expense, net | 2.5 | 1.7 | 1.6 |
Payments, net | (2.9) | (2) | (2.5) |
Changes in currency exchange rates and other | (0.1) | ||
Balance at the end of the period | 96.9 | 97.3 | 97.6 |
Amounts recognized in the Consolidated Balance Sheet at the end of the year: | |||
Current liabilities | 3.7 | 3.8 | 3.5 |
Noncurrent liabilities | $ 93.2 | $ 93.5 | $ 94.1 |
Environmental Loss Contingency, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other Liabilities Noncurrent | Other Liabilities Noncurrent | Other Liabilities Noncurrent |
Total | $ 96.9 | $ 97.3 | $ 97.6 |
Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration] | Accrued Liabilities, Current, Other Liabilities Noncurrent | Accrued Liabilities, Current, Other Liabilities Noncurrent | Accrued Liabilities, Current, Other Liabilities Noncurrent |
Commitments and contingencies_3
Commitments and contingencies - Other Litigation and Other Matters - Additional Information (Detail) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 USD ($) customer | Dec. 31, 2022 | Dec. 31, 2021 | Jan. 01, 2024 USD ($) | |
Component Products Segment | Customer Concentration Risk | Top Ten Customers | Net Sales | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 52% | 51% | ||
Component Products [Member] | Customer Concentration Risk | One customer | Net Sales | Security Products Reporting Unit | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 24% | 14% | 16% | |
Component Products [Member] | Customer Concentration Risk | One customer | Net Sales | Security Products Reporting Unit | Pilot project | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 11% | |||
Component Products [Member] | Customer Concentration Risk | One customer | Net Sales | Marine Components Reporting Unit | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 12% | |||
TiO2 | Chemicals | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Number of customers | customer | 3,000 | |||
TiO2 | Chemicals | Product Concentration Risk [Member] | Net Sales | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 90% | 92% | 92% | |
TiO2 | Chemicals | Customer Concentration Risk | Top Ten Customers | Net Sales | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 35% | 33% | 32% | |
TiO2 | Chemicals | Customer Concentration Risk | One customer | Net Sales | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 12% | 10% | ||
TiO2 | Chemicals | Geographic Concentration Risk | Europe | Net Sales | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 44% | 45% | 46% | |
TiO2 | Chemicals | Geographic Concentration Risk | North America | Net Sales | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 41% | 39% | 37% | |
Feedstock Ore | Chemicals | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Minimum purchase commitments | $ 583,000 | |||
Purchase obligation due in next fiscal year | $ 465 | |||
Other Supply And Service Contracts | Chemicals | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Minimum purchase commitments | $ 72 | |||
Purchase obligation due in next fiscal year | $ 38 | |||
Land Sales [Member] | Real Estate Management And Development [Member] | Customer Concentration Risk | One customer | Net Sales | Minimum [Member] | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 10% | 10% | 10% | |
Land Sales [Member] | Real Estate Management And Development [Member] | Customer Concentration Risk | Second Customer | Net Sales | Minimum [Member] | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 10% | 10% | ||
Land Sales [Member] | Real Estate Management And Development [Member] | Customer Concentration Risk | Third Customer | Net Sales | Minimum [Member] | ||||
Commitments And Contingent Liabilities [Line Items] | ||||
Concentration risk percentage | 10% |
Financial instruments - Financi
Financial instruments - Financial Instruments not Carried at Fair Value (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Reported Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Cash, cash equivalents and restricted cash equivalents | $ 462 | $ 562 |
Estimate of Fair Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Cash, cash equivalents and restricted cash equivalents | 462 | 562 |
Kronos Worldwide, Inc. | 3.75% Senior Secured Notes due September 15, 2025 | Kronos International, Inc | Reported Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Long term debt, carrying amount | 440.9 | 424.1 |
Kronos Worldwide, Inc. | 3.75% Senior Secured Notes due September 15, 2025 | Kronos International, Inc | Estimate of Fair Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Long term debt, fair value | 424.5 | 374.2 |
VALHI, INC. | Contran Credit Facility | Reported Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Long term debt, carrying amount | 93.4 | 121.4 |
VALHI, INC. | Contran Credit Facility | Estimate of Fair Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Long term debt, fair value | 93.4 | 121.4 |
LandWell | Bank note payable | Reported Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Long term debt, carrying amount | 12.2 | 12.9 |
LandWell | Bank note payable | Estimate of Fair Value Measurement [Member] | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Long term debt, fair value | $ 12.2 | $ 12.9 |
Financial instruments - Additio
Financial instruments - Additional Information (Detail) - Kronos Worldwide, Inc. - 3.75% Senior Secured Notes due September 15, 2025 - Kronos International, Inc - EUR (€) | Dec. 31, 2023 | Sep. 13, 2017 |
Financial Instrument At Fair Value [Line Items] | ||
Estimated market price of the notes | € 959 | |
Principal amount of debt instrument | € 1,000 | |
Interest rate | 3.75% | 3.75% |
Restructuring costs (Details)
Restructuring costs (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2023 USD ($) individual | |
Restructuring Cost and Reserve [Line Items] | |
Number of individuals impacted from workforce reductions | individual | 100 |
Workforce reduction | |
Restructuring Cost and Reserve [Line Items] | |
Workforce reduction costs accrued | $ 5.8 |
Workforce reduction costs paid | (0.9) |
Currency translation adjustments, net | 0.1 |
Accrued workforce reduction costs, end of period | 5 |
Workforce reduction | Current Liability | |
Restructuring Cost and Reserve [Line Items] | |
Accrued workforce reduction costs, end of period | 5 |
Selling, General and Administrative Expenses [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Workforce reduction costs accrued | $ 6 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure | |||
Net Income (Loss) | $ (12.1) | $ 90.2 | $ 127.2 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |